data_1cqu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cqu _Structure_validation_residue.Date_analyzed 2017-03-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.509 ' CE ' ' HB2' ' A' ' 27' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.58 ' CB ' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -49.66 151.25 1.75 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.622 HG23 ' CZ ' ' A' ' 31' ' ' PHE 0.26 3.9 t -133.0 130.94 58.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 117.195 -1.802 . . . . 0.0 114.816 -175.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.61 ' CG2' ' O ' ' A' ' 4' ' ' ILE 0.286 0.2 OUTLIER -96.87 89.99 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.784 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.6 ' O ' ' N ' ' A' ' 16' ' ' GLY . 10.7 m-85 -64.76 124.6 22.37 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 116.785 -1.966 . . . . 0.0 106.977 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.5 HD21 ' CA ' ' A' ' 36' ' ' ALA . 0.7 OUTLIER -78.67 -24.77 44.92 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.688 -179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' CD ' HD11 ' A' ' 6' ' ' LEU . 1.7 mttm -133.09 166.34 22.65 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.268 0.556 . . . . 0.0 109.646 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.403 ' OD2' ' O ' ' A' ' 13' ' ' GLY . 10.5 t70 -74.14 166.24 23.76 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.388 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.56 HG21 ' CE2' ' A' ' 5' ' ' PHE . 2.5 t -123.24 -142.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 109.249 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.407 ' H ' ' CG1' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -71.96 56.58 0.31 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.851 -1.155 . . . . 0.0 109.861 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.62 21.89 77.85 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.39 -66.49 1.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -1.121 . . . . 0.0 110.174 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.52 ' HA2' ' OE2' ' A' ' 17' ' ' GLU . . . -70.63 167.65 50.17 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.522 ' N ' ' OE2' ' A' ' 17' ' ' GLU . 13.5 mtmt -142.45 151.94 42.25 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.247 -1.149 . . . . 0.0 109.414 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.624 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -32.85 137.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.757 -0.589 . . . . 0.0 110.869 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 19.94 45.8 0.01 OUTLIER Glycine 0 N--CA 1.51 3.622 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -90.42 128.9 36.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.534 -1.568 . . . . 0.0 108.9 178.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.608 ' CG1' ' CD1' ' A' ' 4' ' ' ILE . 1.9 mp -95.11 117.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 122.595 1.188 . . . . 0.0 110.844 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.52 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -160.64 153.74 21.57 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.419 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 1.1 p-10 -88.02 125.39 34.52 Favored 'General case' 0 C--N 1.273 -2.723 0 C-N-CA 116.986 -1.886 . . . . 0.0 109.36 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.666 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.327 4.0 p -86.94 -143.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 103.621 -2.733 . . . . 0.0 103.621 178.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.674 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -74.38 112.61 10.72 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 104.195 -2.521 . . . . 0.0 104.195 174.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -31.61 -31.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.994 -0.441 . . . . 0.0 111.748 -176.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -99.52 -36.39 4.34 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.82 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.295 0.1 OUTLIER -48.6 -55.91 9.89 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.105 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.669 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -29.78 -61.52 0.15 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.362 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.618 ' HA ' ' CD2' ' A' ' 31' ' ' PHE . 28.2 t30 -86.26 -10.26 54.92 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -102.17 11.66 37.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.281 -1.512 . . . . 0.0 111.661 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.82 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.96 -52.68 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.838 -1.164 . . . . 0.0 111.503 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.667 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 13.4 mt -77.65 -34.1 53.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.725 -1.234 . . . . 0.0 110.033 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.713 ' CE2' ' HA ' ' A' ' 38' ' ' GLU 0.277 6.9 m-30 -85.57 -49.16 8.25 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.765 -178.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.55 7.21 1.5 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 111.618 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 73.2 mm-40 -133.22 -93.2 0.34 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.816 -1.178 . . . . 0.0 110.899 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -172.11 42.2 0.17 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.667 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 3.1 mp -113.65 -44.38 3.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -1.167 . . . . 0.0 109.287 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.545 ' CB ' ' HA ' ' A' ' 5' ' ' PHE . . . -149.82 -178.58 6.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.909 0.861 . . . . 0.0 112.06 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.529 ' C ' ' CE1' ' A' ' 31' ' ' PHE . 14.3 pt -138.35 156.13 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.713 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 20.7 pt-20 -56.17 108.73 0.5 Allowed 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.571 -0.706 . . . . 0.0 109.948 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.58 ' HB2' ' CB ' ' A' ' 2' ' ' LYS . . . -49.88 113.67 0.9 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.116 -1.434 . . . . 0.0 109.506 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.564 ' OG1' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -143.89 148.15 41.24 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.369 -0.832 . . . . 0.0 109.852 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.564 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 44.9 Cg_endo -49.15 -51.88 9.8 Favored 'Trans proline' 0 C--N 1.298 -2.108 0 O-C-N 123.815 1.429 . . . . 0.0 108.907 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.05 -42.12 0.4 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.68 -0.637 . . . . 0.0 110.641 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 44' ' ' LEU . 4.4 m-20 -102.32 -50.95 3.47 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.129 -0.982 . . . . 0.0 111.596 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 40' ' ' THR . 42.6 mt -37.92 -46.7 0.99 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.409 -0.807 . . . . 0.0 110.181 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -53.64 -61.54 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 109.58 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 50' ' ' GLN . . . -43.49 -44.06 5.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 110.423 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.583 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -50.08 -35.75 26.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.115 -0.991 . . . . 0.0 110.044 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.455 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 43.7 tp10 -88.52 -49.75 6.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 108.932 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 52' ' ' GLN . . . -53.52 -42.21 67.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.395 -0.816 . . . . 0.0 108.97 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 23.4 mm100 -55.07 -21.31 12.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.21 -0.931 . . . . 0.0 109.191 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 47' ' ' LEU . 8.8 mmmt -91.02 9.29 31.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.714 . . . . 0.0 111.075 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -82.12 136.77 35.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.073 -1.017 . . . . 0.0 110.287 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.42 ' C ' ' HG2' ' A' ' 54' ' ' GLU . 8.2 mttt -131.66 -100.58 0.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.348 -0.845 . . . . 0.0 110.549 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.439 ' C ' ' HG3' ' A' ' 55' ' ' GLN . 2.5 mm-40 -131.25 88.13 2.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.871 -1.143 . . . . 0.0 110.139 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.439 ' HG3' ' C ' ' A' ' 54' ' ' GLU . 18.7 mt-30 -139.16 21.71 2.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.589 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 . . . . . 0 C--N 1.304 -1.382 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.394 -179.342 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.535 ' CB ' ' O ' ' A' ' 23' ' ' ASP . 4.8 tpt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.555 ' CB ' ' HB2' ' A' ' 39' ' ' ALA . 25.0 mttt -49.23 152.12 1.26 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.624 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.274 3.9 t -133.68 133.89 56.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 119.933 -1.729 . . . . 0.0 115.02 -174.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.612 ' CG2' ' O ' ' A' ' 4' ' ' ILE 0.272 0.1 OUTLIER -100.51 87.95 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.294 177.657 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.6 ' O ' ' CA ' ' A' ' 16' ' ' GLY . 11.9 m-85 -60.92 123.0 16.3 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 119.667 -1.896 . . . . 0.0 106.417 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 35' ' ' LEU . 1.2 pp -78.71 -25.24 44.67 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.371 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.448 ' HG3' HD11 ' A' ' 6' ' ' LEU . 24.1 mttm -124.7 171.45 10.07 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.232 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -88.15 139.89 30.04 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.598 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.531 HG23 ' CE2' ' A' ' 5' ' ' PHE . 1.5 t -97.32 -155.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 109.83 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -82.56 71.24 9.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.031 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.16 18.01 68.68 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.38 -31.79 6.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -1.165 . . . . 0.0 110.613 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.541 ' CA ' ' OE2' ' A' ' 17' ' ' GLU . . . -139.25 173.25 22.82 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -142.98 -179.74 6.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.157 -1.202 . . . . 0.0 110.308 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.598 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -48.14 135.0 13.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.42 -0.8 . . . . 0.0 111.703 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.6 ' CA ' ' O ' ' A' ' 5' ' ' PHE . . . 28.32 37.91 0.01 OUTLIER Glycine 0 N--CA 1.504 3.219 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -67.76 124.87 24.51 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.577 -1.543 . . . . 0.0 108.988 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.574 ' CG2' HG12 ' A' ' 4' ' ' ILE . 1.4 mp -110.65 120.66 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 122.295 1.045 . . . . 0.0 111.694 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.547 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 17.8 tttt -161.83 -125.88 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.452 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 15.6 p-10 -151.88 119.17 5.95 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.679 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.302 3.3 p -86.78 -147.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 178.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.681 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -71.76 110.0 6.02 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 103.832 -2.655 . . . . 0.0 103.832 174.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 1' ' ' MET . 3.4 m-20 -31.36 -31.63 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.832 -0.543 . . . . 0.0 111.393 -176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -95.6 -38.66 4.64 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.83 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.277 0.1 OUTLIER -48.54 -55.4 11.18 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 177.264 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.649 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -30.43 -63.02 0.15 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.73 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 16.0 p30 -89.48 28.54 1.26 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.436 -0.79 . . . . 0.0 111.57 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -135.84 2.51 2.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.89 -1.131 . . . . 0.0 110.604 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.83 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -161.32 -47.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.238 -0.914 . . . . 0.0 110.093 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.685 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 12.5 mt -82.11 -35.09 28.93 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.8 -1.187 . . . . 0.0 110.062 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.649 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.265 9.4 m-30 -83.43 -65.68 0.98 Allowed 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.467 -179.301 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -52.44 -16.46 0.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.863 . . . . 0.0 111.574 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.538 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 21.8 mt-30 -107.94 -100.87 0.36 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.856 -1.153 . . . . 0.0 110.684 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.87 38.28 0.24 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.167 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.661 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 3.6 mp -106.74 -43.87 4.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.984 -1.303 . . . . 0.0 109.383 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.577 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . -144.54 -179.86 6.83 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.876 0.846 . . . . 0.0 111.922 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -141.46 151.1 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.601 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 2.8 tt0 -43.03 111.47 0.27 Allowed 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.448 -0.782 . . . . 0.0 110.15 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.555 ' HB2' ' CB ' ' A' ' 2' ' ' LYS . . . -54.39 95.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.014 -1.475 . . . . 0.0 110.113 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.567 ' OG1' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -109.6 155.58 41.11 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 121.1 -1.0 . . . . 0.0 110.243 179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.567 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 41.1 Cg_endo -50.07 -55.12 4.42 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.824 1.434 . . . . 0.0 109.292 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.17 -50.27 0.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.536 -0.727 . . . . 0.0 110.113 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.9 m120 -79.29 -59.2 2.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.719 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.529 ' HG ' ' CG2' ' A' ' 18' ' ' ILE . 10.6 mp -47.88 -24.33 0.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.295 -0.878 . . . . 0.0 110.178 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.37 -39.65 53.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.273 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 49' ' ' ALA . . . -72.48 -46.33 55.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.511 -0.743 . . . . 0.0 110.042 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' CG ' HD12 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -41.29 -50.62 3.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 110.529 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -41.99 -43.03 3.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.739 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -57.03 -53.71 54.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.992 . . . . 0.0 111.065 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -43.4 -51.0 6.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.043 -1.036 . . . . 0.0 110.558 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -41.08 89.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.223 -0.923 . . . . 0.0 110.97 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -48.96 -42.67 38.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.322 -0.861 . . . . 0.0 110.519 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -56.36 129.33 40.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.228 -0.92 . . . . 0.0 110.515 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.23 -83.8 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 109.734 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.98 24.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 109.97 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.237 -179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.561 ' HE1' ' CE2' ' A' ' 31' ' ' PHE . 4.8 ttt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.6 0.238 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.547 ' CA ' ' O ' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -49.45 156.7 0.59 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.63 HG21 ' CZ ' ' A' ' 31' ' ' PHE 0.272 2.9 t -132.13 133.72 60.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 119.973 -1.704 . . . . 0.0 114.462 -176.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.604 HG12 ' CG2' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -101.58 95.28 3.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 16' ' ' GLY . 9.9 m-85 -64.9 128.14 34.51 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 116.439 -2.104 . . . . 0.0 105.82 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 35' ' ' LEU . 1.2 pp -78.83 -28.39 44.4 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -133.33 172.89 12.08 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.714 0.769 . . . . 0.0 109.898 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.52 166.03 23.05 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.656 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.514 HG21 ' HA3' ' A' ' 13' ' ' GLY . 2.5 t -116.12 -146.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.301 -0.875 . . . . 0.0 108.913 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.404 ' H ' ' CG1' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -70.96 56.26 0.19 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.571 -1.331 . . . . 0.0 110.017 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 78.18 18.22 76.82 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.3 -70.67 0.77 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.135 -1.215 . . . . 0.0 110.504 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.514 ' HA3' HG21 ' A' ' 9' ' ' VAL . . . -57.8 -179.57 0.87 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.518 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 3.3 mtmt -150.7 169.27 22.03 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.322 -1.105 . . . . 0.0 108.699 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.636 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -67.34 137.85 56.33 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.962 -1.086 . . . . 0.0 110.32 -178.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 39.09 26.92 0.06 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -70.28 122.69 20.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.418 -1.637 . . . . 0.0 108.571 179.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.604 ' CG2' HG12 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -111.75 122.72 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.287 1.042 . . . . 0.0 112.283 -177.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.547 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 16.0 tptp -161.68 -124.27 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.506 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 50.0 p-10 -151.96 120.6 6.49 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 122.511 1.148 . . . . 0.0 108.503 175.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.679 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.299 5.0 p -86.36 -140.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.673 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -77.91 110.62 12.98 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 174.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 22' ' ' ALA . 32.5 t0 -29.46 -34.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.303 0.573 . . . . 0.0 111.53 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -96.01 -37.61 4.86 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.824 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.299 0.0 OUTLIER -48.27 -55.26 11.02 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.425 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.69 ' O ' ' CG ' ' A' ' 31' ' ' PHE 0.251 . . -28.75 -58.26 0.13 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.393 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.554 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 10.6 p30 -85.64 -0.48 55.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.031 -1.043 . . . . 0.0 113.587 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 25' ' ' TYR . 7.3 t30 -112.94 2.55 15.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.185 -1.572 . . . . 0.0 112.048 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -151.61 -46.86 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.769 -1.207 . . . . 0.0 110.499 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.793 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 14.0 mt -82.78 -38.2 23.5 Favored 'General case' 0 C--N 1.284 -2.269 0 O-C-N 120.359 -1.463 . . . . 0.0 110.375 -177.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.69 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.273 8.5 m-30 -82.34 -53.74 5.78 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.844 -179.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.45 -2.04 7.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 0.0 112.289 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.58 ' HG2' ' CD1' ' A' ' 35' ' ' LEU . 1.1 tt0 -130.98 -10.82 3.8 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.513 -1.367 . . . . 0.0 110.715 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.461 ' O ' ' CD2' ' A' ' 6' ' ' LEU . . . 102.1 19.46 14.67 Favored Glycine 0 N--CA 1.498 2.802 0 C-N-CA 119.543 -1.313 . . . . 0.0 114.918 177.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.793 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 4.7 mp -86.89 -40.74 14.58 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-N 120.837 2.318 . . . . 0.0 107.707 176.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.567 ' CB ' ' HA ' ' A' ' 5' ' ' PHE 0.257 . . -144.58 -174.49 4.34 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.477 -178.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.562 ' C ' ' CE1' ' A' ' 31' ' ' PHE . 1.8 pt -141.8 155.38 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.584 0.706 . . . . 0.0 109.195 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.682 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -51.04 108.83 0.27 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.432 -0.793 . . . . 0.0 110.059 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.534 ' HB2' ' CB ' ' A' ' 2' ' ' LYS . . . -49.33 100.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.091 -1.444 . . . . 0.0 109.771 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.537 ' OG1' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -110.22 150.59 41.74 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.067 -1.021 . . . . 0.0 110.067 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.537 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 42.2 Cg_endo -49.58 -52.26 9.17 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 124.058 1.557 . . . . 0.0 108.959 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.18 -50.11 0.95 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.637 -0.665 . . . . 0.0 110.54 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.463 ' HB2' HG23 ' A' ' 40' ' ' THR . 1.0 OUTLIER -81.92 -54.24 5.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 110.221 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.487 HD12 HG21 ' A' ' 18' ' ' ILE . 2.8 mm? -39.95 -44.64 1.73 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.499 -0.751 . . . . 0.0 109.993 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt -63.74 -46.41 85.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -0.998 . . . . 0.0 108.749 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 43' ' ' ASN . . . -57.88 -49.89 75.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.601 -0.687 . . . . 0.0 109.413 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' A' ' 51' ' ' LYS . 3.4 mm? -52.47 -37.38 56.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.515 -0.741 . . . . 0.0 109.145 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -69.68 -44.96 69.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.597 -0.689 . . . . 0.0 110.497 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.57 -58.75 3.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.13 -0.981 . . . . 0.0 110.418 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.14 -36.3 18.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.062 -1.024 . . . . 0.0 110.054 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -66.15 -51.26 59.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.253 -0.905 . . . . 0.0 110.312 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -48.32 104.19 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.881 -1.137 . . . . 0.0 109.838 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.8 41.1 0.89 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 110.165 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.27 107.66 4.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.452 -0.78 . . . . 0.0 109.74 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.43 28.28 4.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.392 -0.817 . . . . 0.0 108.91 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.338 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 23' ' ' ASP . 7.1 tpt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.58 ' HB3' ' CB ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -49.91 147.72 3.67 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.637 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.303 2.8 t -134.63 135.37 53.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -174.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.584 HG12 ' CG1' ' A' ' 18' ' ' ILE 0.271 0.1 OUTLIER -104.03 99.92 9.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.195 177.699 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.588 ' O ' ' N ' ' A' ' 16' ' ' GLY . 8.9 m-85 -72.66 129.18 37.66 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 117.782 -1.567 . . . . 0.0 107.605 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.645 ' CD1' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -77.66 -30.39 52.07 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.162 -1.586 . . . . 0.0 107.295 179.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -112.37 -177.19 3.1 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.824 0.821 . . . . 0.0 111.039 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 15.1 p-10 -109.41 139.58 44.2 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.479 0.657 . . . . 0.0 110.804 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 13' ' ' GLY . 2.1 t -99.24 170.47 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.564 -0.71 . . . . 0.0 109.158 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -74.35 83.34 1.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 110.216 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.89 35.58 54.03 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.486 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -137.74 -41.69 0.54 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -1.152 . . . . 0.0 110.435 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -154.53 161.8 30.36 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 17' ' ' GLU . 12.6 pttt -132.33 175.41 9.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -1.141 . . . . 0.0 110.595 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.583 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -41.5 136.11 1.89 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.313 -0.867 . . . . 0.0 111.92 -179.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 29.91 35.11 0.01 OUTLIER Glycine 0 N--CA 1.507 3.409 0 O-C-N 121.963 -0.46 . . . . 0.0 112.131 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.55 ' CB ' ' HG2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -72.97 123.66 23.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.331 -1.688 . . . . 0.0 108.635 178.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.584 ' CG1' HG12 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -107.29 123.43 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.142 0.973 . . . . 0.0 111.029 -178.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 7.9 ttpt -161.17 -127.53 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 9.0 p30 -152.11 120.24 6.27 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.347 1.07 . . . . 0.0 108.314 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.695 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.303 1.4 p -87.48 -146.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 178.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.673 ' CB ' ' HB3' ' A' ' 25' ' ' TYR . . . -72.09 108.7 5.43 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 1' ' ' MET . 1.9 m-20 -30.65 -32.28 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.121 0.486 . . . . 0.0 111.602 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -94.45 -38.85 4.9 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.829 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.299 0.1 OUTLIER -48.61 -57.08 6.76 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.543 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.639 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -29.39 -60.23 0.15 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.007 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.586 ' HA ' ' CD2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -89.58 11.69 18.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.992 -1.068 . . . . 0.0 112.786 -179.018 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.0 10.88 8.87 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.522 -1.361 . . . . 0.0 110.616 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.829 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.65 -52.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.144 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.727 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 19.1 mt -75.67 -39.94 56.78 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.735 -1.228 . . . . 0.0 109.94 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.665 ' CE2' ' HA ' ' A' ' 38' ' ' GLU 0.281 8.5 m-30 -81.74 -44.6 16.82 Favored 'General case' 0 C--N 1.272 -2.786 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.88 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -68.29 -5.22 17.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.461 -0.774 . . . . 0.0 111.147 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.563 ' HB2' ' CD1' ' A' ' 35' ' ' LEU . 23.2 mm100 -129.64 -14.96 4.04 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.778 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.69 18.53 20.44 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.414 -1.374 . . . . 0.0 111.675 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.727 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 5.3 mp -79.72 -43.24 23.01 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' CA ' HD21 ' A' ' 6' ' ' LEU . . . -142.08 -176.69 4.9 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.157 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.469 ' O ' ' C ' ' A' ' 38' ' ' GLU . 10.6 mt -141.99 136.67 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.468 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.665 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 9.7 pt-20 -38.65 113.83 0.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.613 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.58 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . . . -48.58 99.24 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 117.804 -1.558 . . . . 0.0 110.057 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.569 ' OG1' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -112.71 153.51 45.04 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.537 -0.727 . . . . 0.0 109.692 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.569 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 40.1 Cg_endo -50.79 -60.83 0.68 Allowed 'Trans proline' 0 C--N 1.299 -2.031 0 O-C-N 123.971 1.511 . . . . 0.0 110.149 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.79 -54.13 0.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.486 -0.759 . . . . 0.0 111.814 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.452 ' O ' HD22 ' A' ' 47' ' ' LEU . 1.5 m-20 -79.21 -34.7 42.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.956 -1.09 . . . . 0.0 111.193 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.461 HD11 HG13 ' A' ' 4' ' ' ILE . 5.3 mp -66.59 -66.58 0.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 44' ' ' LEU . 1.7 ttpt -41.53 -48.93 4.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 110.094 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.89 -46.86 88.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.86 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.513 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -47.58 -53.02 15.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.337 -0.852 . . . . 0.0 110.004 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.464 ' OE1' ' HB2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -57.88 -37.93 74.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.416 -0.803 . . . . 0.0 110.565 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.35 -49.57 76.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.149 -0.969 . . . . 0.0 109.977 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -31.71 71.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 110.115 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -82.58 -25.45 33.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.0 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.464 ' HB2' ' OE1' ' A' ' 48' ' ' GLU . 4.3 tp60 -73.01 -78.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.195 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HG2' ' OE1' ' A' ' 55' ' ' GLN . 8.3 tptt -58.16 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.377 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 114.64 1.71 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 110.171 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.408 ' OE1' ' HG2' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -139.18 16.16 2.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 108.991 179.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? . . . . . 0 C--N 1.304 -1.375 0 CA-C-O 117.825 -1.083 . . . . 0.0 110.054 -179.468 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.531 ' CE ' ' HB3' ' A' ' 27' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.778 0.323 . . . . 0.0 110.43 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.612 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 30.4 mttt -59.45 149.71 28.75 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.644 HG23 ' CZ ' ' A' ' 31' ' ' PHE 0.27 2.8 t -129.51 131.77 66.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.295 -1.503 . . . . 0.0 114.74 -175.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.59 HG12 ' CG2' ' A' ' 18' ' ' ILE 0.254 0.0 OUTLIER -99.58 98.4 7.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.534 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.866 ' CD1' ' HA3' ' A' ' 13' ' ' GLY . 8.6 m-85 -75.65 124.23 26.89 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.106 -1.621 . . . . 0.0 107.854 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.557 ' CD1' HG21 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -83.03 -27.31 30.43 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 120.656 -1.277 . . . . 0.0 112.144 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -95.72 -152.52 0.37 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.776 ' C ' ' O ' ' A' ' 13' ' ' GLY . 37.7 p-10 -99.02 133.71 42.89 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.465 -0.772 . . . . 0.0 109.543 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.751 ' HA ' ' N ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -88.1 2.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.72 70.12 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 101.75 9.13 44.09 Favored Glycine 0 CA--C 1.549 2.208 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 10.5 mttm -151.15 -87.06 0.07 Allowed 'General case' 0 N--CA 1.511 2.604 0 O-C-N 120.47 -1.606 . . . . 0.0 113.487 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.866 ' HA3' ' CD1' ' A' ' 5' ' ' PHE . . . -156.22 144.67 11.1 Favored Glycine 0 N--CA 1.505 3.292 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.566 ' N ' ' HB ' ' A' ' 9' ' ' VAL . 2.3 mtmt -88.68 145.75 25.47 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 119.895 1.848 . . . . 0.0 111.011 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.618 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -28.7 121.32 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.867 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 20.51 46.3 0.01 OUTLIER Glycine 0 N--CA 1.512 3.74 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -80.04 121.85 26.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.665 -1.491 . . . . 0.0 109.646 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.59 ' CG2' HG12 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -104.53 123.07 58.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-O 122.482 1.134 . . . . 0.0 111.661 -178.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.551 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -161.54 -127.87 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -152.17 120.67 6.42 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 122.37 1.081 . . . . 0.0 108.863 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.676 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.29 2.5 p -87.55 -149.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.678 ' CB ' ' HB3' ' A' ' 25' ' ' TYR . . . -70.5 109.84 5.05 Favored 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 1' ' ' MET . 2.1 m-20 -30.59 -31.53 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.046 0.451 . . . . 0.0 111.677 -176.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -98.65 -35.68 4.82 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.777 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.274 0.1 OUTLIER -48.83 -53.51 19.02 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.613 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.642 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -30.32 -57.99 0.19 Allowed 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.177 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 12.5 p30 -90.15 5.82 45.27 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.958 -1.089 . . . . 0.0 112.054 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 25' ' ' TYR . 4.9 t-20 -108.95 -0.15 19.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.102 . . . . 0.0 111.23 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.777 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.56 -52.88 0.05 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.885 -1.135 . . . . 0.0 111.132 -178.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.733 ' HG ' ' CE1' ' A' ' 25' ' ' TYR . 20.9 mt -71.39 -44.91 64.07 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 122.269 1.033 . . . . 0.0 110.71 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.644 ' CZ ' HG23 ' A' ' 3' ' ' VAL 0.277 7.2 m-30 -78.62 -42.74 28.06 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.573 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 31.0 tptt -69.95 0.28 6.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.468 -0.77 . . . . 0.0 111.446 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.559 ' HB2' ' CD1' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -132.58 -14.4 2.86 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.795 -1.19 . . . . 0.0 111.349 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.498 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 100.82 18.62 19.87 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.149 -1.5 . . . . 0.0 111.005 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.709 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 4.6 mp -80.83 -49.77 10.65 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.665 -1.491 . . . . 0.0 107.734 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.615 ' HB2' ' CD1' ' A' ' 5' ' ' PHE 0.262 . . -139.23 -177.06 4.74 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.015 -178.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.537 HG12 HG21 ' A' ' 4' ' ' ILE . 5.8 pt -139.37 161.72 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.574 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 6.4 tt0 -55.11 105.06 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.249 -0.907 . . . . 0.0 109.162 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.612 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -54.17 89.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 118.323 -1.351 . . . . 0.0 110.355 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.59 ' OG1' ' CD ' ' A' ' 41' ' ' PRO . 0.9 OUTLIER -115.16 156.46 45.42 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.153 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' OG1' ' A' ' 40' ' ' THR . 50.2 Cg_endo -49.79 -61.27 0.6 Allowed 'Trans proline' 0 C--N 1.3 -2.003 0 O-C-N 124.155 1.608 . . . . 0.0 110.496 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.1 -35.13 0.07 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.689 -0.632 . . . . 0.0 111.267 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 44' ' ' LEU . 2.9 t-20 -99.31 -51.19 3.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.975 -1.078 . . . . 0.0 110.862 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.547 ' CD1' HG21 ' A' ' 18' ' ' ILE . 1.8 mm? -40.85 -47.47 2.93 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 110.754 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.86 -35.57 75.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 110.757 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -71.38 -39.2 71.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 0.0 110.272 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.528 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -40.52 -45.08 2.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 110.251 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 44.3 tt0 -70.85 -50.64 33.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.149 -0.969 . . . . 0.0 110.551 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.67 67.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.109 -0.994 . . . . 0.0 110.321 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -51.69 -32.22 29.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.854 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -63.77 -38.47 91.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.483 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -59.63 2.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.789 . . . . 0.0 109.334 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -53.45 -72.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.488 -0.757 . . . . 0.0 109.819 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.11 135.21 42.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 109.916 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -148.45 60.08 1.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.485 -179.069 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' CE ' ' HG3' ' A' ' 38' ' ' GLU . 7.6 tpt . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.624 ' CB ' ' HB2' ' A' ' 39' ' ' ALA . 5.8 mtmm -50.57 152.35 1.98 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.635 HG23 ' CZ ' ' A' ' 31' ' ' PHE 0.273 3.7 t -132.37 131.84 60.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 119.836 -1.79 . . . . 0.0 114.972 -175.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.618 ' CG2' ' O ' ' A' ' 4' ' ' ILE 0.25 0.1 OUTLIER -98.99 89.26 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.838 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.615 ' O ' ' N ' ' A' ' 16' ' ' GLY . 11.2 m-85 -65.56 116.18 6.55 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 119.622 -1.924 . . . . 0.0 106.545 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -79.36 -23.46 43.34 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.523 ' N ' ' HG ' ' A' ' 6' ' ' LEU . 20.5 mttt -111.67 -172.4 2.03 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.795 0.807 . . . . 0.0 110.391 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 15.7 p30 -109.06 153.06 24.19 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.969 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.575 HG22 ' CE2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -130.92 -157.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 109.144 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -77.82 75.51 4.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.963 -1.086 . . . . 0.0 110.012 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.58 17.41 13.37 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.9 -40.36 11.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.314 -1.109 . . . . 0.0 109.73 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.475 ' HA2' ' OE1' ' A' ' 17' ' ' GLU . . . -152.11 157.81 27.46 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.448 ' HB2' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -116.18 175.55 5.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -1.083 . . . . 0.0 110.58 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -37.95 134.43 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.583 -0.698 . . . . 0.0 111.19 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 27.14 39.24 0.01 OUTLIER Glycine 0 N--CA 1.507 3.406 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.63 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -74.61 132.01 41.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.669 -1.489 . . . . 0.0 108.94 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.572 HG23 ' CD2' ' A' ' 44' ' ' LEU . 1.2 mp -112.22 123.54 68.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.907 -1.121 . . . . 0.0 111.693 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 5.5 ttmt -160.97 -126.37 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -151.93 119.86 6.2 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.674 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.301 3.6 p -87.23 -143.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 178.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.672 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -73.17 109.98 7.11 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -31.42 -30.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.976 -0.452 . . . . 0.0 111.697 -176.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.84 -37.96 4.28 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.836 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.305 0.1 OUTLIER -48.04 -56.92 6.57 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.539 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.661 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -28.69 -60.6 0.12 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.686 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 24.1 t30 -89.3 34.03 0.81 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.02 -1.05 . . . . 0.0 112.44 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -147.56 9.1 0.91 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.437 -1.414 . . . . 0.0 110.613 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.836 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.69 -46.42 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.068 -1.02 . . . . 0.0 109.254 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.672 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 10.9 mt -87.03 -36.14 18.37 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 120.926 -1.109 . . . . 0.0 109.473 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.661 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.277 8.6 m-30 -82.71 -49.0 10.24 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.508 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -70.4 1.24 5.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.267 -0.896 . . . . 0.0 110.605 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -127.97 -114.31 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.944 -1.098 . . . . 0.0 110.781 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 7' ' ' LYS . . . -145.61 14.97 1.8 Allowed Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.779 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.649 ' CD1' ' HA ' ' A' ' 30' ' ' LEU . 1.7 mp -83.93 -51.45 7.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.776 -1.426 . . . . 0.0 109.836 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.555 ' CB ' ' HA ' ' A' ' 5' ' ' PHE . . . -143.72 -179.61 6.56 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.377 1.084 . . . . 0.0 112.99 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.574 HG12 HG22 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -144.48 149.18 17.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.623 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 17.2 tt0 -37.05 108.94 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.882 -0.511 . . . . 0.0 110.97 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.624 ' HB2' ' CB ' ' A' ' 2' ' ' LYS . . . -55.97 97.85 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 118.113 -1.435 . . . . 0.0 110.289 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.561 ' OG1' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -119.09 155.27 53.39 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.112 -0.993 . . . . 0.0 110.577 179.428 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.561 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 39.6 Cg_endo -49.31 -45.26 30.92 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.803 1.423 . . . . 0.0 108.967 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.96 -57.26 0.83 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.282 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 58.5 m-20 -88.31 -46.31 9.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 0.0 110.318 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.572 ' CD2' HG23 ' A' ' 18' ' ' ILE . 2.9 mm? -36.86 -66.58 0.22 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.512 -0.743 . . . . 0.0 110.769 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -55.06 -36.65 65.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.067 -1.02 . . . . 0.0 110.41 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 43' ' ' ASN . . . -66.22 -39.24 89.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.085 -1.01 . . . . 0.0 110.274 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.543 HD23 ' CD1' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -43.55 -50.22 7.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.028 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' LEU . 20.5 tt0 -45.26 -31.62 1.61 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.19 -0.944 . . . . 0.0 109.012 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . -85.2 -48.46 9.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.504 -0.748 . . . . 0.0 109.456 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.404 ' C ' ' OE1' ' A' ' 50' ' ' GLN . 1.2 tm0? -51.51 -38.81 55.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 109.238 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.468 ' HE2' ' HE3' ' A' ' 15' ' ' LYS . 2.4 tppp? -62.53 -52.45 63.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.421 -0.799 . . . . 0.0 109.607 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.52 92.47 9.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 110.146 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.416 ' CE ' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -80.98 72.24 7.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.403 -0.811 . . . . 0.0 109.912 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -116.42 155.19 28.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.335 -0.853 . . . . 0.0 110.574 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -137.28 -31.36 0.82 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.4 -0.812 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.331 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.566 ' CE ' ' HB2' ' A' ' 27' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.577 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 2.2 mttp -49.4 145.79 4.4 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.627 HG23 ' CZ ' ' A' ' 31' ' ' PHE 0.283 2.9 t -136.66 130.24 46.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 118.312 -1.355 . . . . 0.0 114.361 -175.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.586 ' CD1' ' CG1' ' A' ' 18' ' ' ILE 0.262 0.1 OUTLIER -98.81 95.3 4.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.633 178.283 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.602 ' CE2' HG23 ' A' ' 9' ' ' VAL . 11.5 m-85 -66.67 124.41 22.79 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.02 -1.675 . . . . 0.0 106.674 177.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.561 HD23 ' CA ' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -78.52 -24.78 45.58 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.672 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.493 ' HD3' HD12 ' A' ' 6' ' ' LEU . 8.3 mptt -118.65 -163.75 0.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.463 0.649 . . . . 0.0 110.361 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -109.65 153.99 23.45 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.904 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.602 HG23 ' CE2' ' A' ' 5' ' ' PHE . 1.7 t -124.89 -162.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -0.98 . . . . 0.0 109.86 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 11' ' ' GLY . 4.4 mmtt -65.74 83.05 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 0.0 109.799 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' LYS . . . 45.49 26.5 1.65 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -108.54 -67.61 0.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.351 -1.088 . . . . 0.0 110.111 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' C ' ' HG2' ' A' ' 14' ' ' LYS . . . -106.2 162.65 13.86 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.522 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 6.1 mmpt? -128.38 -172.56 2.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.358 -1.084 . . . . 0.0 109.541 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.556 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -53.95 129.62 34.69 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 110.302 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 5' ' ' PHE . . . 32.68 37.22 0.04 OUTLIER Glycine 0 N--CA 1.503 3.105 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -76.49 128.35 34.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.879 -1.365 . . . . 0.0 109.48 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.586 ' CG1' ' CD1' ' A' ' 4' ' ' ILE . 1.7 mp -100.51 118.44 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 122.456 1.122 . . . . 0.0 111.258 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 1.5 tttt -161.92 152.05 16.92 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -87.39 123.91 32.84 Favored 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 116.871 -1.932 . . . . 0.0 109.005 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.714 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.328 2.7 p -87.14 -144.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 178.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.675 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -74.28 111.26 9.28 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HA ' ' N ' ' A' ' 1' ' ' MET . 1.1 m-20 -31.51 -31.2 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.965 -0.46 . . . . 0.0 111.906 -176.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -98.05 -36.89 4.55 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.83 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.309 0.1 OUTLIER -48.73 -57.09 6.85 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 176.797 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.648 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -30.14 -63.97 0.13 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.448 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.626 ' HA ' ' CD2' ' A' ' 31' ' ' PHE . 20.3 t30 -85.84 4.62 36.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.521 -0.737 . . . . 0.0 112.814 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -118.19 11.43 13.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.508 -1.37 . . . . 0.0 111.165 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.83 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -161.17 -46.78 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.953 -1.092 . . . . 0.0 110.531 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.679 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 16.8 mt -84.03 -34.17 24.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.67 -1.268 . . . . 0.0 110.014 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.648 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.261 7.2 m-30 -82.64 -58.14 3.03 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.236 -178.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -68.87 -1.11 6.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 111.873 -178.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.511 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 2.4 mt-30 -114.57 -92.89 0.49 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.734 -1.229 . . . . 0.0 110.273 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.86 28.84 0.11 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.552 -1.309 . . . . 0.0 110.067 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.671 ' CD1' ' HA ' ' A' ' 30' ' ' LEU . 2.9 mp -101.44 -50.51 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.091 -1.24 . . . . 0.0 110.54 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.575 ' CB ' ' HA ' ' A' ' 5' ' ' PHE 0.263 . . -144.36 179.09 7.47 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.906 0.86 . . . . 0.0 112.831 -177.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.507 ' C ' ' CZ ' ' A' ' 31' ' ' PHE . 4.9 pt -136.56 162.25 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 175.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.575 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 15.3 tt0 -55.5 118.88 4.86 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.971 -1.081 . . . . 0.0 109.66 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -59.21 83.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 117.877 -1.529 . . . . 0.0 110.073 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.61 ' OG1' ' CD ' ' A' ' 41' ' ' PRO . 0.9 OUTLIER -112.0 162.72 19.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.187 -0.946 . . . . 0.0 109.544 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.61 ' CD ' ' OG1' ' A' ' 40' ' ' THR . 45.4 Cg_endo -48.58 -66.4 0.14 Allowed 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 123.78 1.411 . . . . 0.0 110.615 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.52 -30.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.485 -0.76 . . . . 0.0 110.883 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' PRO . 18.4 m-20 -93.71 -60.65 1.71 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 110.337 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.512 HD12 HG12 ' A' ' 18' ' ' ILE . 2.4 mm? -44.7 -39.02 4.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.05 -1.031 . . . . 0.0 110.029 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 21.8 mttt -72.63 -39.52 67.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 109.25 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.3 -40.41 71.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.027 -1.046 . . . . 0.0 109.214 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.455 ' N ' HD22 ' A' ' 47' ' ' LEU . 3.1 mm? -56.46 -39.3 72.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.698 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 45' ' ' LYS . 12.7 tt0 -59.7 -22.17 61.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.493 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.04 -47.1 30.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.133 -0.98 . . . . 0.0 110.563 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -60.7 -27.78 68.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.514 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -82.06 -46.49 13.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.15 -0.969 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -59.2 110.85 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.06 -1.025 . . . . 0.0 110.302 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.8 119.85 20.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.297 -0.877 . . . . 0.0 110.363 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -123.02 105.0 9.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 110.228 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.83 -41.04 0.17 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.9 . . . . 0.0 108.956 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.597 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.589 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.573 ' CE ' ' HB2' ' A' ' 27' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.717 0.294 . . . . 0.0 110.593 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.567 ' CB ' ' HB2' ' A' ' 39' ' ' ALA . 8.8 mtmt -57.46 149.39 21.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.642 HG21 ' CZ ' ' A' ' 31' ' ' PHE 0.283 2.9 t -135.57 130.78 50.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 117.527 -1.669 . . . . 0.0 114.863 -175.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.563 HG12 ' CG1' ' A' ' 18' ' ' ILE 0.264 0.0 OUTLIER -100.28 98.24 6.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.421 178.324 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.584 ' CE1' HG23 ' A' ' 9' ' ' VAL . 13.5 m-85 -70.15 127.89 34.4 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.052 -1.655 . . . . 0.0 106.923 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.534 HD22 ' CA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -76.5 -29.2 56.71 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 120.538 -1.352 . . . . 0.0 108.207 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.35 165.88 18.2 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.98 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.07 156.57 29.95 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.458 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.584 HG23 ' CE1' ' A' ' 5' ' ' PHE . 1.9 t -111.18 166.27 5.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 109.082 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.24 82.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 0.0 110.327 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 61.41 48.47 84.94 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -142.99 -61.44 0.42 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.079 -1.248 . . . . 0.0 111.252 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.458 ' HA2' ' OE1' ' A' ' 17' ' ' GLU . . . -121.15 162.57 14.85 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -119.36 176.98 5.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -1.119 . . . . 0.0 111.307 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.609 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -45.24 132.33 7.51 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.687 -0.633 . . . . 0.0 112.031 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.562 ' CA ' ' O ' ' A' ' 5' ' ' PHE . . . 33.26 32.61 0.01 OUTLIER Glycine 0 N--CA 1.509 3.548 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.646 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -70.16 125.06 25.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.167 -1.196 . . . . 0.0 109.62 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.563 ' CG1' HG12 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -103.38 115.5 45.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 120.505 -1.372 . . . . 0.0 110.233 -179.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.498 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -161.31 152.99 19.25 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 19.3 p30 -87.51 124.15 33.17 Favored 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 117.216 -1.794 . . . . 0.0 109.807 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.679 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.299 1.3 p -87.25 -150.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.678 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -68.16 107.91 2.94 Favored 'General case' 0 C--N 1.272 -2.763 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 22' ' ' ALA . 88.6 m-20 -30.86 -32.24 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.982 -0.449 . . . . 0.0 111.667 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -96.94 -36.38 5.01 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.775 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.308 0.0 OUTLIER -47.83 -59.14 3.54 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 177.289 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.643 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -29.25 -57.41 0.15 Allowed 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.314 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.573 ' HB2' ' CE ' ' A' ' 1' ' ' MET . 21.2 t30 -80.72 -35.56 33.3 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.883 -1.136 . . . . 0.0 113.263 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -80.58 15.27 1.74 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.519 -1.363 . . . . 0.0 110.717 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.775 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -160.31 -99.58 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.32 -0.863 . . . . 0.0 109.983 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.693 ' HA ' ' CD1' ' A' ' 35' ' ' LEU . 14.2 mt -29.81 -42.48 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.574 0 CA-C-O 122.431 1.11 . . . . 0.0 110.296 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.643 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.264 8.8 m-30 -79.37 -56.44 4.34 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.41 -178.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.29 11.9 6.06 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.953 -1.092 . . . . 0.0 110.693 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.55 ' HB2' ' CD1' ' A' ' 35' ' ' LEU . 1.9 mt-30 -121.08 -19.37 7.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.873 -1.142 . . . . 0.0 111.061 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.04 41.62 2.59 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.947 -1.121 . . . . 0.0 111.594 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.693 ' CD1' ' HA ' ' A' ' 30' ' ' LEU . 1.9 mp -122.16 -46.49 2.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.008 -1.289 . . . . 0.0 109.433 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.579 ' CB ' ' HA ' ' A' ' 5' ' ' PHE 0.264 . . -142.14 177.77 8.0 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.656 0.741 . . . . 0.0 111.222 -178.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.606 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 2.7 pp -135.69 174.51 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.03 111.1 2.38 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.228 -0.92 . . . . 0.0 110.007 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HB2' ' CB ' ' A' ' 2' ' ' LYS . . . -54.4 99.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 118.122 -1.431 . . . . 0.0 110.188 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.59 ' OG1' ' CD ' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -118.37 160.38 39.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 109.647 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' OG1' ' A' ' 40' ' ' THR . 50.1 Cg_endo -50.12 -62.43 0.41 Allowed 'Trans proline' 0 C--N 1.299 -2.048 0 O-C-N 123.846 1.446 . . . . 0.0 110.662 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.09 -40.64 0.22 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.493 -0.754 . . . . 0.0 110.865 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.434 ' ND2' HG23 ' A' ' 40' ' ' THR . 76.1 m-20 -85.86 -57.42 3.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.14 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.551 HD11 ' CG2' ' A' ' 18' ' ' ILE . 3.7 mm? -42.33 -55.08 3.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.865 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.42 -43.03 88.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.12 -0.987 . . . . 0.0 109.365 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 49' ' ' ALA . . . -56.23 -49.81 73.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.656 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.508 ' N ' HD23 ' A' ' 47' ' ' LEU . 2.8 mm? -48.9 -31.85 7.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.349 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 52' ' ' GLN . 4.1 tp10 -72.26 -24.46 61.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.843 . . . . 0.0 110.111 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . -74.84 -59.21 2.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 0.0 109.877 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -45.19 -37.24 4.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 110.657 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 52' ' ' GLN . 0.6 OUTLIER -76.96 -40.38 47.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.224 -0.922 . . . . 0.0 110.63 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 11.0 mt-30 -53.4 -174.35 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.149 -0.969 . . . . 0.0 109.57 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.45 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -127.23 -18.31 4.56 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 111.363 -178.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 53' ' ' LYS . 15.6 tm-20 -104.32 122.51 45.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.883 -1.136 . . . . 0.0 110.887 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.407 ' CD ' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -159.96 22.84 0.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.921 . . . . 0.0 109.953 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.332 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.518 ' N ' ' CG ' ' A' ' 23' ' ' ASP . 3.0 ttt . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 8.1 mttp -54.47 149.3 10.6 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.627 HG21 ' CZ ' ' A' ' 31' ' ' PHE 0.294 3.1 t -133.33 134.78 57.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 117.716 -1.593 . . . . 0.0 115.252 -175.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.602 ' O ' ' CG2' ' A' ' 4' ' ' ILE 0.271 0.1 OUTLIER -98.91 92.39 2.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.888 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.619 ' O ' ' N ' ' A' ' 16' ' ' GLY . 9.3 m-85 -68.22 126.47 29.65 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 116.881 -1.928 . . . . 0.0 106.9 178.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 35' ' ' LEU . 1.3 pp -78.22 -27.91 47.85 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HG3' HD12 ' A' ' 6' ' ' LEU . 9.0 mttm -117.76 -165.75 1.13 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.36 159.78 23.52 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.362 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.66 -154.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 0.0 109.091 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -83.23 64.77 7.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.684 -1.26 . . . . 0.0 110.665 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.85 25.52 45.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -67.8 0.84 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.076 -1.249 . . . . 0.0 110.063 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.04 165.52 34.62 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 67.0 mttt -138.5 173.65 11.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.246 . . . . 0.0 110.282 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -47.1 139.32 5.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.869 . . . . 0.0 111.32 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 25.49 39.44 0.01 OUTLIER Glycine 0 N--CA 1.511 3.672 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -76.34 127.87 33.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.93 -1.335 . . . . 0.0 108.452 179.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.598 ' CG1' HG12 ' A' ' 4' ' ' ILE . 2.9 mp -108.67 120.93 60.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 122.201 1.001 . . . . 0.0 110.687 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 3.0 tttt -160.99 -127.09 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -151.55 120.3 6.56 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-O 122.18 0.991 . . . . 0.0 108.351 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.652 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.29 5.4 p -87.02 -141.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 178.421 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.674 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -74.77 113.39 11.99 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 174.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -31.16 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 120.934 0.397 . . . . 0.0 111.583 -176.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -99.49 -36.58 4.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.867 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.307 0.1 OUTLIER -48.25 -55.28 10.93 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 177.396 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.659 ' O ' ' CG ' ' A' ' 31' ' ' PHE 0.254 . . -29.44 -64.08 0.11 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.25 177.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.592 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 5.5 t30 -89.75 33.54 0.85 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.055 -1.028 . . . . 0.0 112.27 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 25' ' ' TYR . 1.1 m-20 -144.89 8.05 1.25 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.485 -1.385 . . . . 0.0 110.573 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.867 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -160.73 -49.48 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.874 0.845 . . . . 0.0 108.945 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.683 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 12.2 mt -80.85 -34.93 33.42 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 122.629 1.204 . . . . 0.0 109.09 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.659 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.281 7.1 m-30 -88.0 -52.61 5.17 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.448 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -7.76 6.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.621 -0.674 . . . . 0.0 110.75 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 5.3 mt-30 -123.9 -111.16 0.31 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.929 -1.107 . . . . 0.0 110.328 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.39 36.48 0.81 Allowed Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.285 -1.436 . . . . 0.0 110.914 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.668 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 3.0 mp -104.46 -38.64 6.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.832 -1.393 . . . . 0.0 109.403 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.596 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . -153.3 -176.74 5.93 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.132 0.968 . . . . 0.0 112.703 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.567 ' C ' ' CE1' ' A' ' 31' ' ' PHE . 7.9 pt -143.51 160.15 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.345 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.649 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 8.2 tt0 -51.11 110.3 0.42 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.382 -0.824 . . . . 0.0 110.191 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.535 ' HB1' ' CB ' ' A' ' 2' ' ' LYS . . . -51.31 97.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 118.008 -1.477 . . . . 0.0 110.206 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.55 ' OG1' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -109.06 152.34 42.43 Favored Pre-proline 0 N--CA 1.505 2.298 0 O-C-N 121.124 -0.985 . . . . 0.0 110.472 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.55 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 41.6 Cg_endo -49.78 -58.8 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.827 1.435 . . . . 0.0 110.056 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.73 -60.22 0.62 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.415 -0.803 . . . . 0.0 110.816 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.489 ' ND2' ' CG2' ' A' ' 40' ' ' THR . 29.5 m-20 -67.47 -49.68 62.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.267 -0.896 . . . . 0.0 110.557 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.575 ' CD2' HG23 ' A' ' 18' ' ' ILE . 2.2 mm? -45.91 -33.88 3.53 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.41 -0.806 . . . . 0.0 110.094 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -64.63 -51.29 63.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.051 -1.031 . . . . 0.0 109.551 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.39 -46.85 66.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.936 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.593 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -66.63 -51.71 53.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 0.0 109.116 179.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -51.34 -31.7 22.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.588 -0.695 . . . . 0.0 110.256 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.64 -43.87 71.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.046 -1.034 . . . . 0.0 110.041 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -79.79 -18.04 51.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 0.0 109.52 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -90.06 -13.33 36.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.819 . . . . 0.0 110.411 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -57.89 -16.18 11.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.099 -1.001 . . . . 0.0 110.333 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.7 -166.72 1.59 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.075 -1.016 . . . . 0.0 110.069 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.48 -51.01 0.25 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.057 -1.027 . . . . 0.0 110.129 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.15 48.89 0.27 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.947 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.41 ' CD ' ' O ' ' A' ' 56' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.293 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.482 ' CB ' ' O ' ' A' ' 23' ' ' ASP . 6.5 ttt . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.631 ' CB ' ' HB1' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -54.64 156.71 3.36 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.626 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.295 3.2 t -134.05 131.55 55.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 120.161 -1.587 . . . . 0.0 114.918 -175.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.643 ' CG2' ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -95.45 89.6 2.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.67 ' O ' ' N ' ' A' ' 16' ' ' GLY . 7.2 m-85 -65.0 122.34 16.78 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 116.342 -2.143 . . . . 0.0 106.248 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.551 HD22 ' N ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -78.98 -23.11 44.69 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.033 -1.067 . . . . 0.0 108.524 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HD2' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -137.95 170.95 15.16 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.397 0.617 . . . . 0.0 109.509 178.078 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -81.12 168.98 17.99 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.336 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.46 HG22 ' CE1' ' A' ' 5' ' ' PHE . 2.1 t -125.72 -143.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.33 -0.856 . . . . 0.0 109.132 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 11' ' ' GLY . 14.6 mttp -75.2 83.78 2.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.993 -1.067 . . . . 0.0 109.543 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 10' ' ' LYS . . . 44.74 51.77 7.99 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -146.06 -75.71 0.21 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -1.077 . . . . 0.0 111.218 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' HA2' ' OE2' ' A' ' 17' ' ' GLU . . . -62.87 -175.91 2.95 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.445 -0.884 . . . . 0.0 110.932 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.584 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 10.9 mttt -147.26 166.5 26.85 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.641 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -65.71 136.06 55.78 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.842 -1.161 . . . . 0.0 110.72 -178.159 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 34.35 30.58 0.01 OUTLIER Glycine 0 N--CA 1.503 3.11 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -177.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.584 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -72.23 126.11 28.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.842 -1.387 . . . . 0.0 109.789 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.592 ' CG1' ' CD1' ' A' ' 4' ' ' ILE . 2.2 mp -106.38 122.59 60.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.043 0.925 . . . . 0.0 110.577 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.567 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -161.0 -128.96 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 36.6 p-10 -152.39 119.57 5.89 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 122.221 1.01 . . . . 0.0 108.921 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.67 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.3 3.9 p -87.51 -146.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.624 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 177.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.672 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -71.52 109.72 5.66 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 22' ' ' ALA . 3.1 m-20 -32.24 -29.88 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.802 -0.561 . . . . 0.0 111.798 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.25 -38.2 4.36 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.321 -1.911 . . . . 0.0 108.321 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.797 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.298 0.1 OUTLIER -48.44 -54.95 12.24 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 177.219 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.66 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -29.39 -60.39 0.15 Allowed 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.837 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.571 ' HA ' ' CD2' ' A' ' 31' ' ' PHE . 16.7 t30 -90.18 14.77 11.68 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.175 -0.953 . . . . 0.0 112.5 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.94 6.24 10.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.67 -1.269 . . . . 0.0 110.044 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.797 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -161.24 -58.59 0.05 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.99 0.9 . . . . 0.0 110.527 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.71 ' HG ' ' CE1' ' A' ' 25' ' ' TYR . 22.3 mt -67.98 -39.71 83.26 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 122.674 1.226 . . . . 0.0 110.357 -176.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.66 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.259 10.1 m-30 -77.62 -44.54 27.92 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 114.869 -1.059 . . . . 0.0 113.46 -177.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.22 9.9 24.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.506 -1.371 . . . . 0.0 111.906 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.656 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 4.5 mt-30 -125.94 -11.76 6.52 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.59 -1.319 . . . . 0.0 111.474 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.461 ' O ' HD13 ' A' ' 6' ' ' LEU . . . 101.03 27.63 7.28 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.419 -1.372 . . . . 0.0 111.673 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.679 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 4.4 mp -101.53 -47.29 4.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.629 -1.512 . . . . 0.0 108.382 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.595 ' CB ' ' HA ' ' A' ' 5' ' ' PHE 0.255 . . -145.77 -174.81 4.51 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.839 0.828 . . . . 0.0 111.032 -178.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.588 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 1.8 pt -142.3 169.4 13.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.482 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 20.4 tt0 -59.66 107.17 0.56 Allowed 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.393 -0.817 . . . . 0.0 109.774 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.631 ' HB1' ' CB ' ' A' ' 2' ' ' LYS . . . -63.64 96.88 0.13 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.822 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.532 HG23 ' HB2' ' A' ' 43' ' ' ASN . 0.2 OUTLIER -111.61 145.58 32.92 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.028 -1.045 . . . . 0.0 108.91 178.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.501 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 46.0 Cg_endo -48.87 -54.76 4.93 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 O-C-N 123.781 1.411 . . . . 0.0 109.217 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.35 -52.55 1.11 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 111.16 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.532 ' HB2' HG23 ' A' ' 40' ' ' THR . 4.1 m-20 -80.29 -48.48 12.97 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.035 -1.041 . . . . 0.0 111.075 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 39' ' ' ALA . 6.3 mp -46.12 -22.58 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.966 . . . . 0.0 109.85 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -77.67 -34.77 52.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 48' ' ' GLU . . . -68.76 -37.62 79.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.495 -0.753 . . . . 0.0 110.194 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -38.84 -27.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.655 -0.653 . . . . 0.0 110.298 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 46' ' ' ALA . 7.6 tm-20 -68.86 -41.12 78.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 0.0 110.527 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . -76.67 -46.42 25.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 110.124 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -46.53 -41.88 14.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.973 -1.08 . . . . 0.0 109.153 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 50' ' ' GLN . 8.9 tttt -43.9 -49.04 8.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.432 -0.793 . . . . 0.0 109.546 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.63 109.49 2.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 0.0 109.726 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.6 175.07 6.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.058 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.431 ' C ' ' HG2' ' A' ' 55' ' ' GLN . 1.5 mt-10 -158.8 -80.56 0.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.322 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HG2' ' C ' ' A' ' 54' ' ' GLU . 5.1 mm100 -134.47 8.23 3.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.798 . . . . 0.0 109.389 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.144 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.53 ' N ' ' OD2' ' A' ' 23' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.83 0.347 . . . . 0.0 110.801 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.595 ' HB3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -55.5 150.82 11.32 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 178.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.619 HG23 ' CZ ' ' A' ' 31' ' ' PHE 0.293 3.3 t -137.16 134.63 47.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -174.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.59 ' CG2' ' O ' ' A' ' 4' ' ' ILE 0.285 0.1 OUTLIER -100.64 92.84 2.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.853 178.044 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.565 ' O ' ' CA ' ' A' ' 16' ' ' GLY . 8.5 m-85 -63.13 119.46 9.59 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 119.363 -2.085 . . . . 0.0 105.906 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -79.28 -25.04 42.52 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -115.31 -163.39 0.88 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.555 0.693 . . . . 0.0 109.489 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 9' ' ' VAL . 26.4 t0 -106.45 160.78 15.14 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.909 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.472 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 1.4 t -121.18 -158.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.7 54.38 0.97 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.096 -1.003 . . . . 0.0 109.416 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.46 3.61 86.43 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.06 -37.67 10.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -1.225 . . . . 0.0 110.713 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' C ' ' HG3' ' A' ' 14' ' ' LYS . . . -121.03 164.18 14.33 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 5.8 mttp -134.61 173.78 11.29 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.508 -0.995 . . . . 0.0 109.596 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.598 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -43.11 134.04 3.68 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 110.95 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' CA ' ' O ' ' A' ' 5' ' ' PHE . . . 27.44 39.03 0.01 OUTLIER Glycine 0 N--CA 1.503 3.166 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -77.41 125.74 29.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.462 -1.611 . . . . 0.0 109.198 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.581 ' CG1' ' CD1' ' A' ' 4' ' ' ILE . 1.1 mp -100.55 116.79 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 122.899 1.333 . . . . 0.0 111.572 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.45 155.16 19.55 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.469 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 10.1 p30 -87.37 126.46 34.88 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 117.242 -1.783 . . . . 0.0 109.83 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.678 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.308 2.3 p -87.54 -144.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.679 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -73.86 112.09 9.65 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 174.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -33.57 -30.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.665 -0.647 . . . . 0.0 111.753 -176.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.63 -36.99 4.63 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.811 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.291 0.1 OUTLIER -48.58 -58.37 4.8 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.223 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.631 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -29.01 -59.21 0.14 Allowed 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.1 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 4.1 t30 -86.81 -18.19 31.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.024 -1.047 . . . . 0.0 111.981 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.454 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 39.6 t30 -88.64 7.78 31.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.671 -1.268 . . . . 0.0 111.351 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.811 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.71 -77.51 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.941 -1.1 . . . . 0.0 110.715 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.719 ' HG ' ' CE1' ' A' ' 25' ' ' TYR . 25.7 mt -45.08 -47.95 11.9 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 122.678 1.228 . . . . 0.0 109.561 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.631 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.28 7.2 m-30 -75.85 -47.44 25.53 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.271 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -70.13 -6.11 31.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.52 -0.738 . . . . 0.0 111.489 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.576 ' HB2' ' CD1' ' A' ' 35' ' ' LEU . 8.3 mm-40 -121.42 -17.38 7.61 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.784 -1.166 . . . . 0.0 112.36 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.04 25.46 7.94 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.007 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.712 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 5.3 mp -93.19 -45.38 7.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.239 . . . . 0.0 108.126 177.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.543 ' CB ' ' HA ' ' A' ' 5' ' ' PHE 0.258 . . -143.8 178.25 7.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.175 0.988 . . . . 0.0 111.994 -177.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' C ' ' CZ ' ' A' ' 31' ' ' PHE . 24.4 pt -132.08 166.86 27.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' O ' HG21 ' A' ' 40' ' ' THR . 2.4 tm-20 -64.98 115.3 5.25 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.334 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.595 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . . . -49.53 107.07 0.13 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 117.865 -1.534 . . . . 0.0 110.626 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.548 ' OG1' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -118.96 156.12 52.36 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.305 -0.872 . . . . 0.0 109.973 179.077 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.548 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 43.2 Cg_endo -56.6 -57.69 1.29 Allowed 'Trans proline' 0 C--N 1.302 -1.898 0 O-C-N 123.92 1.484 . . . . 0.0 110.149 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.86 -54.05 0.93 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.609 -0.682 . . . . 0.0 110.431 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' HB2' HG23 ' A' ' 40' ' ' THR . 41.7 m-20 -73.84 -54.52 7.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.856 . . . . 0.0 110.638 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.517 HD11 HG12 ' A' ' 18' ' ' ILE . 1.5 mm? -44.92 -27.07 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.903 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -73.07 -49.46 28.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.58 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.14 -42.01 96.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -0.788 . . . . 0.0 109.701 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -51.16 29.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 110.103 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -52.72 -35.15 55.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.374 -0.829 . . . . 0.0 110.581 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.88 -44.61 82.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.838 . . . . 0.0 110.412 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -58.72 -53.86 53.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 110.091 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -60.8 -14.38 21.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.181 -0.95 . . . . 0.0 110.13 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.33 -149.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.914 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -57.93 -171.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.128 -0.983 . . . . 0.0 109.89 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.7 115.41 15.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 109.874 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.97 27.56 0.37 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.422 -0.798 . . . . 0.0 109.528 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.114 -179.699 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.532 ' CE ' ' HB2' ' A' ' 27' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.795 0.331 . . . . 0.0 110.249 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.601 ' HB3' ' CB ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -53.62 149.85 7.72 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.619 HG21 ' CZ ' ' A' ' 31' ' ' PHE 0.272 3.3 t -136.06 131.91 49.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 O-C-N 120.169 -1.582 . . . . 0.0 115.259 -176.064 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.604 HG12 ' CG2' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -99.36 94.35 3.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.59 ' O ' ' N ' ' A' ' 16' ' ' GLY . 11.5 m-85 -67.82 127.02 31.28 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 120.034 -1.666 . . . . 0.0 107.218 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 35' ' ' LEU . 0.5 OUTLIER -77.97 -28.83 49.5 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HA ' ' HD2' ' A' ' 15' ' ' LYS . 17.3 mtpt -115.81 -166.16 1.11 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.438 0.637 . . . . 0.0 109.833 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.88 143.55 48.86 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.464 -0.773 . . . . 0.0 110.902 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.533 ' CG2' ' CE2' ' A' ' 5' ' ' PHE . 5.7 t -97.63 149.17 5.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -74.38 63.46 1.05 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.84 -1.162 . . . . 0.0 110.595 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.42 -45.96 0.08 OUTLIER Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -151.55 -25.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.09 -1.241 . . . . 0.0 112.947 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.426 ' HA2' ' CD ' ' A' ' 17' ' ' GLU . . . -63.16 160.97 34.47 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 120.579 -1.326 . . . . 0.0 110.224 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.532 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 3.9 mtpp -151.27 173.26 14.67 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.654 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -65.93 133.21 50.41 Favored 'General case' 0 C--N 1.289 -2.04 0 O-C-N 120.953 -1.092 . . . . 0.0 110.304 -178.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 38.38 27.66 0.05 OUTLIER Glycine 0 N--CA 1.5 2.916 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 1.1 pt-20 -60.68 125.69 24.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.66 -1.494 . . . . 0.0 109.218 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.604 ' CG2' HG12 ' A' ' 4' ' ' ILE . 1.1 mp -115.52 119.37 61.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.422 1.106 . . . . 0.0 111.142 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 16.8 tttt -161.79 -121.87 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.415 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 31.9 p-10 -152.02 120.8 6.54 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.668 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.299 4.3 p -86.78 -144.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 178.393 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.682 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -74.34 111.01 9.1 Favored 'General case' 0 C--N 1.274 -2.711 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 174.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 1' ' ' MET . 1.7 m-20 -30.38 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.152 0.501 . . . . 0.0 111.415 -176.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -96.6 -36.86 4.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.871 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.3 0.1 OUTLIER -48.67 -55.25 11.84 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 177.115 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.647 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -30.88 -67.26 0.09 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.302 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.612 ' HA ' ' CD2' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -84.87 7.8 19.67 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.208 -0.933 . . . . 0.0 111.829 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 25' ' ' TYR . 3.6 t30 -115.7 4.3 14.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.573 -1.329 . . . . 0.0 111.246 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.871 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -161.01 -43.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.89 -1.131 . . . . 0.0 111.245 -178.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.695 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 12.4 mt -84.94 -32.78 22.89 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.369 -1.457 . . . . 0.0 110.088 -177.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.679 ' CE2' ' HA ' ' A' ' 38' ' ' GLU 0.266 7.1 m-30 -84.59 -57.54 3.09 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.739 -178.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -7.24 8.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.096 -1.003 . . . . 0.0 110.883 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 2.6 mt-30 -113.89 -105.7 0.39 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.981 -1.074 . . . . 0.0 110.419 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.07 27.57 0.39 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.683 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 2.6 mp -97.32 -49.48 4.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.032 -1.275 . . . . 0.0 110.023 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 5' ' ' PHE . . . -144.23 -176.42 5.01 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 122.062 0.934 . . . . 0.0 112.827 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.476 HG12 HG21 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -143.81 137.17 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.679 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 6.5 pt-20 -38.85 116.96 0.62 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.178 0.513 . . . . 0.0 110.425 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.601 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . . . -54.8 125.02 18.4 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.601 -1.24 . . . . 0.0 110.786 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' A' ' 41' ' ' PRO . 0.2 OUTLIER -144.12 149.43 45.33 Favored Pre-proline 0 N--CA 1.501 2.105 0 O-C-N 121.406 -0.809 . . . . 0.0 109.242 179.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.529 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 43.4 Cg_endo -48.81 -56.69 2.93 Favored 'Trans proline' 0 C--N 1.298 -2.117 0 O-C-N 123.562 1.296 . . . . 0.0 109.994 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.1 -55.87 0.93 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.494 -0.754 . . . . 0.0 110.58 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' ALA . 1.5 m-20 -77.24 -51.38 11.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.196 -0.94 . . . . 0.0 110.873 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.565 ' CD2' HG21 ' A' ' 18' ' ' ILE . 12.0 mt -46.69 -29.12 1.73 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.967 -1.083 . . . . 0.0 108.428 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -79.34 -31.69 43.14 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' ASN . . . -65.87 -43.8 87.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.452 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 1.5 mm? -48.84 -47.0 42.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.378 -0.826 . . . . 0.0 109.067 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.97 -21.72 60.81 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.908 . . . . 0.0 109.375 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.24 -41.89 16.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.787 . . . . 0.0 109.361 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.64 -34.13 64.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.47 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -36.84 81.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.89 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -48.88 -35.92 15.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 110.393 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.03 71.67 0.68 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.192 -0.943 . . . . 0.0 110.306 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.581 ' CG ' ' O ' ' A' ' 54' ' ' GLU . 4.3 pt-20 -75.62 107.2 7.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 109.542 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -140.64 19.37 2.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.104 -0.998 . . . . 0.0 109.579 -179.211 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 56' ' ' ARG . 4.5 tmm_? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.042 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.543 ' CE ' ' HB2' ' A' ' 27' ' ' ASN . 2.0 ttt . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.863 0.363 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.554 ' CA ' ' O ' ' A' ' 19' ' ' LYS . 12.5 mtpt -50.12 154.14 1.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.776 -1.203 . . . . 0.0 107.841 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.598 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.299 3.4 t -137.24 133.22 46.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -175.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.639 ' CG2' ' O ' ' A' ' 4' ' ' ILE 0.261 0.1 OUTLIER -98.04 91.67 2.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.83 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.648 ' O ' ' N ' ' A' ' 16' ' ' GLY . 15.5 m-85 -70.21 124.05 23.16 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 119.589 -1.944 . . . . 0.0 107.553 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.561 HD21 ' CA ' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -77.52 -28.24 51.95 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.652 -1.28 . . . . 0.0 108.32 179.258 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -116.86 -170.66 1.87 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.42 0.628 . . . . 0.0 109.349 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -107.5 155.09 20.46 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.054 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.603 HG21 ' CE2' ' A' ' 5' ' ' PHE . 1.7 t -106.96 -157.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.812 -1.18 . . . . 0.0 109.833 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.73 76.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.821 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 53.08 41.11 59.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -131.65 -83.73 0.51 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -1.126 . . . . 0.0 110.205 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.45 ' HA2' ' OE2' ' A' ' 17' ' ' GLU . . . -71.73 161.24 54.22 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 1.5 mttt -130.71 173.73 10.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.389 -1.065 . . . . 0.0 109.78 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -42.87 141.73 1.04 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 111.079 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 21.85 45.24 0.01 OUTLIER Glycine 0 N--CA 1.512 3.731 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.6 pt-20 -80.6 127.57 32.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.697 -1.472 . . . . 0.0 108.911 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.608 ' CG1' ' CD1' ' A' ' 4' ' ' ILE . 1.8 mp -106.91 121.13 59.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 111.222 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.554 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 22.4 tttt -161.54 -125.72 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 177.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -152.49 121.19 6.47 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.677 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.303 4.2 p -87.33 -142.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 178.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.677 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -75.63 111.27 10.77 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 174.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.502 ' C ' ' O ' ' A' ' 22' ' ' ALA . 6.2 m-20 -31.66 -31.46 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.836 -0.54 . . . . 0.0 111.37 -176.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -96.31 -37.91 4.69 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.861 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.295 0.1 OUTLIER -48.58 -55.15 11.95 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 177.182 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.664 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -31.52 -66.22 0.12 Allowed 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.462 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.615 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -85.1 11.09 10.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.334 -0.853 . . . . 0.0 112.671 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 3.5 m-80 -123.92 10.43 8.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.07 -1.644 . . . . 0.0 110.946 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.861 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -161.33 -50.85 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.687 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 10.9 mt -79.55 -36.48 38.23 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.805 -1.184 . . . . 0.0 109.775 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.664 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.296 7.0 m-30 -85.3 -60.32 2.07 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.436 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -49.93 -21.65 1.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.76 -0.587 . . . . 0.0 111.801 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.566 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -114.33 -88.6 0.56 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.618 -1.301 . . . . 0.0 110.445 -179.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.566 ' N ' ' CG ' ' A' ' 33' ' ' GLN . . . -174.61 38.45 0.12 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.808 -1.663 . . . . 0.0 111.433 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.659 ' CD1' ' HA ' ' A' ' 30' ' ' LEU . 3.6 mp -104.58 -45.3 4.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.723 -1.457 . . . . 0.0 108.541 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.603 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . -141.2 -176.92 4.88 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.125 0.964 . . . . 0.0 112.27 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.485 ' O ' ' C ' ' A' ' 38' ' ' GLU . 4.1 mt -143.43 135.92 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 31' ' ' PHE . 4.5 tt0 -39.49 115.04 0.47 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.384 -0.823 . . . . 0.0 109.813 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.548 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -48.34 102.21 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.356 -1.338 . . . . 0.0 109.865 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.523 ' OG1' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -113.01 149.08 40.74 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.721 . . . . 0.0 109.757 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.523 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 42.4 Cg_endo -49.19 -59.56 1.19 Allowed 'Trans proline' 0 C--N 1.297 -2.171 0 O-C-N 123.968 1.51 . . . . 0.0 109.858 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -37.13 -53.18 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.599 -0.688 . . . . 0.0 111.364 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.505 ' HB2' HG23 ' A' ' 40' ' ' THR . 2.2 m-20 -77.64 -44.26 28.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.96 -1.088 . . . . 0.0 111.657 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.544 ' CD1' HG13 ' A' ' 4' ' ' ILE . 4.6 mp -53.25 -39.78 64.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.085 . . . . 0.0 110.665 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 25.6 tptt -78.92 -39.46 34.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.981 -1.075 . . . . 0.0 109.214 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -59.89 -36.72 77.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -0.79 . . . . 0.0 109.496 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.524 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -58.8 -29.77 67.11 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.446 -0.784 . . . . 0.0 109.368 179.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -81.93 -47.96 12.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 110.113 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.58 -41.7 61.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.134 -0.979 . . . . 0.0 110.141 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.63 -28.58 63.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.396 -0.815 . . . . 0.0 110.27 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.04 -46.18 8.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.273 -0.892 . . . . 0.0 111.013 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.68 90.47 5.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.105 -0.997 . . . . 0.0 111.36 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -99.74 -131.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 108.877 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.9 143.14 36.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.765 -1.209 . . . . 0.0 109.092 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.74 73.16 0.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 109.848 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.188 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.563 ' CB ' ' O ' ' A' ' 23' ' ' ASP . 7.2 tpt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.641 ' CB ' ' HB1' ' A' ' 39' ' ' ALA . 3.1 mttm -50.67 152.31 2.06 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.638 HG21 ' CZ ' ' A' ' 31' ' ' PHE 0.285 3.4 t -134.26 132.3 55.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 119.972 -1.705 . . . . 0.0 114.739 -176.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.588 HG12 ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -97.25 99.9 9.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.59 ' O ' ' N ' ' A' ' 16' ' ' GLY . 10.5 m-85 -77.11 127.25 32.32 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 119.983 -1.698 . . . . 0.0 107.318 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.622 ' CD1' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -77.01 -28.84 55.17 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 120.539 -1.35 . . . . 0.0 107.585 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 34' ' ' GLY . 5.5 mppt? -113.47 -174.49 2.47 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.316 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 13' ' ' GLY . 6.3 p-10 -107.4 160.55 15.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 110.146 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 11' ' ' GLY . 0.9 OUTLIER -123.37 -174.73 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 109.867 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 62.81 0.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 109.652 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 77.33 9.03 87.05 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.427 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -94.45 -33.77 12.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -1.03 . . . . 0.0 110.558 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 8' ' ' ASP . . . -158.52 157.42 28.35 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 11.5 mmmt -123.28 178.83 4.95 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.438 -1.037 . . . . 0.0 111.115 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -42.35 137.67 1.96 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.259 -0.901 . . . . 0.0 111.722 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 22.29 45.6 0.01 OUTLIER Glycine 0 N--CA 1.509 3.526 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.623 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -82.16 125.66 31.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.948 -1.325 . . . . 0.0 109.547 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.588 ' CG1' HG12 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -105.5 122.56 59.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 120.436 -1.415 . . . . 0.0 110.086 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -160.79 -127.82 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 178.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.497 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 52.1 p-10 -151.88 122.1 7.22 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 122.713 1.244 . . . . 0.0 109.154 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.693 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.301 3.9 p -86.89 -142.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 178.229 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.671 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -76.62 110.54 11.28 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 1' ' ' MET . 17.7 p-10 -29.67 -37.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.782 0.801 . . . . 0.0 111.045 -176.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -90.3 -40.02 5.87 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.869 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.299 0.1 OUTLIER -48.7 -56.34 8.84 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.683 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.654 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -29.97 -63.94 0.12 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.236 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.564 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 62.0 t30 -88.68 35.31 0.77 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 112.484 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 25' ' ' TYR . 0.9 OUTLIER -147.9 8.01 0.84 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.761 -1.212 . . . . 0.0 110.562 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.869 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.74 -47.24 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.247 -0.908 . . . . 0.0 109.225 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.687 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 10.8 mt -86.39 -35.33 19.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.918 -1.113 . . . . 0.0 110.135 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.654 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.271 8.9 m-30 -82.65 -57.59 3.26 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.501 -178.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HD2' ' HG2' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -69.63 -1.35 8.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.992 -1.068 . . . . 0.0 111.35 -178.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.551 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 23.8 mt-30 -116.72 -92.13 0.53 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.914 -1.116 . . . . 0.0 110.525 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . -173.46 23.67 0.07 OUTLIER Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.03 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.642 ' CD1' ' HA ' ' A' ' 30' ' ' LEU . 2.6 mp -95.59 -50.18 5.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.773 -1.428 . . . . 0.0 109.294 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.563 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . -139.55 -179.54 5.96 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.926 0.869 . . . . 0.0 111.444 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.563 ' CG2' HG21 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -140.79 160.06 23.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.63 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 18.2 mp0 -48.94 115.65 1.36 Allowed 'General case' 0 C--N 1.293 -1.87 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.641 ' HB1' ' CB ' ' A' ' 2' ' ' LYS . . . -66.99 60.64 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 118.276 -1.369 . . . . 0.0 109.657 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.614 ' OG1' ' CD ' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -88.85 164.69 30.53 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.222 -0.923 . . . . 0.0 109.343 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.614 ' CD ' ' OG1' ' A' ' 40' ' ' THR . 49.4 Cg_endo -49.05 -62.38 0.44 Allowed 'Trans proline' 0 C--N 1.299 -2.069 0 O-C-N 123.909 1.478 . . . . 0.0 109.768 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.56 -54.78 0.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.673 -0.642 . . . . 0.0 111.173 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.517 ' ND2' ' CG1' ' A' ' 37' ' ' ILE . 83.6 m-20 -71.23 -43.49 67.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.015 . . . . 0.0 110.512 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.536 ' CD2' HG22 ' A' ' 18' ' ' ILE . 2.7 mm? -58.02 -61.72 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.924 . . . . 0.0 109.632 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -48.35 -47.12 37.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 0.0 109.643 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -63.98 -37.8 88.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.502 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.518 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -48.7 -64.67 0.73 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.529 -0.732 . . . . 0.0 109.139 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.82 -25.2 60.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.318 -0.864 . . . . 0.0 109.0 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 52' ' ' GLN . . . -75.55 -45.0 40.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 0.0 109.539 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.92 -15.11 54.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.996 -1.065 . . . . 0.0 108.915 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -89.25 -14.35 36.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.555 -0.716 . . . . 0.0 110.056 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 1.7 mp0 -61.98 -170.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.11 -0.994 . . . . 0.0 110.175 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.417 ' C ' ' HG2' ' A' ' 54' ' ' GLU . 3.2 tptp -138.15 31.57 2.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.857 . . . . 0.0 110.369 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HG2' ' C ' ' A' ' 53' ' ' LYS . 6.3 mm-40 -127.64 40.17 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 0.0 110.24 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -150.64 44.06 0.84 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 110.198 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.035 -0.984 . . . . 0.0 110.086 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 2.2 ttt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.893 0.378 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 7.9 mmtt -55.38 148.8 14.32 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.631 HG21 ' CZ ' ' A' ' 31' ' ' PHE 0.297 3.0 t -132.92 133.32 58.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.268 -1.52 . . . . 0.0 114.921 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.597 ' CG2' ' O ' ' A' ' 4' ' ' ILE 0.267 0.1 OUTLIER -98.58 91.64 2.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.56 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.616 ' O ' ' N ' ' A' ' 16' ' ' GLY . 11.8 m-85 -66.42 118.51 10.17 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 119.393 -2.067 . . . . 0.0 105.863 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -78.98 -20.22 49.68 Favored 'General case' 0 C--N 1.287 -2.149 0 O-C-N 121.445 -0.784 . . . . 0.0 109.175 -178.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HD2' ' O ' ' A' ' 34' ' ' GLY . 21.2 mttt -121.97 -164.58 1.17 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 13' ' ' GLY . 44.8 t0 -96.92 167.01 11.34 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.333 -0.854 . . . . 0.0 110.299 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.594 HG23 ' CE1' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -139.71 167.75 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.523 -0.736 . . . . 0.0 109.034 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.09 85.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.981 -1.074 . . . . 0.0 110.494 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 44.36 48.66 8.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -146.72 -32.83 0.31 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.068 -1.254 . . . . 0.0 110.918 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.464 ' HA2' ' OE1' ' A' ' 17' ' ' GLU . . . -135.7 162.17 24.88 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.538 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 16.6 mtmm -136.74 -174.08 3.61 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.297 -1.119 . . . . 0.0 110.004 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.599 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -51.61 131.36 29.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 110.258 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 29.79 39.88 0.03 OUTLIER Glycine 0 N--CA 1.504 3.168 0 O-C-N 121.762 -0.586 . . . . 0.0 111.889 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -78.05 127.53 32.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.409 -1.642 . . . . 0.0 109.096 178.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.597 HG12 ' CD1' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -104.61 126.59 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 122.051 0.929 . . . . 0.0 111.923 -178.348 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -161.4 -130.93 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.509 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 2.4 p-10 -151.68 118.3 5.72 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.687 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.307 5.0 p -86.88 -144.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.674 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -73.07 111.27 8.02 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 1' ' ' MET . 1.6 m-20 -32.05 -30.33 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.96 -0.462 . . . . 0.0 111.47 -176.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.81 -37.57 4.41 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.83 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.307 0.1 OUTLIER -48.58 -55.62 10.65 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 177.384 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.648 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -29.57 -64.48 0.11 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.76 178.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.567 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 17.8 t30 -88.5 52.92 2.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 111.03 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.94 -32.35 0.07 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.262 -0.899 . . . . 0.0 110.862 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.83 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -126.92 -37.89 2.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.303 -0.873 . . . . 0.0 109.743 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.684 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 11.9 mt -90.64 -35.42 14.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.433 -1.417 . . . . 0.0 110.161 -177.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.648 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.278 8.5 m-30 -84.36 -51.65 6.8 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.774 -178.373 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -68.19 -3.46 10.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.025 -1.047 . . . . 0.0 110.814 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.566 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 1.7 mt-30 -118.84 -102.22 0.42 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 110.335 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.503 ' O ' ' HD2' ' A' ' 7' ' ' LYS . . . -160.67 17.33 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.468 -1.348 . . . . 0.0 110.673 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.665 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 3.0 mp -84.24 -51.33 7.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.659 -1.495 . . . . 0.0 109.547 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.575 ' CB ' ' HA ' ' A' ' 5' ' ' PHE . . . -142.22 -178.68 5.84 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.179 0.99 . . . . 0.0 112.841 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.561 HG12 HG23 ' A' ' 4' ' ' ILE . 2.4 pt -140.04 161.62 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.638 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 2.4 pt-20 -51.06 108.88 0.27 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.313 -0.867 . . . . 0.0 111.15 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.558 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -49.94 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 117.823 -1.551 . . . . 0.0 109.564 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.547 ' OG1' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -107.51 148.54 37.41 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.898 -1.126 . . . . 0.0 110.223 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.547 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 43.8 Cg_endo -49.1 -58.58 1.67 Allowed 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.753 1.396 . . . . 0.0 109.872 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.01 -51.18 0.92 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 110.379 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.466 ' ND2' HD13 ' A' ' 37' ' ' ILE . 5.0 t-20 -77.12 -54.69 6.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -0.999 . . . . 0.0 110.853 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.538 ' CD1' HG23 ' A' ' 18' ' ' ILE . 7.3 mp -45.75 -51.82 12.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 0.0 110.296 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -20.53 65.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 109.749 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -84.06 -43.78 14.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.417 -0.802 . . . . 0.0 110.617 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.445 ' CD2' ' OD1' ' A' ' 43' ' ' ASN . 2.8 mm? -42.16 -49.34 4.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 109.835 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -54.01 -60.07 3.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 0.0 110.233 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.02 -40.2 6.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.333 -0.854 . . . . 0.0 110.643 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -27.7 69.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 110.622 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HB3' ' NZ ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -85.96 -26.48 25.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.246 -0.909 . . . . 0.0 110.385 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.86 134.59 35.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 110.721 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.4 120.47 18.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.523 -0.736 . . . . 0.0 110.05 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.36 126.77 9.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -0.929 . . . . 0.0 110.706 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.26 -41.39 0.15 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.833 0.825 . . . . 0.0 108.861 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.462 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.018 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.521 ' CB ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 120.606 0.241 . . . . 0.0 110.444 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.612 ' CA ' ' O ' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -50.79 156.21 1.0 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.208 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.626 HG21 ' CZ ' ' A' ' 31' ' ' PHE 0.311 3.6 t -134.43 134.47 54.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 O-C-N 119.961 -1.712 . . . . 0.0 114.924 -174.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.61 HG12 ' CG1' ' A' ' 18' ' ' ILE 0.255 0.0 OUTLIER -96.98 108.01 20.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.15 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.746 ' CG ' ' HA3' ' A' ' 13' ' ' GLY . 2.0 m-85 -86.58 125.33 33.72 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.631 -1.293 . . . . 0.0 107.766 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.631 ' CD1' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -82.1 -28.09 32.49 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 120.808 -1.182 . . . . 0.0 112.844 -178.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.656 ' O ' ' O ' ' A' ' 13' ' ' GLY . 3.0 mttp -108.98 -142.86 0.38 Allowed 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 118.976 -1.089 . . . . 0.0 113.16 -176.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.826 ' C ' ' O ' ' A' ' 13' ' ' GLY . 5.4 t70 -96.73 154.21 17.42 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.03 -1.043 . . . . 0.0 108.347 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.8 ' HA ' ' H ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -85.96 -5.31 9.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.57 -1.331 . . . . 0.0 114.431 -173.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.419 ' NZ ' ' HA ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -72.77 57.24 0.42 Allowed 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 100.96 19.47 17.02 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 2.9 mtpp -151.03 -18.97 0.21 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.566 -1.55 . . . . 0.0 112.64 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.826 ' O ' ' C ' ' A' ' 8' ' ' ASP . . . 101.5 159.64 26.96 Favored Glycine 0 C--O 1.175 -3.574 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 5' ' ' PHE . 17.7 mttp -87.56 146.33 25.82 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 121.121 2.461 . . . . 0.0 109.565 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -29.81 122.03 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.65 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 16.23 51.69 0.01 OUTLIER Glycine 1 N--CA 1.516 4.032 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -177.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.594 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -86.72 124.67 33.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.966 -1.314 . . . . 0.0 109.627 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.61 ' CG1' HG12 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -105.84 123.5 60.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.729 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.612 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -160.96 -129.94 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 178.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.411 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . 13.3 p-10 -151.67 119.95 6.36 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 120.676 -1.265 . . . . 0.0 109.702 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.673 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.299 4.4 p -87.07 -142.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.817 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.667 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -75.65 110.87 10.41 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 174.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 1' ' ' MET . 1.4 m-20 -32.72 -30.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.942 -0.474 . . . . 0.0 111.82 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.61 -37.84 4.38 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.808 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.299 0.1 OUTLIER -48.9 -56.13 9.71 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.232 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.667 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -28.75 -58.49 0.13 Allowed 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.136 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.52 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 11.6 p30 -90.4 15.11 11.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.862 -1.149 . . . . 0.0 112.629 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -125.74 9.35 7.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.339 -1.475 . . . . 0.0 110.625 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.808 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -159.93 -53.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 109.832 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.711 ' HG ' ' CE1' ' A' ' 25' ' ' TYR . 18.7 mt -76.43 -39.26 53.96 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 122.358 1.075 . . . . 0.0 110.577 -176.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.667 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.256 2.6 m-30 -81.46 -68.85 0.66 Allowed 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.315 -178.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -50.29 -16.36 0.32 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.728 -0.608 . . . . 0.0 112.139 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 33.1 mm-40 -106.39 -90.06 0.43 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.615 -1.303 . . . . 0.0 111.229 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.41 39.53 0.11 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.429 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.665 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 4.2 mp -109.5 -50.15 3.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.144 -1.21 . . . . 0.0 109.517 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.657 ' HB3' ' CD1' ' A' ' 5' ' ' PHE 0.265 . . -144.31 -166.16 2.31 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.402 1.096 . . . . 0.0 112.057 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.579 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 3.5 pt -146.28 173.07 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.136 175.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.661 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 8.0 pt-20 -66.8 112.49 4.28 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.134 -0.978 . . . . 0.0 110.096 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.583 ' HB2' ' CB ' ' A' ' 2' ' ' LYS . . . -51.76 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 117.835 -1.546 . . . . 0.0 109.764 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -108.84 148.73 38.42 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.094 -1.004 . . . . 0.0 109.963 179.318 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.53 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 45.2 Cg_endo -49.73 -50.03 14.28 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 O-C-N 123.971 1.511 . . . . 0.0 108.774 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.77 -46.03 0.58 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.286 0.565 . . . . 0.0 110.211 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -91.36 -46.53 7.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.921 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.567 ' CD2' ' CG2' ' A' ' 18' ' ' ILE . 2.5 mm? -39.2 -37.77 0.44 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.155 -0.965 . . . . 0.0 110.974 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.51 -29.7 33.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.06 -1.025 . . . . 0.0 109.944 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . . . -75.92 -34.4 59.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.465 -0.772 . . . . 0.0 110.152 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.521 HD23 ' CD1' ' A' ' 4' ' ' ILE . 2.2 mm? -51.76 -23.62 4.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.464 -0.773 . . . . 0.0 110.957 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.61 -33.95 41.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.974 -1.079 . . . . 0.0 110.068 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.78 26.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.063 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -45.35 -26.94 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.63 -63.72 1.24 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -66.91 95.88 0.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.328 -0.857 . . . . 0.0 110.451 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -82.74 126.91 32.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.281 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -115.65 -39.79 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.738 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -152.08 35.37 0.53 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.903 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.098 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.53 ' CE ' ' HB2' ' A' ' 27' ' ' ASN . 2.1 ttt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.678 ' CB ' ' HB2' ' A' ' 39' ' ' ALA . 10.1 mtmm -51.3 152.63 2.39 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.633 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.271 3.3 t -133.21 130.77 58.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 119.991 -1.693 . . . . 0.0 114.532 -176.069 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.6 HG12 ' CG1' ' A' ' 18' ' ' ILE 0.257 0.0 OUTLIER -98.65 102.5 13.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.461 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.595 ' O ' ' N ' ' A' ' 16' ' ' GLY . 11.4 m-85 -78.58 125.93 30.04 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 117.204 -1.798 . . . . 0.0 106.915 177.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.666 ' CD1' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -78.21 -29.62 48.44 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.278 -1.514 . . . . 0.0 107.725 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.459 ' HE3' ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -116.36 179.99 3.84 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.843 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 2.8 p30 -89.23 141.68 28.32 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.556 HG21 ' CA ' ' A' ' 13' ' ' GLY . 0.7 OUTLIER -97.92 -167.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.263 -0.898 . . . . 0.0 109.929 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -75.32 62.63 1.31 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.56 17.37 79.04 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 3.7 mttp -108.2 -41.17 4.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.207 -1.172 . . . . 0.0 110.4 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.556 ' CA ' HG21 ' A' ' 9' ' ' VAL . . . -135.32 171.86 22.37 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 15' ' ' LYS . 7.9 mtpt -140.41 177.12 8.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.171 -1.194 . . . . 0.0 109.737 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -34.33 135.06 0.17 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.618 -0.676 . . . . 0.0 111.261 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 21.36 45.06 0.01 OUTLIER Glycine 0 N--CA 1.512 3.72 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -81.36 125.16 30.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.51 -1.582 . . . . 0.0 109.246 179.274 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.6 ' CG1' HG12 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -106.4 124.98 62.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 122.219 1.009 . . . . 0.0 110.062 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -159.89 -130.28 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 179.254 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 40.6 p30 -151.76 119.39 6.09 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.678 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.303 3.7 p -86.62 -145.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.672 ' CB ' ' HB3' ' A' ' 25' ' ' TYR . . . -71.68 110.1 6.02 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 174.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 22' ' ' ALA . 1.1 m-20 -30.8 -30.48 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 122.093 -0.379 . . . . 0.0 111.607 -176.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -99.36 -36.95 4.19 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.788 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.289 0.0 OUTLIER -48.25 -54.52 13.33 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.139 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.639 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -29.89 -63.57 0.13 Allowed 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.259 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.566 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 52.4 t30 -86.7 29.83 0.77 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.267 -0.896 . . . . 0.0 112.409 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 25' ' ' TYR . 3.2 t-20 -133.78 -21.64 1.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.727 -1.233 . . . . 0.0 111.103 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.788 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -135.68 -43.09 0.68 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -0.952 . . . . 0.0 110.525 -178.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.687 ' HG ' ' CE1' ' A' ' 25' ' ' TYR . 15.0 mt -83.05 -37.36 23.99 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.871 -1.143 . . . . 0.0 109.871 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.639 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.277 7.0 m-30 -85.49 -53.05 5.43 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.825 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -64.27 -4.04 3.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.474 -0.766 . . . . 0.0 111.565 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 17.3 mt-30 -124.61 -103.08 0.37 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.741 -1.224 . . . . 0.0 110.642 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.63 46.55 0.42 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.648 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.641 ' CD1' ' HA ' ' A' ' 30' ' ' LEU . 3.0 mp -117.47 -48.01 2.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.986 -1.302 . . . . 0.0 109.898 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.576 ' CA ' HD21 ' A' ' 6' ' ' LEU . . . -144.03 -177.51 5.48 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.132 0.967 . . . . 0.0 112.118 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.604 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 4.0 pt -139.21 168.2 19.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.605 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 3.8 pt-20 -58.28 107.97 0.55 Allowed 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.5 -0.75 . . . . 0.0 109.561 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.678 ' HB2' ' CB ' ' A' ' 2' ' ' LYS . . . -59.25 93.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 118.167 -1.413 . . . . 0.0 110.499 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -105.28 153.05 39.9 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.219 -0.925 . . . . 0.0 109.746 178.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.525 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 43.3 Cg_endo -53.28 -55.16 3.89 Favored 'Trans proline' 0 C--N 1.296 -2.2 0 O-C-N 124.057 1.556 . . . . 0.0 109.573 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.19 -51.09 1.0 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.709 -0.619 . . . . 0.0 110.837 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.458 ' HB2' HG21 ' A' ' 40' ' ' THR . 70.0 m-20 -83.27 -47.96 10.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.237 -0.914 . . . . 0.0 111.066 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.588 ' CD1' HG21 ' A' ' 18' ' ' ILE . 5.1 mp -47.86 -45.48 30.32 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 110.376 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -30.09 61.15 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.007 -1.058 . . . . 0.0 108.949 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 49' ' ' ALA . . . -71.64 -42.37 67.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 109.347 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.519 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 1.2 mm? -55.08 -42.71 73.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.515 -0.741 . . . . 0.0 109.353 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 51' ' ' LYS . 21.5 tt0 -45.45 -43.56 11.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.366 -0.834 . . . . 0.0 109.534 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 52' ' ' GLN . . . -43.4 -40.59 3.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.272 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 2.4 tp-100 -67.33 -39.56 85.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 48' ' ' GLU . 52.3 mmtt -90.91 12.32 19.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.557 -0.714 . . . . 0.0 110.139 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 15.1 tt0 -43.13 -66.33 0.39 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -85.82 95.69 9.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.216 -0.927 . . . . 0.0 110.205 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 32.3 mt-10 -93.11 -107.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.915 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.05 19.46 0.77 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 109.478 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.203 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.605 ' CE ' ' HB2' ' A' ' 27' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.619 0.247 . . . . 0.0 110.425 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.569 ' HB2' ' HB1' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -50.08 151.63 1.92 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.046 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.622 ' CG2' ' HB1' ' A' ' 26' ' ' ALA 0.288 3.0 t -133.11 133.85 58.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 119.88 -1.762 . . . . 0.0 114.874 -175.587 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.62 ' CG2' ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -98.13 89.95 2.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.038 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.618 ' O ' ' N ' ' A' ' 16' ' ' GLY . 10.0 m-85 -62.35 122.64 16.18 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 116.672 -2.011 . . . . 0.0 105.838 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.504 HD22 ' CA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -78.72 -22.13 47.03 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.136 -178.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -132.14 176.57 8.28 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.524 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.66 144.9 34.96 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.737 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.506 HG22 ' CE1' ' A' ' 5' ' ' PHE . 1.1 t -106.16 -170.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 109.489 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -70.24 67.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 110.104 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 69.55 39.36 79.09 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.35 -55.16 0.8 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -1.121 . . . . 0.0 110.877 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.96 167.78 12.93 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.253 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 4.4 mttt -128.65 167.66 16.88 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.384 -1.068 . . . . 0.0 109.205 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -41.84 142.73 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.964 . . . . 0.0 111.375 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 25.64 39.7 0.01 OUTLIER Glycine 0 N--CA 1.502 3.061 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -83.37 121.85 27.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.586 -1.538 . . . . 0.0 108.64 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.576 ' CG1' HG12 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -100.33 125.24 54.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.308 1.051 . . . . 0.0 110.503 -178.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.526 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 3.8 ttpp -161.22 -129.98 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -151.95 117.98 5.52 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.275 1.035 . . . . 0.0 108.913 175.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.693 ' CG2' ' CE2' ' A' ' 25' ' ' TYR 0.302 4.1 p -87.34 -146.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 177.581 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.687 ' CB ' ' CB ' ' A' ' 25' ' ' TYR . . . -72.31 110.16 6.55 Favored 'General case' 0 C--N 1.273 -2.759 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 1' ' ' MET . 3.0 p30 -29.34 -36.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.655 0.741 . . . . 0.0 111.122 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -92.26 -38.73 5.58 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.829 ' CE1' ' CD2' ' A' ' 29' ' ' PHE 0.287 0.1 OUTLIER -48.25 -55.21 11.11 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.396 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.671 ' O ' ' CG ' ' A' ' 31' ' ' PHE . . . -29.46 -64.34 0.11 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.547 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.605 ' HB2' ' CE ' ' A' ' 1' ' ' MET . 24.0 t30 -89.71 53.91 2.71 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.105 -0.997 . . . . 0.0 110.678 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 25' ' ' TYR . 1.2 t-20 -154.89 -31.32 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.419 -0.8 . . . . 0.0 110.2 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.829 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -130.69 -42.81 1.13 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.335 -0.853 . . . . 0.0 109.849 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.757 ' HG ' ' CE1' ' A' ' 25' ' ' TYR . 14.4 mt -81.73 -39.08 24.74 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.613 -1.305 . . . . 0.0 109.868 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.671 ' CG ' ' O ' ' A' ' 26' ' ' ALA 0.275 7.2 m-30 -83.06 -51.93 7.1 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.353 -178.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -62.84 -7.46 5.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.358 -0.839 . . . . 0.0 111.363 -178.633 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 11.8 mt-30 -120.02 -93.78 0.51 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.887 -1.133 . . . . 0.0 110.658 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -172.03 41.86 0.17 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.173 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.646 ' CD1' ' HA ' ' A' ' 30' ' ' LEU . 3.9 mp -109.78 -47.76 3.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.091 -1.241 . . . . 0.0 109.873 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.555 ' CB ' ' HA ' ' A' ' 5' ' ' PHE . . . -142.29 178.4 7.6 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.788 0.804 . . . . 0.0 112.423 -177.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.55 ' C ' ' CZ ' ' A' ' 31' ' ' PHE . 13.1 pt -131.67 163.69 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.65 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 56.1 tt0 -61.47 115.32 3.8 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.401 -0.812 . . . . 0.0 109.659 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 2' ' ' LYS . . . -57.2 82.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.58 -1.248 . . . . 0.0 110.784 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -99.96 146.83 32.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.061 -1.024 . . . . 0.0 109.014 178.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 45.0 Cg_endo -49.14 -51.74 10.05 Favored 'Trans proline' 0 C--N 1.293 -2.384 0 O-C-N 124.061 1.559 . . . . 0.0 108.808 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.06 -59.28 0.73 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.694 -0.629 . . . . 0.0 110.464 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 46' ' ' ALA . 2.3 m120 -72.71 -49.33 31.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.52 -0.737 . . . . 0.0 111.051 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.514 HD13 HG21 ' A' ' 18' ' ' ILE . 2.5 mm? -40.68 -36.96 0.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -77.38 -31.01 53.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 109.131 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 43' ' ' ASN . . . -61.58 -38.73 88.63 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 108.797 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -44.45 -24.27 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.477 -0.765 . . . . 0.0 109.409 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -71.87 -35.98 69.95 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.156 -0.965 . . . . 0.0 109.069 179.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 52' ' ' GLN . . . -48.93 -40.03 28.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.981 . . . . 0.0 108.776 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -52.48 -20.57 2.99 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.119 -0.988 . . . . 0.0 109.589 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 48' ' ' GLU . 1.4 tttm -90.33 -27.72 19.2 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.422 -0.798 . . . . 0.0 111.116 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -71.59 158.71 35.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.698 -1.252 . . . . 0.0 110.634 -179.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -102.59 -159.97 0.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.669 -0.645 . . . . 0.0 110.624 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.58 -70.58 0.15 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.328 -0.858 . . . . 0.0 110.951 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.32 41.52 1.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.205 -0.934 . . . . 0.0 109.994 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.243 -179.555 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.786 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.593 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -49.66 151.25 1.75 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.077 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.26 3.9 t -133.0 130.94 58.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 117.195 -1.802 . . . . 0.0 114.816 -175.065 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 4' ' ' ILE 0.286 0.2 OUTLIER -96.87 89.99 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.784 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.953 ' CE2' HD22 ' A' ' 30' ' ' LEU . 10.7 m-85 -64.76 124.6 22.37 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 116.785 -1.966 . . . . 0.0 106.977 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.589 HD12 ' HD2' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -78.67 -24.77 44.92 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.688 -179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.589 ' HD2' HD12 ' A' ' 6' ' ' LEU . 1.7 mttm -133.09 166.34 22.65 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.268 0.556 . . . . 0.0 109.646 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.403 ' OD2' ' O ' ' A' ' 13' ' ' GLY . 10.5 t70 -74.14 166.24 23.76 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.388 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.764 HG21 ' CE2' ' A' ' 5' ' ' PHE . 2.5 t -123.24 -142.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 109.249 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.618 ' H ' HG12 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -71.96 56.58 0.31 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.851 -1.155 . . . . 0.0 109.861 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.62 21.89 77.85 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.39 -66.49 1.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -1.121 . . . . 0.0 110.174 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.523 ' HA2' ' OE2' ' A' ' 17' ' ' GLU . . . -70.63 167.65 50.17 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.522 ' N ' ' OE2' ' A' ' 17' ' ' GLU . 13.5 mtmt -142.45 151.94 42.25 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.247 -1.149 . . . . 0.0 109.414 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.624 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -32.85 137.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.757 -0.589 . . . . 0.0 110.869 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 19.94 45.8 0.01 OUTLIER Glycine 0 N--CA 1.51 3.622 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -90.42 128.9 36.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.534 -1.568 . . . . 0.0 108.9 178.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.608 ' CG1' ' CD1' ' A' ' 4' ' ' ILE . 1.9 mp -95.11 117.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 122.595 1.188 . . . . 0.0 110.844 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.511 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -160.64 153.74 21.57 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -88.02 125.39 34.52 Favored 'General case' 0 C--N 1.273 -2.723 0 C-N-CA 116.986 -1.886 . . . . 0.0 109.36 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.937 HG22 ' CD2' ' A' ' 25' ' ' TYR 0.327 4.0 p -86.94 -143.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 103.621 -2.733 . . . . 0.0 103.621 178.245 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.205 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -74.38 112.61 10.72 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 104.195 -2.521 . . . . 0.0 104.195 174.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -31.61 -31.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.994 -0.441 . . . . 0.0 111.748 -176.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -99.52 -36.39 4.34 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.205 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.295 0.1 OUTLIER -48.6 -55.91 9.89 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.105 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.778 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.78 -61.52 0.15 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.362 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.734 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 28.2 t30 -86.26 -10.26 54.92 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -102.17 11.66 37.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.281 -1.512 . . . . 0.0 111.661 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.82 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.96 -52.68 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.838 -1.164 . . . . 0.0 111.503 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.953 HD22 ' CE2' ' A' ' 5' ' ' PHE . 13.4 mt -77.65 -34.1 53.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.725 -1.234 . . . . 0.0 110.033 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.077 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.277 6.9 m-30 -85.57 -49.16 8.25 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.765 -178.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.55 7.21 1.5 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 111.618 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 73.2 mm-40 -133.22 -93.2 0.34 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.816 -1.178 . . . . 0.0 110.899 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.68 ' H ' HD12 ' A' ' 35' ' ' LEU . . . -172.11 42.2 0.17 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.807 HD13 ' HA ' ' A' ' 30' ' ' LEU . 3.1 mp -113.65 -44.38 3.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -1.167 . . . . 0.0 109.287 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.724 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -149.82 -178.58 6.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.909 0.861 . . . . 0.0 112.06 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.529 ' C ' ' CE1' ' A' ' 31' ' ' PHE . 14.3 pt -138.35 156.13 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.976 ' O ' HG22 ' A' ' 40' ' ' THR . 20.7 pt-20 -56.17 108.73 0.5 Allowed 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.571 -0.706 . . . . 0.0 109.948 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.593 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -49.88 113.67 0.9 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.116 -1.434 . . . . 0.0 109.506 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.976 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -143.89 148.15 41.24 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.369 -0.832 . . . . 0.0 109.852 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.561 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 44.9 Cg_endo -49.15 -51.88 9.8 Favored 'Trans proline' 0 C--N 1.298 -2.108 0 O-C-N 123.815 1.429 . . . . 0.0 108.907 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.05 -42.12 0.4 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.68 -0.637 . . . . 0.0 110.641 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.485 ' HB2' HG23 ' A' ' 40' ' ' THR . 4.4 m-20 -102.32 -50.95 3.47 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.129 -0.982 . . . . 0.0 111.596 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.506 HD12 ' C ' ' A' ' 40' ' ' THR . 42.6 mt -37.92 -46.7 0.99 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.409 -0.807 . . . . 0.0 110.181 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -53.64 -61.54 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 109.58 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 50' ' ' GLN . . . -43.49 -44.06 5.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 110.423 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.599 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -50.08 -35.75 26.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.115 -0.991 . . . . 0.0 110.044 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.45 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 43.7 tp10 -88.52 -49.75 6.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 108.932 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 52' ' ' GLN . . . -53.52 -42.21 67.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.395 -0.816 . . . . 0.0 108.97 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 23.4 mm100 -55.07 -21.31 12.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.21 -0.931 . . . . 0.0 109.191 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 47' ' ' LEU . 8.8 mmmt -91.02 9.29 31.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.714 . . . . 0.0 111.075 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -82.12 136.77 35.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.073 -1.017 . . . . 0.0 110.287 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.423 ' C ' ' HG2' ' A' ' 54' ' ' GLU . 8.2 mttt -131.66 -100.58 0.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.348 -0.845 . . . . 0.0 110.549 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.439 ' C ' ' HG3' ' A' ' 55' ' ' GLN . 2.5 mm-40 -131.25 88.13 2.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.871 -1.143 . . . . 0.0 110.139 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.439 ' HG3' ' C ' ' A' ' 54' ' ' GLU . 18.7 mt-30 -139.16 21.71 2.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.589 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 . . . . . 0 C--N 1.304 -1.382 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.394 -179.342 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.765 ' O ' HG23 ' A' ' 3' ' ' VAL . 4.8 tpt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 25.0 mttt -49.23 152.12 1.26 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.069 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.274 3.9 t -133.68 133.89 56.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 119.933 -1.729 . . . . 0.0 115.02 -174.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.877 HG12 HG23 ' A' ' 18' ' ' ILE 0.272 0.1 OUTLIER -100.51 87.95 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.294 177.657 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.842 ' CE2' HD22 ' A' ' 30' ' ' LEU . 11.9 m-85 -60.92 123.0 16.3 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 119.667 -1.896 . . . . 0.0 106.417 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 35' ' ' LEU . 1.2 pp -78.71 -25.24 44.67 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.371 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.431 ' HG3' HD12 ' A' ' 6' ' ' LEU . 24.1 mttm -124.7 171.45 10.07 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.232 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -88.15 139.89 30.04 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.598 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 10' ' ' LYS . 1.5 t -97.32 -155.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 109.83 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.618 ' H ' HG12 ' A' ' 9' ' ' VAL . 12.9 mtmt -82.56 71.24 9.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.031 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.16 18.01 68.68 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.38 -31.79 6.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -1.165 . . . . 0.0 110.613 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.541 ' CA ' ' OE2' ' A' ' 17' ' ' GLU . . . -139.25 173.25 22.82 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -142.98 -179.74 6.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.157 -1.202 . . . . 0.0 110.308 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.614 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -48.14 135.0 13.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.42 -0.8 . . . . 0.0 111.703 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.6 ' CA ' ' O ' ' A' ' 5' ' ' PHE . . . 28.32 37.91 0.01 OUTLIER Glycine 0 N--CA 1.504 3.219 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -67.76 124.87 24.51 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.577 -1.543 . . . . 0.0 108.988 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.07 HG21 ' HG ' ' A' ' 44' ' ' LEU . 1.4 mp -110.65 120.66 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 122.295 1.045 . . . . 0.0 111.694 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 17.8 tttt -161.83 -125.88 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.452 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 15.6 p-10 -151.88 119.17 5.95 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.946 HG21 HD11 ' A' ' 30' ' ' LEU 0.302 3.3 p -86.78 -147.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 178.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.211 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -71.76 110.0 6.02 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 103.832 -2.655 . . . . 0.0 103.832 174.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 1' ' ' MET . 3.4 m-20 -31.36 -31.63 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.832 -0.543 . . . . 0.0 111.393 -176.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -95.6 -38.66 4.64 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.211 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.277 0.1 OUTLIER -48.54 -55.4 11.18 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 177.264 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.78 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -30.43 -63.02 0.15 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.73 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.613 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 16.0 p30 -89.48 28.54 1.26 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.436 -0.79 . . . . 0.0 111.57 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' TYR . 10.8 t-20 -135.84 2.51 2.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.89 -1.131 . . . . 0.0 110.604 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.83 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -161.32 -47.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.238 -0.914 . . . . 0.0 110.093 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.946 HD11 HG21 ' A' ' 21' ' ' VAL . 12.5 mt -82.11 -35.09 28.93 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.8 -1.187 . . . . 0.0 110.062 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.069 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.265 9.4 m-30 -83.43 -65.68 0.98 Allowed 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.467 -179.301 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -52.44 -16.46 0.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.863 . . . . 0.0 111.574 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 21.8 mt-30 -107.94 -100.87 0.36 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.856 -1.153 . . . . 0.0 110.684 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.5 ' H ' HD12 ' A' ' 35' ' ' LEU . . . -166.87 38.28 0.24 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.167 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 30' ' ' LEU . 3.6 mp -106.74 -43.87 4.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.984 -1.303 . . . . 0.0 109.383 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.729 ' HB3' ' CB ' ' A' ' 30' ' ' LEU . . . -144.54 -179.86 6.83 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.876 0.846 . . . . 0.0 111.922 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -141.46 151.1 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.734 ' O ' HG22 ' A' ' 40' ' ' THR . 2.8 tt0 -43.03 111.47 0.27 Allowed 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.448 -0.782 . . . . 0.0 110.15 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -54.39 95.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.014 -1.475 . . . . 0.0 110.113 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -109.6 155.58 41.11 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 121.1 -1.0 . . . . 0.0 110.243 179.478 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.558 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 41.1 Cg_endo -50.07 -55.12 4.42 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.824 1.434 . . . . 0.0 109.292 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.17 -50.27 0.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.536 -0.727 . . . . 0.0 110.113 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.9 m120 -79.29 -59.2 2.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.719 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.07 ' HG ' HG21 ' A' ' 18' ' ' ILE . 10.6 mp -47.88 -24.33 0.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.295 -0.878 . . . . 0.0 110.178 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.37 -39.65 53.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.273 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -72.48 -46.33 55.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.511 -0.743 . . . . 0.0 110.042 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.643 ' CD1' HD11 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -41.29 -50.62 3.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 110.529 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -41.99 -43.03 3.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.739 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 50' ' ' GLN . . . -57.03 -53.71 54.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.992 . . . . 0.0 111.065 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -43.4 -51.0 6.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.043 -1.036 . . . . 0.0 110.558 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -41.08 89.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.223 -0.923 . . . . 0.0 110.97 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -48.96 -42.67 38.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.322 -0.861 . . . . 0.0 110.519 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -56.36 129.33 40.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.228 -0.92 . . . . 0.0 110.515 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.23 -83.8 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 109.734 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.98 24.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 109.97 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.414 ' C ' ' HD3' ' A' ' 56' ' ' ARG . 3.1 tmt_? . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.237 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.806 ' HE1' ' HB3' ' A' ' 27' ' ' ASN . 4.8 ttt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.6 0.238 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -49.45 156.7 0.59 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.066 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.272 2.9 t -132.13 133.72 60.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 119.973 -1.704 . . . . 0.0 114.462 -176.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.885 HG12 HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -101.58 95.28 3.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.911 ' CE1' HD22 ' A' ' 30' ' ' LEU . 9.9 m-85 -64.9 128.14 34.51 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 116.439 -2.104 . . . . 0.0 105.82 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.932 HD21 ' O ' ' A' ' 34' ' ' GLY . 1.2 pp -78.83 -28.39 44.4 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -133.33 172.89 12.08 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.714 0.769 . . . . 0.0 109.898 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.52 166.03 23.05 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.656 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.765 HG23 ' HA3' ' A' ' 13' ' ' GLY . 2.5 t -116.12 -146.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.301 -0.875 . . . . 0.0 108.913 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.648 ' H ' HG12 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -70.96 56.26 0.19 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.571 -1.331 . . . . 0.0 110.017 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 78.18 18.22 76.82 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.3 -70.67 0.77 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.135 -1.215 . . . . 0.0 110.504 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.765 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -57.8 -179.57 0.87 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.518 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 3.3 mtmt -150.7 169.27 22.03 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.322 -1.105 . . . . 0.0 108.699 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.624 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -67.34 137.85 56.33 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.962 -1.086 . . . . 0.0 110.32 -178.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 39.09 26.92 0.06 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.588 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -70.28 122.69 20.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.418 -1.637 . . . . 0.0 108.571 179.3 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.885 HG23 HG12 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -111.75 122.72 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.287 1.042 . . . . 0.0 112.283 -177.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.547 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 16.0 tptp -161.68 -124.27 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.506 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 50.0 p-10 -151.96 120.6 6.49 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 122.511 1.148 . . . . 0.0 108.503 175.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.029 HG21 HD11 ' A' ' 30' ' ' LEU 0.299 5.0 p -86.36 -140.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.201 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -77.91 110.62 12.98 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 174.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 22' ' ' ALA . 32.5 t0 -29.46 -34.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.303 0.573 . . . . 0.0 111.53 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -96.01 -37.61 4.86 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.201 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.299 0.0 OUTLIER -48.27 -55.26 11.02 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.425 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.749 ' HB2' HG12 ' A' ' 21' ' ' VAL 0.251 . . -28.75 -58.26 0.13 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.393 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.806 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 10.6 p30 -85.64 -0.48 55.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.031 -1.043 . . . . 0.0 113.587 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 25' ' ' TYR . 7.3 t30 -112.94 2.55 15.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.185 -1.572 . . . . 0.0 112.048 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -151.61 -46.86 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.769 -1.207 . . . . 0.0 110.499 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.029 HD11 HG21 ' A' ' 21' ' ' VAL . 14.0 mt -82.78 -38.2 23.5 Favored 'General case' 0 C--N 1.284 -2.269 0 O-C-N 120.359 -1.463 . . . . 0.0 110.375 -177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.066 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.273 8.5 m-30 -82.34 -53.74 5.78 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.844 -179.461 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.45 -2.04 7.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 0.0 112.289 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.587 ' HG2' ' CD1' ' A' ' 35' ' ' LEU . 1.1 tt0 -130.98 -10.82 3.8 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.513 -1.367 . . . . 0.0 110.715 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.932 ' O ' HD21 ' A' ' 6' ' ' LEU . . . 102.1 19.46 14.67 Favored Glycine 0 N--CA 1.498 2.802 0 C-N-CA 119.543 -1.313 . . . . 0.0 114.918 177.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.812 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 4.7 mp -86.89 -40.74 14.58 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-N 120.837 2.318 . . . . 0.0 107.707 176.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.708 ' HB3' ' HB3' ' A' ' 30' ' ' LEU 0.257 . . -144.58 -174.49 4.34 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.477 -178.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.692 HD11 HG21 ' A' ' 4' ' ' ILE . 1.8 pt -141.8 155.38 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.584 0.706 . . . . 0.0 109.195 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.654 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -51.04 108.83 0.27 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.432 -0.793 . . . . 0.0 110.059 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . . . -49.33 100.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.091 -1.444 . . . . 0.0 109.771 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -110.22 150.59 41.74 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.067 -1.021 . . . . 0.0 110.067 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.528 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 42.2 Cg_endo -49.58 -52.26 9.17 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 124.058 1.557 . . . . 0.0 108.959 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.18 -50.11 0.95 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.637 -0.665 . . . . 0.0 110.54 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' HB2' HG23 ' A' ' 40' ' ' THR . 1.0 OUTLIER -81.92 -54.24 5.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 110.221 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.84 ' CD1' HG21 ' A' ' 18' ' ' ILE . 2.8 mm? -39.95 -44.64 1.73 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.499 -0.751 . . . . 0.0 109.993 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt -63.74 -46.41 85.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -0.998 . . . . 0.0 108.749 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 43' ' ' ASN . . . -57.88 -49.89 75.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.601 -0.687 . . . . 0.0 109.413 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.803 HD12 HD11 ' A' ' 18' ' ' ILE . 3.4 mm? -52.47 -37.38 56.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.515 -0.741 . . . . 0.0 109.145 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -69.68 -44.96 69.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.597 -0.689 . . . . 0.0 110.497 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.57 -58.75 3.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.13 -0.981 . . . . 0.0 110.418 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.14 -36.3 18.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.062 -1.024 . . . . 0.0 110.054 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -66.15 -51.26 59.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.253 -0.905 . . . . 0.0 110.312 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -48.32 104.19 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.881 -1.137 . . . . 0.0 109.838 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.8 41.1 0.89 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 110.165 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.27 107.66 4.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.452 -0.78 . . . . 0.0 109.74 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.43 28.28 4.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.392 -0.817 . . . . 0.0 108.91 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.338 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.807 ' O ' HG23 ' A' ' 3' ' ' VAL . 7.1 tpt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -49.91 147.72 3.67 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.067 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.303 2.8 t -134.63 135.37 53.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -174.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.845 HG12 HG23 ' A' ' 18' ' ' ILE 0.271 0.1 OUTLIER -104.03 99.92 9.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.195 177.699 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.981 ' CE1' HD22 ' A' ' 30' ' ' LEU . 8.9 m-85 -72.66 129.18 37.66 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 117.782 -1.567 . . . . 0.0 107.605 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.893 HD13 ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -77.66 -30.39 52.07 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.162 -1.586 . . . . 0.0 107.295 179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -112.37 -177.19 3.1 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.824 0.821 . . . . 0.0 111.039 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' CB ' ' HA ' ' A' ' 14' ' ' LYS . 15.1 p-10 -109.41 139.58 44.2 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.479 0.657 . . . . 0.0 110.804 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 13' ' ' GLY . 2.1 t -99.24 170.47 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.564 -0.71 . . . . 0.0 109.158 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -74.35 83.34 1.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 110.216 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.89 35.58 54.03 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.483 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -137.74 -41.69 0.54 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -1.152 . . . . 0.0 110.435 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -154.53 161.8 30.36 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.582 ' HG2' ' CB ' ' A' ' 17' ' ' GLU . 12.6 pttt -132.33 175.41 9.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -1.141 . . . . 0.0 110.595 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.583 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -41.5 136.11 1.89 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.313 -0.867 . . . . 0.0 111.92 -179.086 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 29.91 35.11 0.01 OUTLIER Glycine 0 N--CA 1.507 3.409 0 O-C-N 121.963 -0.46 . . . . 0.0 112.131 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.582 ' CB ' ' HG2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -72.97 123.66 23.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.331 -1.688 . . . . 0.0 108.635 178.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.845 HG23 HG12 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -107.29 123.43 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.142 0.973 . . . . 0.0 111.029 -178.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 7.9 ttpt -161.17 -127.53 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 9.0 p30 -152.11 120.24 6.27 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.347 1.07 . . . . 0.0 108.314 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.927 HG21 HD11 ' A' ' 30' ' ' LEU 0.303 1.4 p -87.48 -146.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 178.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.187 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -72.09 108.7 5.43 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 1' ' ' MET . 1.9 m-20 -30.65 -32.28 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.121 0.486 . . . . 0.0 111.602 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -94.45 -38.85 4.9 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.187 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.299 0.1 OUTLIER -48.61 -57.08 6.76 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.543 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.867 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.39 -60.23 0.15 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.007 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.6 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -89.58 11.69 18.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.992 -1.068 . . . . 0.0 112.786 -179.018 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.0 10.88 8.87 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.522 -1.361 . . . . 0.0 110.616 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.829 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.65 -52.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.144 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.981 HD22 ' CE1' ' A' ' 5' ' ' PHE . 19.1 mt -75.67 -39.94 56.78 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.735 -1.228 . . . . 0.0 109.94 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.067 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.281 8.5 m-30 -81.74 -44.6 16.82 Favored 'General case' 0 C--N 1.272 -2.786 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.88 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -68.29 -5.22 17.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.461 -0.774 . . . . 0.0 111.147 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.59 ' HB2' ' CD1' ' A' ' 35' ' ' LEU . 23.2 mm100 -129.64 -14.96 4.04 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.778 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.681 ' O ' HD23 ' A' ' 6' ' ' LEU . . . 100.69 18.53 20.44 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.414 -1.374 . . . . 0.0 111.675 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.859 HD13 ' HA ' ' A' ' 30' ' ' LEU . 5.3 mp -79.72 -43.24 23.01 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.678 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -142.08 -176.69 4.9 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.157 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.469 ' O ' ' C ' ' A' ' 38' ' ' GLU . 10.6 mt -141.99 136.67 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.468 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.683 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 9.7 pt-20 -38.65 113.83 0.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.613 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.638 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -48.58 99.24 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 117.804 -1.558 . . . . 0.0 110.057 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -112.71 153.51 45.04 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.537 -0.727 . . . . 0.0 109.692 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.564 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 40.1 Cg_endo -50.79 -60.83 0.68 Allowed 'Trans proline' 0 C--N 1.299 -2.031 0 O-C-N 123.971 1.511 . . . . 0.0 110.149 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.79 -54.13 0.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.486 -0.759 . . . . 0.0 111.814 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.622 ' HB2' HG23 ' A' ' 40' ' ' THR . 1.5 m-20 -79.21 -34.7 42.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.956 -1.09 . . . . 0.0 111.193 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.638 HD21 ' HB1' ' A' ' 39' ' ' ALA . 5.3 mp -66.59 -66.58 0.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 44' ' ' LEU . 1.7 ttpt -41.53 -48.93 4.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 110.094 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.89 -46.86 88.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.86 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.521 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -47.58 -53.02 15.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.337 -0.852 . . . . 0.0 110.004 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.477 ' OE1' ' HB2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -57.88 -37.93 74.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.416 -0.803 . . . . 0.0 110.565 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.35 -49.57 76.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.149 -0.969 . . . . 0.0 109.977 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -31.71 71.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 110.115 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -82.58 -25.45 33.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.0 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.477 ' HB2' ' OE1' ' A' ' 48' ' ' GLU . 4.3 tp60 -73.01 -78.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.195 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.431 ' HG2' ' OE1' ' A' ' 55' ' ' GLN . 8.3 tptt -58.16 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.377 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 114.64 1.71 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 110.171 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' OE1' ' HG2' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -139.18 16.16 2.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 108.991 179.651 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? . . . . . 0 C--N 1.304 -1.375 0 CA-C-O 117.825 -1.083 . . . . 0.0 110.054 -179.468 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.552 ' CE ' ' HB3' ' A' ' 27' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.778 0.323 . . . . 0.0 110.43 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.613 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 30.4 mttt -59.45 149.71 28.75 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.078 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.27 2.8 t -129.51 131.77 66.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.295 -1.503 . . . . 0.0 114.74 -175.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.834 HG12 HG23 ' A' ' 18' ' ' ILE 0.254 0.0 OUTLIER -99.58 98.4 7.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.534 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.037 ' HE1' HD22 ' A' ' 30' ' ' LEU . 8.6 m-85 -75.65 124.23 26.89 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.106 -1.621 . . . . 0.0 107.854 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.004 HD21 HG23 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -83.03 -27.31 30.43 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 120.656 -1.277 . . . . 0.0 112.144 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -95.72 -152.52 0.37 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.776 ' C ' ' O ' ' A' ' 13' ' ' GLY . 37.7 p-10 -99.02 133.71 42.89 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.465 -0.772 . . . . 0.0 109.543 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.08 HG23 ' HA2' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -88.1 2.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.72 70.12 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 101.75 9.13 44.09 Favored Glycine 0 CA--C 1.549 2.208 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 10.5 mttm -151.15 -87.06 0.07 Allowed 'General case' 0 N--CA 1.511 2.604 0 O-C-N 120.47 -1.606 . . . . 0.0 113.487 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 1.08 ' HA2' HG23 ' A' ' 9' ' ' VAL . . . -156.22 144.67 11.1 Favored Glycine 0 N--CA 1.505 3.292 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.557 ' N ' ' HB ' ' A' ' 9' ' ' VAL . 2.3 mtmt -88.68 145.75 25.47 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 119.895 1.848 . . . . 0.0 111.011 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.64 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -28.7 121.32 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.867 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 20.51 46.3 0.01 OUTLIER Glycine 0 N--CA 1.512 3.74 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -80.04 121.85 26.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.665 -1.491 . . . . 0.0 109.646 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.025 HG21 HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -104.53 123.07 58.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-O 122.482 1.134 . . . . 0.0 111.661 -178.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -161.54 -127.87 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.168 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -152.17 120.67 6.42 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 122.37 1.081 . . . . 0.0 108.863 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.01 HG21 HD11 ' A' ' 30' ' ' LEU 0.29 2.5 p -87.55 -149.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.216 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -70.5 109.84 5.05 Favored 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 1' ' ' MET . 2.1 m-20 -30.59 -31.53 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.046 0.451 . . . . 0.0 111.677 -176.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -98.65 -35.68 4.82 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.216 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.274 0.1 OUTLIER -48.83 -53.51 19.02 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.613 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.769 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -30.32 -57.99 0.19 Allowed 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.177 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.606 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 12.5 p30 -90.15 5.82 45.27 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.958 -1.089 . . . . 0.0 112.054 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 25' ' ' TYR . 4.9 t-20 -108.95 -0.15 19.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.102 . . . . 0.0 111.23 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.777 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.56 -52.88 0.05 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.885 -1.135 . . . . 0.0 111.132 -178.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.037 HD22 ' HE1' ' A' ' 5' ' ' PHE . 20.9 mt -71.39 -44.91 64.07 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 122.269 1.033 . . . . 0.0 110.71 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.078 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.277 7.2 m-30 -78.62 -42.74 28.06 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.573 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 31.0 tptt -69.95 0.28 6.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.468 -0.77 . . . . 0.0 111.446 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.586 ' HB2' ' CD1' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -132.58 -14.4 2.86 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.795 -1.19 . . . . 0.0 111.349 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 100.82 18.62 19.87 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.149 -1.5 . . . . 0.0 111.005 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.928 HD13 ' HA ' ' A' ' 30' ' ' LEU . 4.6 mp -80.83 -49.77 10.65 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.665 -1.491 . . . . 0.0 107.734 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.929 ' HA ' HD22 ' A' ' 6' ' ' LEU 0.262 . . -139.23 -177.06 4.74 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.015 -178.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.004 HG23 HD21 ' A' ' 6' ' ' LEU . 5.8 pt -139.37 161.72 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 6.4 tt0 -55.11 105.06 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.249 -0.907 . . . . 0.0 109.162 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.613 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -54.17 89.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 118.323 -1.351 . . . . 0.0 110.355 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.59 ' OG1' ' CD ' ' A' ' 41' ' ' PRO . 0.9 OUTLIER -115.16 156.46 45.42 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.153 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' OG1' ' A' ' 40' ' ' THR . 50.2 Cg_endo -49.79 -61.27 0.6 Allowed 'Trans proline' 0 C--N 1.3 -2.003 0 O-C-N 124.155 1.608 . . . . 0.0 110.496 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.1 -35.13 0.07 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.689 -0.632 . . . . 0.0 111.267 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.421 ' O ' ' C ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -99.31 -51.19 3.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.975 -1.078 . . . . 0.0 110.862 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.025 HD11 HG21 ' A' ' 18' ' ' ILE . 1.8 mm? -40.85 -47.47 2.93 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 110.754 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.86 -35.57 75.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 110.757 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -71.38 -39.2 71.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 0.0 110.272 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.528 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -40.52 -45.08 2.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 110.251 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 44.3 tt0 -70.85 -50.64 33.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.149 -0.969 . . . . 0.0 110.551 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.67 67.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.109 -0.994 . . . . 0.0 110.321 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -51.69 -32.22 29.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.854 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -63.77 -38.47 91.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.483 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -59.63 2.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.789 . . . . 0.0 109.334 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -53.45 -72.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.488 -0.757 . . . . 0.0 109.819 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.11 135.21 42.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 109.916 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -148.45 60.08 1.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.485 -179.069 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.715 ' O ' HG23 ' A' ' 3' ' ' VAL . 7.6 tpt . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.645 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 5.8 mtmm -50.57 152.35 1.98 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.114 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.273 3.7 t -132.37 131.84 60.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 119.836 -1.79 . . . . 0.0 114.972 -175.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.868 HG22 ' O ' ' A' ' 4' ' ' ILE 0.25 0.1 OUTLIER -98.99 89.26 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.838 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.933 ' CE2' HD22 ' A' ' 30' ' ' LEU . 11.2 m-85 -65.56 116.18 6.55 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 119.622 -1.924 . . . . 0.0 106.545 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -79.36 -23.46 43.34 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.529 ' N ' ' HG ' ' A' ' 6' ' ' LEU . 20.5 mttt -111.67 -172.4 2.03 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.795 0.807 . . . . 0.0 110.391 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 15.7 p30 -109.06 153.06 24.19 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.969 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.66 HG21 ' CE2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -130.92 -157.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 109.144 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -77.82 75.51 4.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.963 -1.086 . . . . 0.0 110.012 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.58 17.41 13.37 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.9 -40.36 11.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.314 -1.109 . . . . 0.0 109.73 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.493 ' HA2' ' OE1' ' A' ' 17' ' ' GLU . . . -152.11 157.81 27.46 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.505 ' HG2' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -116.18 175.55 5.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -1.083 . . . . 0.0 110.58 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -37.95 134.43 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.583 -0.698 . . . . 0.0 111.19 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 27.14 39.24 0.01 OUTLIER Glycine 0 N--CA 1.507 3.406 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.646 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -74.61 132.01 41.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.669 -1.489 . . . . 0.0 108.94 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.018 HG21 HD11 ' A' ' 44' ' ' LEU . 1.2 mp -112.22 123.54 68.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.907 -1.121 . . . . 0.0 111.693 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 5.5 ttmt -160.97 -126.37 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -151.93 119.86 6.2 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.944 HG21 HD11 ' A' ' 30' ' ' LEU 0.301 3.6 p -87.23 -143.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 178.51 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.199 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -73.17 109.98 7.11 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -31.42 -30.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.976 -0.452 . . . . 0.0 111.697 -176.418 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.84 -37.96 4.28 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.199 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.305 0.1 OUTLIER -48.04 -56.92 6.57 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.539 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.79 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -28.69 -60.6 0.12 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.686 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.634 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 24.1 t30 -89.3 34.03 0.81 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.02 -1.05 . . . . 0.0 112.44 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -147.56 9.1 0.91 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.437 -1.414 . . . . 0.0 110.613 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.836 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.69 -46.42 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.068 -1.02 . . . . 0.0 109.254 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.944 HD11 HG21 ' A' ' 21' ' ' VAL . 10.9 mt -87.03 -36.14 18.37 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 120.926 -1.109 . . . . 0.0 109.473 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.114 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.277 8.6 m-30 -82.71 -49.0 10.24 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.508 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -70.4 1.24 5.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.267 -0.896 . . . . 0.0 110.605 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 4.8 mt-30 -127.97 -114.31 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.944 -1.098 . . . . 0.0 110.781 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 7' ' ' LYS . . . -145.61 14.97 1.8 Allowed Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.779 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.728 HD13 HD23 ' A' ' 30' ' ' LEU . 1.7 mp -83.93 -51.45 7.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.776 -1.426 . . . . 0.0 109.836 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.71 ' HB3' ' CB ' ' A' ' 30' ' ' LEU . . . -143.72 -179.61 6.56 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.377 1.084 . . . . 0.0 112.99 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.449 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -144.48 149.18 17.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.273 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.77 ' O ' HG22 ' A' ' 40' ' ' THR . 17.2 tt0 -37.05 108.94 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.882 -0.511 . . . . 0.0 110.97 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.645 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -55.97 97.85 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 118.113 -1.435 . . . . 0.0 110.289 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.77 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -119.09 155.27 53.39 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.112 -0.993 . . . . 0.0 110.577 179.428 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.553 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 39.6 Cg_endo -49.31 -45.26 30.92 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.803 1.423 . . . . 0.0 108.967 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.96 -57.26 0.83 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.282 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 44' ' ' LEU . 58.5 m-20 -88.31 -46.31 9.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 0.0 110.318 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.018 HD11 HG21 ' A' ' 18' ' ' ILE . 2.9 mm? -36.86 -66.58 0.22 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.512 -0.743 . . . . 0.0 110.769 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -55.06 -36.65 65.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.067 -1.02 . . . . 0.0 110.41 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 49' ' ' ALA . . . -66.22 -39.24 89.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.085 -1.01 . . . . 0.0 110.274 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -43.55 -50.22 7.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.028 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' LEU . 20.5 tt0 -45.26 -31.62 1.61 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.19 -0.944 . . . . 0.0 109.012 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . -85.2 -48.46 9.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.504 -0.748 . . . . 0.0 109.456 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.404 ' C ' ' OE1' ' A' ' 50' ' ' GLN . 1.2 tm0? -51.51 -38.81 55.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 109.238 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HE2' ' HE3' ' A' ' 15' ' ' LYS . 2.4 tppp? -62.53 -52.45 63.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.421 -0.799 . . . . 0.0 109.607 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.52 92.47 9.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 110.146 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -80.98 72.24 7.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.403 -0.811 . . . . 0.0 109.912 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -116.42 155.19 28.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.335 -0.853 . . . . 0.0 110.574 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -137.28 -31.36 0.82 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.4 -0.812 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.331 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.757 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.657 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 2.2 mttp -49.4 145.79 4.4 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.085 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.283 2.9 t -136.66 130.24 46.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 118.312 -1.355 . . . . 0.0 114.361 -175.427 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.819 HG22 ' O ' ' A' ' 4' ' ' ILE 0.262 0.1 OUTLIER -98.81 95.3 4.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.633 178.283 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.982 ' CE2' HD22 ' A' ' 30' ' ' LEU . 11.5 m-85 -66.67 124.41 22.79 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.02 -1.675 . . . . 0.0 106.674 177.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.679 HD12 ' HD3' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -78.52 -24.78 45.58 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.672 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.679 ' HD3' HD12 ' A' ' 6' ' ' LEU . 8.3 mptt -118.65 -163.75 0.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.463 0.649 . . . . 0.0 110.361 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -109.65 153.99 23.45 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.904 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 10' ' ' LYS . 1.7 t -124.89 -162.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -0.98 . . . . 0.0 109.86 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.69 ' H ' HG12 ' A' ' 9' ' ' VAL . 4.4 mmtt -65.74 83.05 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 0.0 109.799 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' LYS . . . 45.49 26.5 1.65 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -108.54 -67.61 0.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.351 -1.088 . . . . 0.0 110.111 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' HA2' ' CD ' ' A' ' 17' ' ' GLU . . . -106.2 162.65 13.86 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.522 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 6.1 mmpt? -128.38 -172.56 2.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.358 -1.084 . . . . 0.0 109.541 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.576 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -53.95 129.62 34.69 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 110.302 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 5' ' ' PHE . . . 32.68 37.22 0.04 OUTLIER Glycine 0 N--CA 1.503 3.105 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -76.49 128.35 34.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.879 -1.365 . . . . 0.0 109.48 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 4' ' ' ILE . 1.7 mp -100.51 118.44 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 122.456 1.122 . . . . 0.0 111.258 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.556 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 1.5 tttt -161.92 152.05 16.92 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -87.39 123.91 32.84 Favored 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 116.871 -1.932 . . . . 0.0 109.005 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.919 HG22 ' CD2' ' A' ' 25' ' ' TYR 0.328 2.7 p -87.14 -144.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 178.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.212 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -74.28 111.26 9.28 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 1' ' ' MET . 1.1 m-20 -31.51 -31.2 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.965 -0.46 . . . . 0.0 111.906 -176.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -98.05 -36.89 4.55 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.212 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.309 0.1 OUTLIER -48.73 -57.09 6.85 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 176.797 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.816 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -30.14 -63.97 0.13 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.448 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.703 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 20.3 t30 -85.84 4.62 36.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.521 -0.737 . . . . 0.0 112.814 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -118.19 11.43 13.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.508 -1.37 . . . . 0.0 111.165 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.83 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -161.17 -46.78 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.953 -1.092 . . . . 0.0 110.531 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.982 HD22 ' CE2' ' A' ' 5' ' ' PHE . 16.8 mt -84.03 -34.17 24.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.67 -1.268 . . . . 0.0 110.014 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.085 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.261 7.2 m-30 -82.64 -58.14 3.03 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.236 -178.207 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -68.87 -1.11 6.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 111.873 -178.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 2.4 mt-30 -114.57 -92.89 0.49 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.734 -1.229 . . . . 0.0 110.273 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.418 ' H ' HD12 ' A' ' 35' ' ' LEU . . . -171.86 28.84 0.11 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.552 -1.309 . . . . 0.0 110.067 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 30' ' ' LEU . 2.9 mp -101.44 -50.51 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.091 -1.24 . . . . 0.0 110.54 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 30' ' ' LEU 0.263 . . -144.36 179.09 7.47 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.906 0.86 . . . . 0.0 112.831 -177.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.507 ' C ' ' CZ ' ' A' ' 31' ' ' PHE . 4.9 pt -136.56 162.25 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 175.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 40' ' ' THR . 15.3 tt0 -55.5 118.88 4.86 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.971 -1.081 . . . . 0.0 109.66 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -59.21 83.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 117.877 -1.529 . . . . 0.0 110.073 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.618 HG23 ' HD2' ' A' ' 41' ' ' PRO . 0.9 OUTLIER -112.0 162.72 19.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.187 -0.946 . . . . 0.0 109.544 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 40' ' ' THR . 45.4 Cg_endo -48.58 -66.4 0.14 Allowed 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 123.78 1.411 . . . . 0.0 110.615 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.52 -30.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.485 -0.76 . . . . 0.0 110.883 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' PRO . 18.4 m-20 -93.71 -60.65 1.71 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 110.337 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.499 HD11 HG21 ' A' ' 18' ' ' ILE . 2.4 mm? -44.7 -39.02 4.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.05 -1.031 . . . . 0.0 110.029 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 21.8 mttt -72.63 -39.52 67.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 109.25 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.3 -40.41 71.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.027 -1.046 . . . . 0.0 109.214 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.425 HD11 ' HA3' ' A' ' 16' ' ' GLY . 3.1 mm? -56.46 -39.3 72.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.698 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 45' ' ' LYS . 12.7 tt0 -59.7 -22.17 61.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.493 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.04 -47.1 30.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.133 -0.98 . . . . 0.0 110.563 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -60.7 -27.78 68.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.514 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -82.06 -46.49 13.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.15 -0.969 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -59.2 110.85 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.06 -1.025 . . . . 0.0 110.302 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.8 119.85 20.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.297 -0.877 . . . . 0.0 110.363 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -123.02 105.0 9.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 110.228 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.83 -41.04 0.17 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.9 . . . . 0.0 108.956 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.597 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.589 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.617 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.717 0.294 . . . . 0.0 110.593 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.597 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 8.8 mtmt -57.46 149.39 21.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.087 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.283 2.9 t -135.57 130.78 50.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 117.527 -1.669 . . . . 0.0 114.863 -175.147 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 4' ' ' ILE 0.264 0.0 OUTLIER -100.28 98.24 6.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.421 178.324 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.959 ' CE1' HD22 ' A' ' 30' ' ' LEU . 13.5 m-85 -70.15 127.89 34.4 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.052 -1.655 . . . . 0.0 106.923 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.903 HD22 ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -76.5 -29.2 56.71 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 120.538 -1.352 . . . . 0.0 108.207 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.35 165.88 18.2 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.98 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.07 156.57 29.95 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.458 -179.167 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 11' ' ' GLY . 1.9 t -111.18 166.27 5.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 109.082 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.24 82.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 0.0 110.327 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 61.41 48.47 84.94 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -142.99 -61.44 0.42 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.079 -1.248 . . . . 0.0 111.252 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.478 ' HA2' ' OE1' ' A' ' 17' ' ' GLU . . . -121.15 162.57 14.85 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 4.1 mttt -119.36 176.98 5.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -1.119 . . . . 0.0 111.307 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.63 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -45.24 132.33 7.51 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.687 -0.633 . . . . 0.0 112.031 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.562 ' CA ' ' O ' ' A' ' 5' ' ' PHE . . . 33.26 32.61 0.01 OUTLIER Glycine 0 N--CA 1.509 3.548 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.657 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -70.16 125.06 25.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.167 -1.196 . . . . 0.0 109.62 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.936 HG21 HD11 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -103.38 115.5 45.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 120.505 -1.372 . . . . 0.0 110.233 -179.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -161.31 152.99 19.25 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.571 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -87.51 124.15 33.17 Favored 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 117.216 -1.794 . . . . 0.0 109.807 -179.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.904 HG21 HD11 ' A' ' 30' ' ' LEU 0.299 1.3 p -87.25 -150.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.21 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -68.16 107.91 2.94 Favored 'General case' 0 C--N 1.272 -2.763 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 1' ' ' MET . 88.6 m-20 -30.86 -32.24 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.982 -0.449 . . . . 0.0 111.667 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -96.94 -36.38 5.01 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.21 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.308 0.0 OUTLIER -47.83 -59.14 3.54 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 177.289 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.873 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.25 -57.41 0.15 Allowed 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.314 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.654 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 21.2 t30 -80.72 -35.56 33.3 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.883 -1.136 . . . . 0.0 113.263 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -80.58 15.27 1.74 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.519 -1.363 . . . . 0.0 110.717 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.775 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -160.31 -99.58 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.32 -0.863 . . . . 0.0 109.983 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.062 ' HA ' HD13 ' A' ' 35' ' ' LEU . 14.2 mt -29.81 -42.48 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.574 0 CA-C-O 122.431 1.11 . . . . 0.0 110.296 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.087 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.264 8.8 m-30 -79.37 -56.44 4.34 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.41 -178.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.29 11.9 6.06 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.953 -1.092 . . . . 0.0 110.693 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.7 ' HB3' HD11 ' A' ' 35' ' ' LEU . 1.7 mt-30 -121.08 -19.37 7.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.873 -1.142 . . . . 0.0 111.061 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.466 ' N ' HD12 ' A' ' 35' ' ' LEU . . . 101.04 41.62 2.59 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.947 -1.121 . . . . 0.0 111.594 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.062 HD13 ' HA ' ' A' ' 30' ' ' LEU . 1.9 mp -122.16 -46.49 2.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.008 -1.289 . . . . 0.0 109.433 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.903 ' HA ' HD22 ' A' ' 6' ' ' LEU 0.264 . . -142.14 177.77 8.0 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.656 0.741 . . . . 0.0 111.222 -178.095 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.896 HG23 HD21 ' A' ' 6' ' ' LEU . 2.7 pp -135.69 174.51 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.03 111.1 2.38 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.228 -0.92 . . . . 0.0 110.007 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -54.4 99.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 118.122 -1.431 . . . . 0.0 110.188 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.59 ' OG1' ' CD ' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -118.37 160.38 39.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 109.647 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' OG1' ' A' ' 40' ' ' THR . 50.1 Cg_endo -50.12 -62.43 0.41 Allowed 'Trans proline' 0 C--N 1.299 -2.048 0 O-C-N 123.846 1.446 . . . . 0.0 110.662 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.09 -40.64 0.22 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.493 -0.754 . . . . 0.0 110.865 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 10.0 m120 -85.86 -57.42 3.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.14 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 18' ' ' ILE . 3.7 mm? -42.33 -55.08 3.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.865 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.42 -43.03 88.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.12 -0.987 . . . . 0.0 109.365 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 43' ' ' ASN . . . -56.23 -49.81 73.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.656 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -48.9 -31.85 7.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.349 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 52' ' ' GLN . 4.1 tp10 -72.26 -24.46 61.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.843 . . . . 0.0 110.111 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.84 -59.21 2.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 0.0 109.877 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -45.19 -37.24 4.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 110.657 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 52' ' ' GLN . 0.6 OUTLIER -76.96 -40.38 47.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.224 -0.922 . . . . 0.0 110.63 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 11.0 mt-30 -53.4 -174.35 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.149 -0.969 . . . . 0.0 109.57 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -127.23 -18.31 4.56 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 111.363 -178.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' A' ' 53' ' ' LYS . 15.6 tm-20 -104.32 122.51 45.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.883 -1.136 . . . . 0.0 110.887 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.407 ' CD ' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -159.96 22.84 0.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.921 . . . . 0.0 109.953 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.332 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.672 ' O ' HG23 ' A' ' 3' ' ' VAL . 3.0 ttt . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 8.1 mttp -54.47 149.3 10.6 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.13 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.294 3.1 t -133.33 134.78 57.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 117.716 -1.593 . . . . 0.0 115.252 -175.097 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.862 HG22 ' O ' ' A' ' 4' ' ' ILE 0.271 0.1 OUTLIER -98.91 92.39 2.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.888 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.718 ' CE2' HD22 ' A' ' 30' ' ' LEU . 9.3 m-85 -68.22 126.47 29.65 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 116.881 -1.928 . . . . 0.0 106.9 178.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.649 HD21 ' C ' ' A' ' 34' ' ' GLY . 1.3 pp -78.22 -27.91 47.85 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.62 ' HG3' HD12 ' A' ' 6' ' ' LEU . 9.0 mttm -117.76 -165.75 1.13 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.36 159.78 23.52 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.362 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.68 HG12 ' H ' ' A' ' 10' ' ' LYS . 2.2 t -99.66 -154.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 0.0 109.091 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.68 ' H ' HG12 ' A' ' 9' ' ' VAL . 4.5 ptmt -83.23 64.77 7.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.684 -1.26 . . . . 0.0 110.665 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.85 25.52 45.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -67.8 0.84 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.076 -1.249 . . . . 0.0 110.063 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.04 165.52 34.62 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 67.0 mttt -138.5 173.65 11.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.246 . . . . 0.0 110.282 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -47.1 139.32 5.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.869 . . . . 0.0 111.32 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.673 ' O ' HD12 ' A' ' 47' ' ' LEU . . . 25.49 39.44 0.01 OUTLIER Glycine 0 N--CA 1.511 3.672 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -76.34 127.87 33.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.93 -1.335 . . . . 0.0 108.452 179.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.985 HG21 ' CD1' ' A' ' 44' ' ' LEU . 2.9 mp -108.67 120.93 60.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 122.201 1.001 . . . . 0.0 110.687 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 3.0 tttt -160.99 -127.09 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -151.55 120.3 6.56 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-O 122.18 0.991 . . . . 0.0 108.351 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.913 HG21 HD11 ' A' ' 30' ' ' LEU 0.29 5.4 p -87.02 -141.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 178.421 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.2 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -74.77 113.39 11.99 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 174.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -31.16 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 120.934 0.397 . . . . 0.0 111.583 -176.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -99.49 -36.58 4.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.2 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.307 0.1 OUTLIER -48.25 -55.28 10.93 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 177.396 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.802 ' HB2' HG12 ' A' ' 21' ' ' VAL 0.254 . . -29.44 -64.08 0.11 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.25 177.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.666 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 5.5 t30 -89.75 33.54 0.85 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.055 -1.028 . . . . 0.0 112.27 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 25' ' ' TYR . 1.1 m-20 -144.89 8.05 1.25 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.485 -1.385 . . . . 0.0 110.573 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.867 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -160.73 -49.48 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.874 0.845 . . . . 0.0 108.945 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.913 HD11 HG21 ' A' ' 21' ' ' VAL . 12.2 mt -80.85 -34.93 33.42 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 122.629 1.204 . . . . 0.0 109.09 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.13 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.281 7.1 m-30 -88.0 -52.61 5.17 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.448 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -7.76 6.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.621 -0.674 . . . . 0.0 110.75 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 12.9 mt-30 -123.9 -111.16 0.31 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.929 -1.107 . . . . 0.0 110.328 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.649 ' C ' HD21 ' A' ' 6' ' ' LEU . . . -152.39 36.48 0.81 Allowed Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.285 -1.436 . . . . 0.0 110.914 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.706 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 3.0 mp -104.46 -38.64 6.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.832 -1.393 . . . . 0.0 109.403 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -153.3 -176.74 5.93 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.132 0.968 . . . . 0.0 112.703 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.567 ' C ' ' CE1' ' A' ' 31' ' ' PHE . 7.9 pt -143.51 160.15 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.345 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.623 ' O ' HG22 ' A' ' 40' ' ' THR . 8.2 tt0 -51.11 110.3 0.42 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.382 -0.824 . . . . 0.0 110.191 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.543 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -51.31 97.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 118.008 -1.477 . . . . 0.0 110.206 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -109.06 152.34 42.43 Favored Pre-proline 0 N--CA 1.505 2.298 0 O-C-N 121.124 -0.985 . . . . 0.0 110.472 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 41.6 Cg_endo -49.78 -58.8 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.827 1.435 . . . . 0.0 110.056 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.73 -60.22 0.62 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.415 -0.803 . . . . 0.0 110.816 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.489 ' ND2' ' CG2' ' A' ' 40' ' ' THR . 29.5 m-20 -67.47 -49.68 62.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.267 -0.896 . . . . 0.0 110.557 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.985 ' CD1' HG21 ' A' ' 18' ' ' ILE . 2.2 mm? -45.91 -33.88 3.53 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.41 -0.806 . . . . 0.0 110.094 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -64.63 -51.29 63.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.051 -1.031 . . . . 0.0 109.551 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.39 -46.85 66.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.936 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -66.63 -51.71 53.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 0.0 109.116 179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -51.34 -31.7 22.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.588 -0.695 . . . . 0.0 110.256 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.64 -43.87 71.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.046 -1.034 . . . . 0.0 110.041 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -79.79 -18.04 51.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 0.0 109.52 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -90.06 -13.33 36.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.819 . . . . 0.0 110.411 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -57.89 -16.18 11.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.099 -1.001 . . . . 0.0 110.333 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.7 -166.72 1.59 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.075 -1.016 . . . . 0.0 110.069 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.48 -51.01 0.25 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.057 -1.027 . . . . 0.0 110.129 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.15 48.89 0.27 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.947 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.41 ' CD ' ' O ' ' A' ' 56' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.293 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.534 ' O ' HG23 ' A' ' 3' ' ' VAL . 6.5 ttt . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.626 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -54.64 156.71 3.36 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.026 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.077 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.295 3.2 t -134.05 131.55 55.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 120.161 -1.587 . . . . 0.0 114.918 -175.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.901 HG22 ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -95.45 89.6 2.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.923 ' CE1' HD22 ' A' ' 30' ' ' LEU . 7.2 m-85 -65.0 122.34 16.78 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 116.342 -2.143 . . . . 0.0 106.248 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.819 HD23 ' HA ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -78.98 -23.11 44.69 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.033 -1.067 . . . . 0.0 108.524 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.598 ' HD2' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -137.95 170.95 15.16 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.397 0.617 . . . . 0.0 109.509 178.078 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -81.12 168.98 17.99 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.336 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 10' ' ' LYS . 2.1 t -125.72 -143.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.33 -0.856 . . . . 0.0 109.132 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' H ' HG12 ' A' ' 9' ' ' VAL . 14.6 mttp -75.2 83.78 2.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.993 -1.067 . . . . 0.0 109.543 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 10' ' ' LYS . . . 44.74 51.77 7.99 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -146.06 -75.71 0.21 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -1.077 . . . . 0.0 111.218 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.465 ' HA2' ' OE2' ' A' ' 17' ' ' GLU . . . -62.87 -175.91 2.95 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.445 -0.884 . . . . 0.0 110.932 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.606 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 10.9 mttt -147.26 166.5 26.85 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.638 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -65.71 136.06 55.78 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.842 -1.161 . . . . 0.0 110.72 -178.159 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 34.35 30.58 0.01 OUTLIER Glycine 0 N--CA 1.503 3.11 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -177.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.606 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -72.23 126.11 28.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.842 -1.387 . . . . 0.0 109.789 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.732 HG21 ' HG ' ' A' ' 44' ' ' LEU . 2.2 mp -106.38 122.59 60.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.043 0.925 . . . . 0.0 110.577 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -161.0 -128.96 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 36.6 p-10 -152.39 119.57 5.89 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 122.221 1.01 . . . . 0.0 108.921 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.07 HG21 HD11 ' A' ' 30' ' ' LEU 0.3 3.9 p -87.51 -146.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.624 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 177.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.192 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -71.52 109.72 5.66 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 22' ' ' ALA . 3.1 m-20 -32.24 -29.88 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.802 -0.561 . . . . 0.0 111.798 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.25 -38.2 4.36 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.321 -1.911 . . . . 0.0 108.321 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.192 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.298 0.1 OUTLIER -48.44 -54.95 12.24 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 177.219 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.779 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.39 -60.39 0.15 Allowed 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.837 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.6 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 16.7 t30 -90.18 14.77 11.68 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.175 -0.953 . . . . 0.0 112.5 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.94 6.24 10.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.67 -1.269 . . . . 0.0 110.044 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.797 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -161.24 -58.59 0.05 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.99 0.9 . . . . 0.0 110.527 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.07 HD11 HG21 ' A' ' 21' ' ' VAL . 22.3 mt -67.98 -39.71 83.26 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 122.674 1.226 . . . . 0.0 110.357 -176.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.077 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.259 10.1 m-30 -77.62 -44.54 27.92 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 114.869 -1.059 . . . . 0.0 113.46 -177.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.22 9.9 24.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.506 -1.371 . . . . 0.0 111.906 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 4.5 mt-30 -125.94 -11.76 6.52 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.59 -1.319 . . . . 0.0 111.474 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 27.63 7.28 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.419 -1.372 . . . . 0.0 111.673 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.94 HD13 ' HA ' ' A' ' 30' ' ' LEU . 4.4 mp -101.53 -47.29 4.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.629 -1.512 . . . . 0.0 108.382 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.819 ' HA ' HD23 ' A' ' 6' ' ' LEU 0.255 . . -145.77 -174.81 4.51 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.839 0.828 . . . . 0.0 111.032 -178.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.588 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 1.8 pt -142.3 169.4 13.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.607 ' O ' HG22 ' A' ' 40' ' ' THR . 20.4 tt0 -59.66 107.17 0.56 Allowed 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.393 -0.817 . . . . 0.0 109.774 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.626 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -63.64 96.88 0.13 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.822 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.644 HG23 ' HB2' ' A' ' 43' ' ' ASN . 0.2 OUTLIER -111.61 145.58 32.92 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.028 -1.045 . . . . 0.0 108.91 178.124 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.499 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 46.0 Cg_endo -48.87 -54.76 4.93 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 O-C-N 123.781 1.411 . . . . 0.0 109.217 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.35 -52.55 1.11 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 111.16 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.644 ' HB2' HG23 ' A' ' 40' ' ' THR . 4.1 m-20 -80.29 -48.48 12.97 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.035 -1.041 . . . . 0.0 111.075 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.732 ' HG ' HG21 ' A' ' 18' ' ' ILE . 6.3 mp -46.12 -22.58 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.966 . . . . 0.0 109.85 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -77.67 -34.77 52.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 48' ' ' GLU . . . -68.76 -37.62 79.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.495 -0.753 . . . . 0.0 110.194 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.482 ' HG ' HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -38.84 -27.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.655 -0.653 . . . . 0.0 110.298 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 46' ' ' ALA . 7.6 tm-20 -68.86 -41.12 78.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 0.0 110.527 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . -76.67 -46.42 25.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 110.124 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -46.53 -41.88 14.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.973 -1.08 . . . . 0.0 109.153 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 50' ' ' GLN . 8.9 tttt -43.9 -49.04 8.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.432 -0.793 . . . . 0.0 109.546 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.63 109.49 2.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 0.0 109.726 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.6 175.07 6.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.058 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.431 ' C ' ' HG2' ' A' ' 55' ' ' GLN . 1.5 mt-10 -158.8 -80.56 0.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.322 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HG2' ' C ' ' A' ' 54' ' ' GLU . 5.1 mm100 -134.47 8.23 3.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.798 . . . . 0.0 109.389 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.144 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.749 ' HE2' ' HB2' ' A' ' 27' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.83 0.347 . . . . 0.0 110.801 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -55.5 150.82 11.32 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 178.453 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.077 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.293 3.3 t -137.16 134.63 47.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -174.741 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 4' ' ' ILE 0.285 0.1 OUTLIER -100.64 92.84 2.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.853 178.044 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.997 ' CE1' HD22 ' A' ' 30' ' ' LEU . 8.5 m-85 -63.13 119.46 9.59 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 119.363 -2.085 . . . . 0.0 105.906 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -79.28 -25.04 42.52 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -115.31 -163.39 0.88 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.555 0.693 . . . . 0.0 109.489 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 9' ' ' VAL . 26.4 t0 -106.45 160.78 15.14 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.909 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 10' ' ' LYS . 1.4 t -121.18 -158.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.554 ' H ' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -76.7 54.38 0.97 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.096 -1.003 . . . . 0.0 109.416 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.46 3.61 86.43 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.06 -37.67 10.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -1.225 . . . . 0.0 110.713 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 14' ' ' LYS . . . -121.03 164.18 14.33 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 5.8 mttp -134.61 173.78 11.29 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.508 -0.995 . . . . 0.0 109.596 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.598 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -43.11 134.04 3.68 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 110.95 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' CA ' ' O ' ' A' ' 5' ' ' PHE . . . 27.44 39.03 0.01 OUTLIER Glycine 0 N--CA 1.503 3.166 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -77.41 125.74 29.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.462 -1.611 . . . . 0.0 109.198 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.778 HG23 HG12 ' A' ' 4' ' ' ILE . 1.1 mp -100.55 116.79 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 122.899 1.333 . . . . 0.0 111.572 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.45 155.16 19.55 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.469 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 10.1 p30 -87.37 126.46 34.88 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 117.242 -1.783 . . . . 0.0 109.83 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 30' ' ' LEU 0.308 2.3 p -87.54 -144.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.208 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -73.86 112.09 9.65 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 174.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.532 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.4 OUTLIER -33.57 -30.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.665 -0.647 . . . . 0.0 111.753 -176.46 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.63 -36.99 4.63 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.208 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.291 0.1 OUTLIER -48.58 -58.37 4.8 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.223 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.845 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.01 -59.21 0.14 Allowed 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.1 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.749 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 4.1 t30 -86.81 -18.19 31.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.024 -1.047 . . . . 0.0 111.981 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.454 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 39.6 t30 -88.64 7.78 31.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.671 -1.268 . . . . 0.0 111.351 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.811 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.71 -77.51 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.941 -1.1 . . . . 0.0 110.715 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.997 HD22 ' CE1' ' A' ' 5' ' ' PHE . 25.7 mt -45.08 -47.95 11.9 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 122.678 1.228 . . . . 0.0 109.561 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.077 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.28 7.2 m-30 -75.85 -47.44 25.53 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.271 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -70.13 -6.11 31.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.52 -0.738 . . . . 0.0 111.489 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.603 ' HB2' ' CD1' ' A' ' 35' ' ' LEU . 8.3 mm-40 -121.42 -17.38 7.61 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.784 -1.166 . . . . 0.0 112.36 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.04 25.46 7.94 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.007 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.914 HD13 ' HA ' ' A' ' 30' ' ' LEU . 5.3 mp -93.19 -45.38 7.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.239 . . . . 0.0 108.126 177.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 30' ' ' LEU 0.258 . . -143.8 178.25 7.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.175 0.988 . . . . 0.0 111.994 -177.312 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' C ' ' CZ ' ' A' ' 31' ' ' PHE . 24.4 pt -132.08 166.86 27.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.596 ' O ' HG22 ' A' ' 40' ' ' THR . 2.4 tm-20 -64.98 115.3 5.25 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.334 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -49.53 107.07 0.13 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 117.865 -1.534 . . . . 0.0 110.626 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -118.96 156.12 52.36 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.305 -0.872 . . . . 0.0 109.973 179.077 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.538 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 43.2 Cg_endo -56.6 -57.69 1.29 Allowed 'Trans proline' 0 C--N 1.302 -1.898 0 O-C-N 123.92 1.484 . . . . 0.0 110.149 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.86 -54.05 0.93 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.609 -0.682 . . . . 0.0 110.431 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.615 ' HB2' HG23 ' A' ' 40' ' ' THR . 4.6 m120 -73.84 -54.52 7.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.856 . . . . 0.0 110.638 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.772 HD11 HG21 ' A' ' 18' ' ' ILE . 1.5 mm? -44.92 -27.07 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.903 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -73.07 -49.46 28.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.58 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 49' ' ' ALA . . . -64.14 -42.01 96.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -0.788 . . . . 0.0 109.701 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -48.61 -51.16 29.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 110.103 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -52.72 -35.15 55.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.374 -0.829 . . . . 0.0 110.581 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -56.88 -44.61 82.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.838 . . . . 0.0 110.412 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -58.72 -53.86 53.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 110.091 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -60.8 -14.38 21.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.181 -0.95 . . . . 0.0 110.13 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.33 -149.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.914 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -57.93 -171.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.128 -0.983 . . . . 0.0 109.89 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.7 115.41 15.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 109.874 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.97 27.56 0.37 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.422 -0.798 . . . . 0.0 109.528 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.114 -179.699 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.616 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.795 0.331 . . . . 0.0 110.249 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -53.62 149.85 7.72 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.054 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.272 3.3 t -136.06 131.91 49.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 O-C-N 120.169 -1.582 . . . . 0.0 115.259 -176.064 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.855 HG12 HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -99.36 94.35 3.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.714 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.931 ' CE2' HD22 ' A' ' 30' ' ' LEU . 11.5 m-85 -67.82 127.02 31.28 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 120.034 -1.666 . . . . 0.0 107.218 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.634 HD11 ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER -77.97 -28.83 49.5 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.544 ' HA ' ' HD2' ' A' ' 15' ' ' LYS . 17.3 mtpt -115.81 -166.16 1.11 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.438 0.637 . . . . 0.0 109.833 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.88 143.55 48.86 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.464 -0.773 . . . . 0.0 110.902 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.657 HG23 ' HA3' ' A' ' 13' ' ' GLY . 5.7 t -97.63 149.17 5.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -74.38 63.46 1.05 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.84 -1.162 . . . . 0.0 110.595 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.42 -45.96 0.08 OUTLIER Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -151.55 -25.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.09 -1.241 . . . . 0.0 112.947 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.657 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -63.16 160.97 34.47 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 120.579 -1.326 . . . . 0.0 110.224 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.532 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 3.9 mtpp -151.27 173.26 14.67 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.667 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -65.93 133.21 50.41 Favored 'General case' 0 C--N 1.289 -2.04 0 O-C-N 120.953 -1.092 . . . . 0.0 110.304 -178.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 38.38 27.66 0.05 OUTLIER Glycine 0 N--CA 1.5 2.916 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 1.1 pt-20 -60.68 125.69 24.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.66 -1.494 . . . . 0.0 109.218 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.855 HG23 HG12 ' A' ' 4' ' ' ILE . 1.1 mp -115.52 119.37 61.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.422 1.106 . . . . 0.0 111.142 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 16.8 tttt -161.79 -121.87 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.415 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 31.9 p-10 -152.02 120.8 6.54 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.957 HG22 ' CD2' ' A' ' 25' ' ' TYR 0.299 4.3 p -86.78 -144.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 178.393 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.209 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -74.34 111.01 9.1 Favored 'General case' 0 C--N 1.274 -2.711 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 174.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 1' ' ' MET . 1.7 m-20 -30.38 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.152 0.501 . . . . 0.0 111.415 -176.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -96.6 -36.86 4.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.209 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.3 0.1 OUTLIER -48.67 -55.25 11.84 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 177.115 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.781 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -30.88 -67.26 0.09 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.302 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -84.87 7.8 19.67 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.208 -0.933 . . . . 0.0 111.829 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 25' ' ' TYR . 19.3 t-20 -115.7 4.3 14.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.573 -1.329 . . . . 0.0 111.246 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.871 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -161.01 -43.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.89 -1.131 . . . . 0.0 111.245 -178.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.934 HD11 HG21 ' A' ' 21' ' ' VAL . 12.4 mt -84.94 -32.78 22.89 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.369 -1.457 . . . . 0.0 110.088 -177.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.054 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.266 7.1 m-30 -84.59 -57.54 3.09 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.739 -178.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -7.24 8.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.096 -1.003 . . . . 0.0 110.883 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 2.6 mt-30 -113.89 -105.7 0.39 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.981 -1.074 . . . . 0.0 110.419 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.634 ' O ' HD11 ' A' ' 6' ' ' LEU . . . -159.07 27.57 0.39 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 2.6 mp -97.32 -49.48 4.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.032 -1.275 . . . . 0.0 110.023 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.722 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -144.23 -176.42 5.01 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 122.062 0.934 . . . . 0.0 112.827 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -143.81 137.17 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.742 ' O ' HG22 ' A' ' 40' ' ' THR . 6.5 pt-20 -38.85 116.96 0.62 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.178 0.513 . . . . 0.0 110.425 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.631 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . . . -54.8 125.02 18.4 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.601 -1.24 . . . . 0.0 110.786 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.751 ' C ' HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -144.12 149.43 45.33 Favored Pre-proline 0 N--CA 1.501 2.105 0 O-C-N 121.406 -0.809 . . . . 0.0 109.242 179.528 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.611 ' N ' HD12 ' A' ' 44' ' ' LEU . 43.4 Cg_endo -48.81 -56.69 2.93 Favored 'Trans proline' 0 C--N 1.298 -2.117 0 O-C-N 123.562 1.296 . . . . 0.0 109.994 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.1 -55.87 0.93 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.494 -0.754 . . . . 0.0 110.58 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.671 ' HB2' HG23 ' A' ' 40' ' ' THR . 1.5 m-20 -77.24 -51.38 11.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.196 -0.94 . . . . 0.0 110.873 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.834 ' CD2' HG21 ' A' ' 18' ' ' ILE . 12.0 mt -46.69 -29.12 1.73 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.967 -1.083 . . . . 0.0 108.428 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -79.34 -31.69 43.14 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' ASN . . . -65.87 -43.8 87.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.459 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 1.5 mm? -48.84 -47.0 42.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.378 -0.826 . . . . 0.0 109.067 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.97 -21.72 60.81 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.908 . . . . 0.0 109.375 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 46' ' ' ALA . . . -84.24 -41.89 16.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.787 . . . . 0.0 109.361 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.64 -34.13 64.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.47 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -36.84 81.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.89 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -48.88 -35.92 15.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 110.393 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.03 71.67 0.68 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.192 -0.943 . . . . 0.0 110.306 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.581 ' CG ' ' O ' ' A' ' 54' ' ' GLU . 4.3 pt-20 -75.62 107.2 7.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 109.542 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.64 19.37 2.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.104 -0.998 . . . . 0.0 109.579 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 56' ' ' ARG . 4.5 tmm_? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.042 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.663 ' O ' HG23 ' A' ' 3' ' ' VAL . 2.0 ttt . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.863 0.363 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.628 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 12.5 mtpt -50.12 154.14 1.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.776 -1.203 . . . . 0.0 107.841 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.076 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.299 3.4 t -137.24 133.22 46.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -175.461 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.894 HG22 ' O ' ' A' ' 4' ' ' ILE 0.261 0.1 OUTLIER -98.04 91.67 2.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.83 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.999 ' CE2' HD22 ' A' ' 30' ' ' LEU . 15.5 m-85 -70.21 124.05 23.16 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 119.589 -1.944 . . . . 0.0 107.553 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.763 HD22 ' H ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -77.52 -28.24 51.95 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.652 -1.28 . . . . 0.0 108.32 179.258 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -116.86 -170.66 1.87 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.42 0.628 . . . . 0.0 109.349 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -107.5 155.09 20.46 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.054 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 10' ' ' LYS . 1.7 t -106.96 -157.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.812 -1.18 . . . . 0.0 109.833 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.672 ' H ' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -61.73 76.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.821 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 53.08 41.11 59.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -131.65 -83.73 0.51 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -1.126 . . . . 0.0 110.205 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.478 ' HA2' ' OE2' ' A' ' 17' ' ' GLU . . . -71.73 161.24 54.22 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 1.5 mttt -130.71 173.73 10.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.389 -1.065 . . . . 0.0 109.78 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -42.87 141.73 1.04 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 111.079 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 21.85 45.24 0.01 OUTLIER Glycine 0 N--CA 1.512 3.731 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.6 pt-20 -80.6 127.57 32.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.697 -1.472 . . . . 0.0 108.911 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.732 HG21 ' HG ' ' A' ' 44' ' ' LEU . 1.8 mp -106.91 121.13 59.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 111.222 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 22.4 tttt -161.54 -125.72 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 177.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -152.49 121.19 6.47 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.938 HG22 ' CD2' ' A' ' 25' ' ' TYR 0.303 4.2 p -87.33 -142.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 178.02 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.209 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -75.63 111.27 10.77 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 174.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 1' ' ' MET . 6.2 m-20 -31.66 -31.46 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.836 -0.54 . . . . 0.0 111.37 -176.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -96.31 -37.91 4.69 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.209 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.295 0.1 OUTLIER -48.58 -55.15 11.95 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 177.182 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.786 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -31.52 -66.22 0.12 Allowed 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.462 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.702 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -85.1 11.09 10.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.334 -0.853 . . . . 0.0 112.671 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 3.5 m-80 -123.92 10.43 8.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.07 -1.644 . . . . 0.0 110.946 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.861 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -161.33 -50.85 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.999 HD22 ' CE2' ' A' ' 5' ' ' PHE . 10.9 mt -79.55 -36.48 38.23 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.805 -1.184 . . . . 0.0 109.775 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.076 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.296 7.0 m-30 -85.3 -60.32 2.07 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.436 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -49.93 -21.65 1.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.76 -0.587 . . . . 0.0 111.801 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.566 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -114.33 -88.6 0.56 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.618 -1.301 . . . . 0.0 110.445 -179.141 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.566 ' N ' ' CG ' ' A' ' 33' ' ' GLN . . . -174.61 38.45 0.12 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.808 -1.663 . . . . 0.0 111.433 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 3.6 mp -104.58 -45.3 4.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.723 -1.457 . . . . 0.0 108.541 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.744 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -141.2 -176.92 4.88 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.125 0.964 . . . . 0.0 112.27 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.485 ' O ' ' C ' ' A' ' 38' ' ' GLU . 4.1 mt -143.43 135.92 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 31' ' ' PHE . 4.5 tt0 -39.49 115.04 0.47 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.384 -0.823 . . . . 0.0 109.813 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -48.34 102.21 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.356 -1.338 . . . . 0.0 109.865 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.678 HG23 ' HB2' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -113.01 149.08 40.74 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.721 . . . . 0.0 109.757 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.513 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 42.4 Cg_endo -49.19 -59.56 1.19 Allowed 'Trans proline' 0 C--N 1.297 -2.171 0 O-C-N 123.968 1.51 . . . . 0.0 109.858 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.13 -53.18 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.599 -0.688 . . . . 0.0 111.364 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.678 ' HB2' HG23 ' A' ' 40' ' ' THR . 2.2 m-20 -77.64 -44.26 28.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.96 -1.088 . . . . 0.0 111.657 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.732 ' HG ' HG21 ' A' ' 18' ' ' ILE . 4.6 mp -53.25 -39.78 64.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.085 . . . . 0.0 110.665 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 25.6 tptt -78.92 -39.46 34.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.981 -1.075 . . . . 0.0 109.214 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.72 77.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -0.79 . . . . 0.0 109.496 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -58.8 -29.77 67.11 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.446 -0.784 . . . . 0.0 109.368 179.478 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -81.93 -47.96 12.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 110.113 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.58 -41.7 61.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.134 -0.979 . . . . 0.0 110.141 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.63 -28.58 63.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.396 -0.815 . . . . 0.0 110.27 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.04 -46.18 8.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.273 -0.892 . . . . 0.0 111.013 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.68 90.47 5.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.105 -0.997 . . . . 0.0 111.36 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -99.74 -131.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 108.877 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.9 143.14 36.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.765 -1.209 . . . . 0.0 109.092 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.74 73.16 0.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 109.848 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.188 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.71 ' O ' HG23 ' A' ' 3' ' ' VAL . 7.2 tpt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 3.1 mttm -50.67 152.31 2.06 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.089 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.285 3.4 t -134.26 132.3 55.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 119.972 -1.705 . . . . 0.0 114.739 -176.205 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.786 HG22 ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -97.25 99.9 9.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.813 ' CE2' HD22 ' A' ' 30' ' ' LEU . 10.5 m-85 -77.11 127.25 32.32 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 119.983 -1.698 . . . . 0.0 107.318 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.94 HD11 HG22 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -77.01 -28.84 55.17 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 120.539 -1.35 . . . . 0.0 107.585 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.5 mppt? -113.47 -174.49 2.47 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.316 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 13' ' ' GLY . 6.3 p-10 -107.4 160.55 15.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 110.146 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 10' ' ' LYS . 0.9 OUTLIER -123.37 -174.73 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 109.867 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' H ' HG12 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -67.13 62.81 0.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 109.652 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 77.33 9.03 87.05 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' CE ' ' HA ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -94.45 -33.77 12.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -1.03 . . . . 0.0 110.558 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' ASP . . . -158.52 157.42 28.35 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 11.5 mmmt -123.28 178.83 4.95 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.438 -1.037 . . . . 0.0 111.115 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -42.35 137.67 1.96 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.259 -0.901 . . . . 0.0 111.722 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 22.29 45.6 0.01 OUTLIER Glycine 0 N--CA 1.509 3.526 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.636 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -82.16 125.66 31.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.948 -1.325 . . . . 0.0 109.547 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.033 HG21 HD11 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -105.5 122.56 59.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 120.436 -1.415 . . . . 0.0 110.086 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -160.79 -127.82 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 178.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.497 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 52.1 p-10 -151.88 122.1 7.22 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 122.713 1.244 . . . . 0.0 109.154 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.965 HG21 HD11 ' A' ' 30' ' ' LEU 0.301 3.9 p -86.89 -142.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 178.229 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.196 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -76.62 110.54 11.28 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 1' ' ' MET . 17.7 p-10 -29.67 -37.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.782 0.801 . . . . 0.0 111.045 -176.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -90.3 -40.02 5.87 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.196 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.299 0.1 OUTLIER -48.7 -56.34 8.84 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.683 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.77 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.97 -63.94 0.12 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.236 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.646 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 62.0 t30 -88.68 35.31 0.77 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 112.484 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 25' ' ' TYR . 0.9 OUTLIER -147.9 8.01 0.84 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.761 -1.212 . . . . 0.0 110.562 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.869 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.74 -47.24 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.247 -0.908 . . . . 0.0 109.225 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.965 HD11 HG21 ' A' ' 21' ' ' VAL . 10.8 mt -86.39 -35.33 19.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.918 -1.113 . . . . 0.0 110.135 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.089 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.271 8.9 m-30 -82.65 -57.59 3.26 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.501 -178.134 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HD2' ' HG2' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -69.63 -1.35 8.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.992 -1.068 . . . . 0.0 111.35 -178.274 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.558 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 23.8 mt-30 -116.72 -92.13 0.53 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.914 -1.116 . . . . 0.0 110.525 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.46 23.67 0.07 OUTLIER Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.03 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.691 ' O ' HD22 ' A' ' 6' ' ' LEU . 2.6 mp -95.59 -50.18 5.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.773 -1.428 . . . . 0.0 109.294 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.723 ' HB3' ' CB ' ' A' ' 30' ' ' LEU . . . -139.55 -179.54 5.96 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.926 0.869 . . . . 0.0 111.444 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.94 HG22 HD11 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -140.79 160.06 23.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.317 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.609 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 18.2 mp0 -48.94 115.65 1.36 Allowed 'General case' 0 C--N 1.293 -1.87 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.642 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -66.99 60.64 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 118.276 -1.369 . . . . 0.0 109.657 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.654 HG23 ' HD2' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -88.85 164.69 30.53 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.222 -0.923 . . . . 0.0 109.343 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.654 ' HD2' HG23 ' A' ' 40' ' ' THR . 49.4 Cg_endo -49.05 -62.38 0.44 Allowed 'Trans proline' 0 C--N 1.299 -2.069 0 O-C-N 123.909 1.478 . . . . 0.0 109.768 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.56 -54.78 0.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.673 -0.642 . . . . 0.0 111.173 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -71.23 -43.49 67.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.015 . . . . 0.0 110.512 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.033 HD11 HG21 ' A' ' 18' ' ' ILE . 2.7 mm? -58.02 -61.72 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.924 . . . . 0.0 109.632 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -48.35 -47.12 37.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 0.0 109.643 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -63.98 -37.8 88.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.502 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.633 HD23 ' CD1' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -48.7 -64.67 0.73 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.529 -0.732 . . . . 0.0 109.139 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.82 -25.2 60.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.318 -0.864 . . . . 0.0 109.0 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 46' ' ' ALA . . . -75.55 -45.0 40.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 0.0 109.539 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.92 -15.11 54.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.996 -1.065 . . . . 0.0 108.915 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -89.25 -14.35 36.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.555 -0.716 . . . . 0.0 110.056 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 1.7 mp0 -61.98 -170.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.11 -0.994 . . . . 0.0 110.175 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' C ' ' HG2' ' A' ' 54' ' ' GLU . 3.2 tptp -138.15 31.57 2.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.857 . . . . 0.0 110.369 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' HG2' ' C ' ' A' ' 53' ' ' LYS . 6.3 mm-40 -127.64 40.17 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 0.0 110.24 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 15.6 tp60 -150.64 44.06 0.84 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.035 -0.984 . . . . 0.0 110.086 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.638 ' O ' HG23 ' A' ' 3' ' ' VAL . 2.2 ttt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.893 0.378 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.578 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 7.9 mmtt -55.38 148.8 14.32 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.131 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.297 3.0 t -132.92 133.32 58.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.268 -1.52 . . . . 0.0 114.921 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.85 HG22 ' O ' ' A' ' 4' ' ' ILE 0.267 0.1 OUTLIER -98.58 91.64 2.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.56 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.049 ' CE1' HD22 ' A' ' 30' ' ' LEU . 11.8 m-85 -66.42 118.51 10.17 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 119.393 -2.067 . . . . 0.0 105.863 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -78.98 -20.22 49.68 Favored 'General case' 0 C--N 1.287 -2.149 0 O-C-N 121.445 -0.784 . . . . 0.0 109.175 -178.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.52 ' HD2' ' O ' ' A' ' 34' ' ' GLY . 21.2 mttt -121.97 -164.58 1.17 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 13' ' ' GLY . 44.8 t0 -96.92 167.01 11.34 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.333 -0.854 . . . . 0.0 110.299 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.593 HG21 ' CE1' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -139.71 167.75 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.523 -0.736 . . . . 0.0 109.034 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.09 85.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.981 -1.074 . . . . 0.0 110.494 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 44.36 48.66 8.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -146.72 -32.83 0.31 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.068 -1.254 . . . . 0.0 110.918 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.457 ' HA2' ' OE1' ' A' ' 17' ' ' GLU . . . -135.7 162.17 24.88 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.538 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 16.6 mtmm -136.74 -174.08 3.61 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.297 -1.119 . . . . 0.0 110.004 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.621 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -51.61 131.36 29.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 110.258 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 29.79 39.88 0.03 OUTLIER Glycine 0 N--CA 1.504 3.168 0 O-C-N 121.762 -0.586 . . . . 0.0 111.889 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -78.05 127.53 32.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.409 -1.642 . . . . 0.0 109.096 178.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.979 HG21 ' HG ' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -104.61 126.59 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 122.051 0.929 . . . . 0.0 111.923 -178.348 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER -161.4 -130.93 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 2.4 p-10 -151.68 118.3 5.72 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.985 HG21 HD11 ' A' ' 30' ' ' LEU 0.307 5.0 p -86.88 -144.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.201 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -73.07 111.27 8.02 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 1' ' ' MET . 1.6 m-20 -32.05 -30.33 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.96 -0.462 . . . . 0.0 111.47 -176.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.81 -37.57 4.41 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.201 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.307 0.1 OUTLIER -48.58 -55.62 10.65 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 177.384 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.775 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.57 -64.48 0.11 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.76 178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 17.8 t30 -88.5 52.92 2.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 111.03 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -157.94 -32.35 0.07 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.262 -0.899 . . . . 0.0 110.862 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.83 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -126.92 -37.89 2.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.303 -0.873 . . . . 0.0 109.743 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.049 HD22 ' CE1' ' A' ' 5' ' ' PHE . 11.9 mt -90.64 -35.42 14.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.433 -1.417 . . . . 0.0 110.161 -177.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.131 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.278 8.5 m-30 -84.36 -51.65 6.8 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.774 -178.373 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -68.19 -3.46 10.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.025 -1.047 . . . . 0.0 110.814 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 1.7 mt-30 -118.84 -102.22 0.42 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 110.335 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' HD2' ' A' ' 7' ' ' LYS . . . -160.67 17.33 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.468 -1.348 . . . . 0.0 110.673 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.674 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 3.0 mp -84.24 -51.33 7.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.659 -1.495 . . . . 0.0 109.547 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.89 ' HA ' HD23 ' A' ' 6' ' ' LEU . . . -142.22 -178.68 5.84 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.179 0.99 . . . . 0.0 112.841 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.523 ' C ' ' CE1' ' A' ' 31' ' ' PHE . 2.4 pt -140.04 161.62 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.636 ' O ' HG22 ' A' ' 40' ' ' THR . 2.4 pt-20 -51.06 108.88 0.27 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.313 -0.867 . . . . 0.0 111.15 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.578 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -49.94 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 117.823 -1.551 . . . . 0.0 109.564 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -107.51 148.54 37.41 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.898 -1.126 . . . . 0.0 110.223 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.543 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 43.8 Cg_endo -49.1 -58.58 1.67 Allowed 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.753 1.396 . . . . 0.0 109.872 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.01 -51.18 0.92 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 110.379 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 5.0 t-20 -77.12 -54.69 6.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -0.999 . . . . 0.0 110.853 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.979 ' HG ' HG21 ' A' ' 18' ' ' ILE . 7.3 mp -45.75 -51.82 12.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 0.0 110.296 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -20.53 65.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 109.749 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 43' ' ' ASN . . . -84.06 -43.78 14.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.417 -0.802 . . . . 0.0 110.617 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.501 ' HG ' HD11 ' A' ' 18' ' ' ILE . 2.8 mm? -42.16 -49.34 4.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 109.835 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -54.01 -60.07 3.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 0.0 110.233 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.02 -40.2 6.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.333 -0.854 . . . . 0.0 110.643 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -27.7 69.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 110.622 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -85.96 -26.48 25.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.246 -0.909 . . . . 0.0 110.385 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.86 134.59 35.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 110.721 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.4 120.47 18.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.523 -0.736 . . . . 0.0 110.05 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.36 126.77 9.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -0.929 . . . . 0.0 110.706 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.26 -41.39 0.15 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.833 0.825 . . . . 0.0 108.861 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.462 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.018 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.63 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 120.606 0.241 . . . . 0.0 110.444 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.612 ' CA ' ' O ' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -50.79 156.21 1.0 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.208 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.086 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.311 3.6 t -134.43 134.47 54.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 O-C-N 119.961 -1.712 . . . . 0.0 114.924 -174.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.723 HG12 HG23 ' A' ' 18' ' ' ILE 0.255 0.0 OUTLIER -96.98 108.01 20.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.15 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.081 ' CD1' ' HB2' ' A' ' 36' ' ' ALA . 2.0 m-85 -86.58 125.33 33.72 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.631 -1.293 . . . . 0.0 107.766 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.873 HD13 ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -82.1 -28.09 32.49 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 120.808 -1.182 . . . . 0.0 112.844 -178.546 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.656 ' O ' ' O ' ' A' ' 13' ' ' GLY . 3.0 mttp -108.98 -142.86 0.38 Allowed 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 118.976 -1.089 . . . . 0.0 113.16 -176.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.826 ' C ' ' O ' ' A' ' 13' ' ' GLY . 5.4 t70 -96.73 154.21 17.42 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.03 -1.043 . . . . 0.0 108.347 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.948 ' HA ' ' H ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -85.96 -5.31 9.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.57 -1.331 . . . . 0.0 114.431 -173.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' NZ ' ' HA ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -72.77 57.24 0.42 Allowed 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.245 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 100.96 19.47 17.02 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 2.9 mtpp -151.03 -18.97 0.21 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.566 -1.55 . . . . 0.0 112.64 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.948 ' H ' ' HA ' ' A' ' 9' ' ' VAL . . . 101.5 159.64 26.96 Favored Glycine 0 C--O 1.175 -3.574 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.537 ' HB2' ' CD ' ' A' ' 17' ' ' GLU . 17.7 mttp -87.56 146.33 25.82 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 121.121 2.461 . . . . 0.0 109.565 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.608 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -29.81 122.03 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.65 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 16.23 51.69 0.01 OUTLIER Glycine 1 N--CA 1.516 4.032 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -177.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.594 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -86.72 124.67 33.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.966 -1.314 . . . . 0.0 109.627 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.077 HG21 ' CD2' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -105.84 123.5 60.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.729 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.612 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -160.96 -129.94 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 178.495 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.45 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . 13.3 p-10 -151.67 119.95 6.36 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 120.676 -1.265 . . . . 0.0 109.702 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.996 HG21 HD11 ' A' ' 30' ' ' LEU 0.299 4.4 p -87.07 -142.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.817 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.208 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -75.65 110.87 10.41 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 174.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 1' ' ' MET . 1.4 m-20 -32.72 -30.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.942 -0.474 . . . . 0.0 111.82 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.61 -37.84 4.38 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.208 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.299 0.1 OUTLIER -48.9 -56.13 9.71 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.232 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.755 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -28.75 -58.49 0.13 Allowed 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.136 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.58 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 11.6 p30 -90.4 15.11 11.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.862 -1.149 . . . . 0.0 112.629 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.74 9.35 7.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.339 -1.475 . . . . 0.0 110.625 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.808 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -159.93 -53.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 109.832 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.996 HD11 HG21 ' A' ' 21' ' ' VAL . 18.7 mt -76.43 -39.26 53.96 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 122.358 1.075 . . . . 0.0 110.577 -176.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.086 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.256 2.6 m-30 -81.46 -68.85 0.66 Allowed 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.315 -178.495 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -50.29 -16.36 0.32 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.728 -0.608 . . . . 0.0 112.139 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 33.1 mm-40 -106.39 -90.06 0.43 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.615 -1.303 . . . . 0.0 111.229 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.794 ' H ' HD12 ' A' ' 35' ' ' LEU . . . -175.41 39.53 0.11 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.429 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.937 HD13 ' HA ' ' A' ' 30' ' ' LEU . 4.2 mp -109.5 -50.15 3.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.144 -1.21 . . . . 0.0 109.517 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.081 ' HB2' ' CD1' ' A' ' 5' ' ' PHE 0.265 . . -144.31 -166.16 2.31 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.402 1.096 . . . . 0.0 112.057 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.579 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 3.5 pt -146.28 173.07 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.136 175.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.665 ' O ' HG22 ' A' ' 40' ' ' THR . 8.0 pt-20 -66.8 112.49 4.28 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.134 -0.978 . . . . 0.0 110.096 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.609 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . . . -51.76 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 117.835 -1.546 . . . . 0.0 109.764 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -108.84 148.73 38.42 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.094 -1.004 . . . . 0.0 109.963 179.318 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.521 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 45.2 Cg_endo -49.73 -50.03 14.28 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 O-C-N 123.971 1.511 . . . . 0.0 108.774 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.77 -46.03 0.58 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.286 0.565 . . . . 0.0 110.211 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -91.36 -46.53 7.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.921 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.077 ' CD2' HG21 ' A' ' 18' ' ' ILE . 2.5 mm? -39.2 -37.77 0.44 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.155 -0.965 . . . . 0.0 110.974 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.51 -29.7 33.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.06 -1.025 . . . . 0.0 109.944 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . . . -75.92 -34.4 59.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.465 -0.772 . . . . 0.0 110.152 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.512 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 2.2 mm? -51.76 -23.62 4.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.464 -0.773 . . . . 0.0 110.957 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.61 -33.95 41.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.974 -1.079 . . . . 0.0 110.068 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.78 26.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.063 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -45.35 -26.94 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.63 -63.72 1.24 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -66.91 95.88 0.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.328 -0.857 . . . . 0.0 110.451 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -82.74 126.91 32.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.281 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -115.65 -39.79 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.738 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -152.08 35.37 0.53 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.903 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.098 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.876 ' HE1' ' HB2' ' A' ' 27' ' ' ASN . 2.1 ttt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.677 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 10.1 mtmm -51.3 152.63 2.39 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.098 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.271 3.3 t -133.21 130.77 58.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 119.991 -1.693 . . . . 0.0 114.532 -176.069 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.784 HG22 ' O ' ' A' ' 4' ' ' ILE 0.257 0.0 OUTLIER -98.65 102.5 13.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.461 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.04 ' CE1' HD22 ' A' ' 30' ' ' LEU . 11.4 m-85 -78.58 125.93 30.04 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 117.204 -1.798 . . . . 0.0 106.915 177.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.922 HD13 ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -78.21 -29.62 48.44 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.278 -1.514 . . . . 0.0 107.725 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -116.36 179.99 3.84 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.843 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 2.8 p30 -89.23 141.68 28.32 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.602 HG22 ' CD1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -97.92 -167.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.263 -0.898 . . . . 0.0 109.929 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.511 ' H ' HG12 ' A' ' 9' ' ' VAL . 3.2 tttm -75.32 62.63 1.31 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.56 17.37 79.04 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 3.7 mttp -108.2 -41.17 4.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.207 -1.172 . . . . 0.0 110.4 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.508 ' HA2' ' CD ' ' A' ' 17' ' ' GLU . . . -135.32 171.86 22.37 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 15' ' ' LYS . 7.9 mtpt -140.41 177.12 8.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.171 -1.194 . . . . 0.0 109.737 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -34.33 135.06 0.17 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.618 -0.676 . . . . 0.0 111.261 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 21.36 45.06 0.01 OUTLIER Glycine 0 N--CA 1.512 3.72 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -81.36 125.16 30.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.51 -1.582 . . . . 0.0 109.246 179.274 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.924 HG21 ' HG ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -106.4 124.98 62.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 122.219 1.009 . . . . 0.0 110.062 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -159.89 -130.28 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 179.254 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 40.6 p30 -151.76 119.39 6.09 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.957 HG21 HD11 ' A' ' 30' ' ' LEU 0.303 3.7 p -86.62 -145.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.192 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -71.68 110.1 6.02 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 174.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 22' ' ' ALA . 1.1 m-20 -30.8 -30.48 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 122.093 -0.379 . . . . 0.0 111.607 -176.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -99.36 -36.95 4.19 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.192 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.289 0.0 OUTLIER -48.25 -54.52 13.33 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.139 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.8 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.89 -63.57 0.13 Allowed 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.259 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.876 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 52.4 t30 -86.7 29.83 0.77 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.267 -0.896 . . . . 0.0 112.409 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 25' ' ' TYR . 36.2 t30 -133.78 -21.64 1.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.727 -1.233 . . . . 0.0 111.103 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.788 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -135.68 -43.09 0.68 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -0.952 . . . . 0.0 110.525 -178.564 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.04 HD22 ' CE1' ' A' ' 5' ' ' PHE . 15.0 mt -83.05 -37.36 23.99 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.871 -1.143 . . . . 0.0 109.871 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.098 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.277 7.0 m-30 -85.49 -53.05 5.43 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.825 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -64.27 -4.04 3.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.474 -0.766 . . . . 0.0 111.565 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 17.3 mt-30 -124.61 -103.08 0.37 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.741 -1.224 . . . . 0.0 110.642 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.567 ' H ' HD12 ' A' ' 35' ' ' LEU . . . -159.63 46.55 0.42 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.648 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.855 HD13 ' HA ' ' A' ' 30' ' ' LEU . 3.0 mp -117.47 -48.01 2.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.986 -1.302 . . . . 0.0 109.898 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -144.03 -177.51 5.48 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.132 0.967 . . . . 0.0 112.118 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.659 HG23 HD11 ' A' ' 6' ' ' LEU . 4.0 pt -139.21 168.2 19.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.613 ' O ' HG22 ' A' ' 40' ' ' THR . 3.8 pt-20 -58.28 107.97 0.55 Allowed 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.5 -0.75 . . . . 0.0 109.561 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.677 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -59.25 93.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 118.167 -1.413 . . . . 0.0 110.499 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -105.28 153.05 39.9 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.219 -0.925 . . . . 0.0 109.746 178.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 43.3 Cg_endo -53.28 -55.16 3.89 Favored 'Trans proline' 0 C--N 1.296 -2.2 0 O-C-N 124.057 1.556 . . . . 0.0 109.573 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.19 -51.09 1.0 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.709 -0.619 . . . . 0.0 110.837 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.572 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 70.0 m-20 -83.27 -47.96 10.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.237 -0.914 . . . . 0.0 111.066 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.924 ' HG ' HG21 ' A' ' 18' ' ' ILE . 5.1 mp -47.86 -45.48 30.32 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 110.376 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -30.09 61.15 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.007 -1.058 . . . . 0.0 108.949 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 43' ' ' ASN . . . -71.64 -42.37 67.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 109.347 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 1.2 mm? -55.08 -42.71 73.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.515 -0.741 . . . . 0.0 109.353 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 51' ' ' LYS . 21.5 tt0 -45.45 -43.56 11.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.366 -0.834 . . . . 0.0 109.534 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 52' ' ' GLN . . . -43.4 -40.59 3.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.272 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 2.4 tp-100 -67.33 -39.56 85.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 52.3 mmtt -90.91 12.32 19.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.557 -0.714 . . . . 0.0 110.139 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 15.1 tt0 -43.13 -66.33 0.39 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -85.82 95.69 9.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.216 -0.927 . . . . 0.0 110.205 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 32.3 mt-10 -93.11 -107.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.915 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.05 19.46 0.77 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 109.478 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.203 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.667 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.619 0.247 . . . . 0.0 110.425 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -50.08 151.63 1.92 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.046 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.042 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.288 3.0 t -133.11 133.85 58.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 119.88 -1.762 . . . . 0.0 114.874 -175.587 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.87 HG22 ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -98.13 89.95 2.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.038 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.014 ' CE1' HD22 ' A' ' 30' ' ' LEU . 10.0 m-85 -62.35 122.64 16.18 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 116.672 -2.011 . . . . 0.0 105.838 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.567 HD23 ' CA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -78.72 -22.13 47.03 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.136 -178.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -132.14 176.57 8.28 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.524 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.66 144.9 34.96 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.737 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 5' ' ' PHE . 1.1 t -106.16 -170.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 109.489 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.527 ' H ' HG12 ' A' ' 9' ' ' VAL . 18.7 mttt -70.24 67.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 110.104 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 69.55 39.36 79.09 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.35 -55.16 0.8 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -1.121 . . . . 0.0 110.877 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.438 ' CA ' HG23 ' A' ' 9' ' ' VAL . . . -117.96 167.78 12.93 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.253 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.499 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 4.4 mttt -128.65 167.66 16.88 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.384 -1.068 . . . . 0.0 109.205 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -41.84 142.73 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.964 . . . . 0.0 111.375 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 25.64 39.7 0.01 OUTLIER Glycine 0 N--CA 1.502 3.061 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -83.37 121.85 27.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.586 -1.538 . . . . 0.0 108.64 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.985 HG21 HD11 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -100.33 125.24 54.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.308 1.051 . . . . 0.0 110.503 -178.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 3.8 ttpp -161.22 -129.98 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 11.2 p-10 -151.95 117.98 5.52 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.275 1.035 . . . . 0.0 108.913 175.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.037 HG21 HD11 ' A' ' 30' ' ' LEU 0.302 4.1 p -87.34 -146.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 177.581 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.215 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -72.31 110.16 6.55 Favored 'General case' 0 C--N 1.273 -2.759 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 1' ' ' MET . 3.0 p30 -29.34 -36.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.655 0.741 . . . . 0.0 111.122 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -92.26 -38.73 5.58 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 1.215 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.287 0.1 OUTLIER -48.25 -55.21 11.11 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.396 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.742 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.46 -64.34 0.11 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.547 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.645 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 24.0 t30 -89.71 53.91 2.71 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.105 -0.997 . . . . 0.0 110.678 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.5 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 t-20 -154.89 -31.32 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.419 -0.8 . . . . 0.0 110.2 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.829 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -130.69 -42.81 1.13 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.335 -0.853 . . . . 0.0 109.849 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.037 HD11 HG21 ' A' ' 21' ' ' VAL . 14.4 mt -81.73 -39.08 24.74 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.613 -1.305 . . . . 0.0 109.868 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 1.042 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.275 7.2 m-30 -83.06 -51.93 7.1 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.353 -178.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HG3' ' HA ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -62.84 -7.46 5.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.358 -0.839 . . . . 0.0 111.363 -178.633 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 11.8 mt-30 -120.02 -93.78 0.51 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.887 -1.133 . . . . 0.0 110.658 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.672 ' H ' HD12 ' A' ' 35' ' ' LEU . . . -172.03 41.86 0.17 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.173 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.888 HD13 ' HA ' ' A' ' 30' ' ' LEU . 3.9 mp -109.78 -47.76 3.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.091 -1.241 . . . . 0.0 109.873 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.672 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -142.29 178.4 7.6 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.788 0.804 . . . . 0.0 112.423 -177.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.666 HD12 HD22 ' A' ' 43' ' ' ASN . 13.1 pt -131.67 163.69 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.721 ' O ' HG22 ' A' ' 40' ' ' THR . 56.1 tt0 -61.47 115.32 3.8 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.401 -0.812 . . . . 0.0 109.659 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . . . -57.2 82.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.58 -1.248 . . . . 0.0 110.784 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.721 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -99.96 146.83 32.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.061 -1.024 . . . . 0.0 109.014 178.267 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.488 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 45.0 Cg_endo -49.14 -51.74 10.05 Favored 'Trans proline' 0 C--N 1.293 -2.384 0 O-C-N 124.061 1.559 . . . . 0.0 108.808 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.06 -59.28 0.73 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.694 -0.629 . . . . 0.0 110.464 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.666 HD22 HD12 ' A' ' 37' ' ' ILE . 2.3 m120 -72.71 -49.33 31.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.52 -0.737 . . . . 0.0 111.051 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.985 HD11 HG21 ' A' ' 18' ' ' ILE . 2.5 mm? -40.68 -36.96 0.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -77.38 -31.01 53.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 109.131 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 43' ' ' ASN . . . -61.58 -38.73 88.63 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 108.797 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -44.45 -24.27 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.477 -0.765 . . . . 0.0 109.409 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -71.87 -35.98 69.95 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.156 -0.965 . . . . 0.0 109.069 179.127 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' HG2' ' A' ' 52' ' ' GLN . . . -48.93 -40.03 28.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.981 . . . . 0.0 108.776 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -52.48 -20.57 2.99 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.119 -0.988 . . . . 0.0 109.589 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 48' ' ' GLU . 1.4 tttm -90.33 -27.72 19.2 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.422 -0.798 . . . . 0.0 111.116 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 2.4 pt20 -71.59 158.71 35.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.698 -1.252 . . . . 0.0 110.634 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -102.59 -159.97 0.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.669 -0.645 . . . . 0.0 110.624 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.58 -70.58 0.15 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.328 -0.858 . . . . 0.0 110.951 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.32 41.52 1.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.205 -0.934 . . . . 0.0 109.994 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.243 -179.555 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.786 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.593 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -49.66 151.25 1.75 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.077 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.26 3.9 t -133.0 130.94 58.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 117.195 -1.802 . . . . 0.0 114.816 -175.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 4' ' ' ILE 0.286 0.2 OUTLIER -96.87 89.99 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.784 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.953 ' CE2' HD22 ' A' ' 30' ' ' LEU . 10.7 m-85 -64.76 124.6 22.37 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 116.785 -1.966 . . . . 0.0 106.977 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.589 HD12 ' HD2' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -78.67 -24.77 44.92 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.688 -179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.589 ' HD2' HD12 ' A' ' 6' ' ' LEU . 1.7 mttm -133.09 166.34 22.65 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.268 0.556 . . . . 0.0 109.646 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.403 ' OD2' ' O ' ' A' ' 13' ' ' GLY . 10.5 t70 -74.14 166.24 23.76 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.388 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.764 HG21 ' CE2' ' A' ' 5' ' ' PHE . 2.5 t -123.24 -142.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 109.249 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.618 ' H ' HG12 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -71.96 56.58 0.31 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.851 -1.155 . . . . 0.0 109.861 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.62 21.89 77.85 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.39 -66.49 1.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -1.121 . . . . 0.0 110.174 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.523 ' HA2' ' OE2' ' A' ' 17' ' ' GLU . . . -70.63 167.65 50.17 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.522 ' N ' ' OE2' ' A' ' 17' ' ' GLU . 13.5 mtmt -142.45 151.94 42.25 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.247 -1.149 . . . . 0.0 109.414 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.624 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -32.85 137.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.757 -0.589 . . . . 0.0 110.869 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 19.94 45.8 0.01 OUTLIER Glycine 0 N--CA 1.51 3.622 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -90.42 128.9 36.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.534 -1.568 . . . . 0.0 108.9 178.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.608 ' CG1' ' CD1' ' A' ' 4' ' ' ILE . 1.9 mp -95.11 117.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 122.595 1.188 . . . . 0.0 110.844 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.511 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -160.64 153.74 21.57 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.419 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 1.1 p-10 -88.02 125.39 34.52 Favored 'General case' 0 C--N 1.273 -2.723 0 C-N-CA 116.986 -1.886 . . . . 0.0 109.36 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.937 HG22 ' CD2' ' A' ' 25' ' ' TYR 0.327 4.0 p -86.94 -143.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 103.621 -2.733 . . . . 0.0 103.621 178.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.205 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -74.38 112.61 10.72 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 104.195 -2.521 . . . . 0.0 104.195 174.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -31.61 -31.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.994 -0.441 . . . . 0.0 111.748 -176.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -99.52 -36.39 4.34 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.205 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.295 0.1 OUTLIER -48.6 -55.91 9.89 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.105 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.778 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.78 -61.52 0.15 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.362 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.734 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 28.2 t30 -86.26 -10.26 54.92 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -102.17 11.66 37.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.281 -1.512 . . . . 0.0 111.661 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.82 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.96 -52.68 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.838 -1.164 . . . . 0.0 111.503 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.953 HD22 ' CE2' ' A' ' 5' ' ' PHE . 13.4 mt -77.65 -34.1 53.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.725 -1.234 . . . . 0.0 110.033 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.077 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.277 6.9 m-30 -85.57 -49.16 8.25 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.765 -178.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.55 7.21 1.5 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.332 -0.855 . . . . 0.0 111.618 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 73.2 mm-40 -133.22 -93.2 0.34 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.816 -1.178 . . . . 0.0 110.899 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.68 ' H ' HD12 ' A' ' 35' ' ' LEU . . . -172.11 42.2 0.17 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.807 HD13 ' HA ' ' A' ' 30' ' ' LEU . 3.1 mp -113.65 -44.38 3.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -1.167 . . . . 0.0 109.287 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.724 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -149.82 -178.58 6.54 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.909 0.861 . . . . 0.0 112.06 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.529 ' C ' ' CE1' ' A' ' 31' ' ' PHE . 14.3 pt -138.35 156.13 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.976 ' O ' HG22 ' A' ' 40' ' ' THR . 20.7 pt-20 -56.17 108.73 0.5 Allowed 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.571 -0.706 . . . . 0.0 109.948 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.593 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -49.88 113.67 0.9 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.116 -1.434 . . . . 0.0 109.506 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.976 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -143.89 148.15 41.24 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.369 -0.832 . . . . 0.0 109.852 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.561 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 44.9 Cg_endo -49.15 -51.88 9.8 Favored 'Trans proline' 0 C--N 1.298 -2.108 0 O-C-N 123.815 1.429 . . . . 0.0 108.907 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.05 -42.12 0.4 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.68 -0.637 . . . . 0.0 110.641 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.485 ' HB2' HG23 ' A' ' 40' ' ' THR . 4.4 m-20 -102.32 -50.95 3.47 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.129 -0.982 . . . . 0.0 111.596 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.506 HD12 ' C ' ' A' ' 40' ' ' THR . 42.6 mt -37.92 -46.7 0.99 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.409 -0.807 . . . . 0.0 110.181 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -53.64 -61.54 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 109.58 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 50' ' ' GLN . . . -43.49 -44.06 5.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 110.423 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.599 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -50.08 -35.75 26.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.115 -0.991 . . . . 0.0 110.044 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.45 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 43.7 tp10 -88.52 -49.75 6.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 108.932 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 52' ' ' GLN . . . -53.52 -42.21 67.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.395 -0.816 . . . . 0.0 108.97 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 23.4 mm100 -55.07 -21.31 12.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.21 -0.931 . . . . 0.0 109.191 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 47' ' ' LEU . 8.8 mmmt -91.02 9.29 31.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.714 . . . . 0.0 111.075 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -82.12 136.77 35.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.073 -1.017 . . . . 0.0 110.287 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.423 ' C ' ' HG2' ' A' ' 54' ' ' GLU . 8.2 mttt -131.66 -100.58 0.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.348 -0.845 . . . . 0.0 110.549 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.439 ' C ' ' HG3' ' A' ' 55' ' ' GLN . 2.5 mm-40 -131.25 88.13 2.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.871 -1.143 . . . . 0.0 110.139 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.439 ' HG3' ' C ' ' A' ' 54' ' ' GLU . 18.7 mt-30 -139.16 21.71 2.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.589 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 . . . . . 0 C--N 1.304 -1.382 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.394 -179.342 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.765 ' O ' HG23 ' A' ' 3' ' ' VAL . 4.8 tpt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 25.0 mttt -49.23 152.12 1.26 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.069 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.274 3.9 t -133.68 133.89 56.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 119.933 -1.729 . . . . 0.0 115.02 -174.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.877 HG12 HG23 ' A' ' 18' ' ' ILE 0.272 0.1 OUTLIER -100.51 87.95 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.294 177.657 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.842 ' CE2' HD22 ' A' ' 30' ' ' LEU . 11.9 m-85 -60.92 123.0 16.3 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 119.667 -1.896 . . . . 0.0 106.417 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 35' ' ' LEU . 1.2 pp -78.71 -25.24 44.67 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.371 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.431 ' HG3' HD12 ' A' ' 6' ' ' LEU . 24.1 mttm -124.7 171.45 10.07 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.232 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -88.15 139.89 30.04 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.598 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 10' ' ' LYS . 1.5 t -97.32 -155.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 109.83 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.618 ' H ' HG12 ' A' ' 9' ' ' VAL . 12.9 mtmt -82.56 71.24 9.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.031 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.16 18.01 68.68 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.38 -31.79 6.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -1.165 . . . . 0.0 110.613 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.541 ' CA ' ' OE2' ' A' ' 17' ' ' GLU . . . -139.25 173.25 22.82 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -142.98 -179.74 6.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.157 -1.202 . . . . 0.0 110.308 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.614 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -48.14 135.0 13.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.42 -0.8 . . . . 0.0 111.703 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.6 ' CA ' ' O ' ' A' ' 5' ' ' PHE . . . 28.32 37.91 0.01 OUTLIER Glycine 0 N--CA 1.504 3.219 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -67.76 124.87 24.51 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.577 -1.543 . . . . 0.0 108.988 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.07 HG21 ' HG ' ' A' ' 44' ' ' LEU . 1.4 mp -110.65 120.66 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 122.295 1.045 . . . . 0.0 111.694 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 17.8 tttt -161.83 -125.88 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.452 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 15.6 p-10 -151.88 119.17 5.95 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.946 HG21 HD11 ' A' ' 30' ' ' LEU 0.302 3.3 p -86.78 -147.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 178.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.211 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -71.76 110.0 6.02 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 103.832 -2.655 . . . . 0.0 103.832 174.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 1' ' ' MET . 3.4 m-20 -31.36 -31.63 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.832 -0.543 . . . . 0.0 111.393 -176.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -95.6 -38.66 4.64 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.211 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.277 0.1 OUTLIER -48.54 -55.4 11.18 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 177.264 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.78 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -30.43 -63.02 0.15 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.73 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.613 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 16.0 p30 -89.48 28.54 1.26 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.436 -0.79 . . . . 0.0 111.57 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -135.84 2.51 2.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.89 -1.131 . . . . 0.0 110.604 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.83 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -161.32 -47.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.238 -0.914 . . . . 0.0 110.093 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.946 HD11 HG21 ' A' ' 21' ' ' VAL . 12.5 mt -82.11 -35.09 28.93 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.8 -1.187 . . . . 0.0 110.062 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.069 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.265 9.4 m-30 -83.43 -65.68 0.98 Allowed 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.467 -179.301 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -52.44 -16.46 0.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.863 . . . . 0.0 111.574 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 21.8 mt-30 -107.94 -100.87 0.36 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.856 -1.153 . . . . 0.0 110.684 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.5 ' H ' HD12 ' A' ' 35' ' ' LEU . . . -166.87 38.28 0.24 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.167 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 30' ' ' LEU . 3.6 mp -106.74 -43.87 4.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.984 -1.303 . . . . 0.0 109.383 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.729 ' HB3' ' CB ' ' A' ' 30' ' ' LEU . . . -144.54 -179.86 6.83 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.876 0.846 . . . . 0.0 111.922 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -141.46 151.1 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.734 ' O ' HG22 ' A' ' 40' ' ' THR . 2.8 tt0 -43.03 111.47 0.27 Allowed 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.448 -0.782 . . . . 0.0 110.15 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -54.39 95.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.014 -1.475 . . . . 0.0 110.113 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -109.6 155.58 41.11 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 121.1 -1.0 . . . . 0.0 110.243 179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.558 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 41.1 Cg_endo -50.07 -55.12 4.42 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.824 1.434 . . . . 0.0 109.292 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.17 -50.27 0.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.536 -0.727 . . . . 0.0 110.113 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.9 m120 -79.29 -59.2 2.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.719 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.07 ' HG ' HG21 ' A' ' 18' ' ' ILE . 10.6 mp -47.88 -24.33 0.99 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.295 -0.878 . . . . 0.0 110.178 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.37 -39.65 53.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.273 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -72.48 -46.33 55.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.511 -0.743 . . . . 0.0 110.042 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.643 ' CD1' HD11 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -41.29 -50.62 3.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 110.529 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -41.99 -43.03 3.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.739 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 50' ' ' GLN . . . -57.03 -53.71 54.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.992 . . . . 0.0 111.065 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -43.4 -51.0 6.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.043 -1.036 . . . . 0.0 110.558 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -41.08 89.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.223 -0.923 . . . . 0.0 110.97 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -48.96 -42.67 38.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.322 -0.861 . . . . 0.0 110.519 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -56.36 129.33 40.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.228 -0.92 . . . . 0.0 110.515 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.23 -83.8 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 109.734 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.98 24.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 109.97 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.414 ' C ' ' HD3' ' A' ' 56' ' ' ARG . 3.1 tmt_? . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.237 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.806 ' HE1' ' HB3' ' A' ' 27' ' ' ASN . 4.8 ttt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.6 0.238 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -49.45 156.7 0.59 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.066 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.272 2.9 t -132.13 133.72 60.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 119.973 -1.704 . . . . 0.0 114.462 -176.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.885 HG12 HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -101.58 95.28 3.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.911 ' CE1' HD22 ' A' ' 30' ' ' LEU . 9.9 m-85 -64.9 128.14 34.51 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 116.439 -2.104 . . . . 0.0 105.82 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.932 HD21 ' O ' ' A' ' 34' ' ' GLY . 1.2 pp -78.83 -28.39 44.4 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -133.33 172.89 12.08 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.714 0.769 . . . . 0.0 109.898 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.52 166.03 23.05 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.656 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.765 HG23 ' HA3' ' A' ' 13' ' ' GLY . 2.5 t -116.12 -146.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.301 -0.875 . . . . 0.0 108.913 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.648 ' H ' HG12 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -70.96 56.26 0.19 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.571 -1.331 . . . . 0.0 110.017 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 78.18 18.22 76.82 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.3 -70.67 0.77 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.135 -1.215 . . . . 0.0 110.504 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.765 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -57.8 -179.57 0.87 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.518 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 3.3 mtmt -150.7 169.27 22.03 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.322 -1.105 . . . . 0.0 108.699 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.624 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -67.34 137.85 56.33 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.962 -1.086 . . . . 0.0 110.32 -178.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 39.09 26.92 0.06 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.588 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -70.28 122.69 20.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.418 -1.637 . . . . 0.0 108.571 179.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.885 HG23 HG12 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -111.75 122.72 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.287 1.042 . . . . 0.0 112.283 -177.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.547 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 16.0 tptp -161.68 -124.27 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.506 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 50.0 p-10 -151.96 120.6 6.49 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 122.511 1.148 . . . . 0.0 108.503 175.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.029 HG21 HD11 ' A' ' 30' ' ' LEU 0.299 5.0 p -86.36 -140.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.201 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -77.91 110.62 12.98 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 174.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 22' ' ' ALA . 32.5 t0 -29.46 -34.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.303 0.573 . . . . 0.0 111.53 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -96.01 -37.61 4.86 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.201 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.299 0.0 OUTLIER -48.27 -55.26 11.02 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.425 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.749 ' HB2' HG12 ' A' ' 21' ' ' VAL 0.251 . . -28.75 -58.26 0.13 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.393 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.806 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 10.6 p30 -85.64 -0.48 55.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.031 -1.043 . . . . 0.0 113.587 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 25' ' ' TYR . 7.3 t30 -112.94 2.55 15.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.185 -1.572 . . . . 0.0 112.048 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -151.61 -46.86 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.769 -1.207 . . . . 0.0 110.499 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.029 HD11 HG21 ' A' ' 21' ' ' VAL . 14.0 mt -82.78 -38.2 23.5 Favored 'General case' 0 C--N 1.284 -2.269 0 O-C-N 120.359 -1.463 . . . . 0.0 110.375 -177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.066 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.273 8.5 m-30 -82.34 -53.74 5.78 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.844 -179.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.45 -2.04 7.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 0.0 112.289 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.587 ' HG2' ' CD1' ' A' ' 35' ' ' LEU . 1.1 tt0 -130.98 -10.82 3.8 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.513 -1.367 . . . . 0.0 110.715 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.932 ' O ' HD21 ' A' ' 6' ' ' LEU . . . 102.1 19.46 14.67 Favored Glycine 0 N--CA 1.498 2.802 0 C-N-CA 119.543 -1.313 . . . . 0.0 114.918 177.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.812 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 4.7 mp -86.89 -40.74 14.58 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-N 120.837 2.318 . . . . 0.0 107.707 176.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.708 ' HB3' ' HB3' ' A' ' 30' ' ' LEU 0.257 . . -144.58 -174.49 4.34 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.477 -178.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.692 HD11 HG21 ' A' ' 4' ' ' ILE . 1.8 pt -141.8 155.38 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.584 0.706 . . . . 0.0 109.195 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.654 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -51.04 108.83 0.27 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.432 -0.793 . . . . 0.0 110.059 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . . . -49.33 100.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.091 -1.444 . . . . 0.0 109.771 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -110.22 150.59 41.74 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.067 -1.021 . . . . 0.0 110.067 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.528 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 42.2 Cg_endo -49.58 -52.26 9.17 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 124.058 1.557 . . . . 0.0 108.959 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.18 -50.11 0.95 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.637 -0.665 . . . . 0.0 110.54 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' HB2' HG23 ' A' ' 40' ' ' THR . 1.0 OUTLIER -81.92 -54.24 5.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 110.221 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.84 ' CD1' HG21 ' A' ' 18' ' ' ILE . 2.8 mm? -39.95 -44.64 1.73 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.499 -0.751 . . . . 0.0 109.993 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt -63.74 -46.41 85.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -0.998 . . . . 0.0 108.749 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 43' ' ' ASN . . . -57.88 -49.89 75.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.601 -0.687 . . . . 0.0 109.413 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.803 HD12 HD11 ' A' ' 18' ' ' ILE . 3.4 mm? -52.47 -37.38 56.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.515 -0.741 . . . . 0.0 109.145 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -69.68 -44.96 69.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.597 -0.689 . . . . 0.0 110.497 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.57 -58.75 3.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.13 -0.981 . . . . 0.0 110.418 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.14 -36.3 18.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.062 -1.024 . . . . 0.0 110.054 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -66.15 -51.26 59.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.253 -0.905 . . . . 0.0 110.312 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -48.32 104.19 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.881 -1.137 . . . . 0.0 109.838 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.8 41.1 0.89 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 110.165 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.27 107.66 4.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.452 -0.78 . . . . 0.0 109.74 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.43 28.28 4.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.392 -0.817 . . . . 0.0 108.91 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.338 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.807 ' O ' HG23 ' A' ' 3' ' ' VAL . 7.1 tpt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -49.91 147.72 3.67 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.067 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.303 2.8 t -134.63 135.37 53.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -174.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.845 HG12 HG23 ' A' ' 18' ' ' ILE 0.271 0.1 OUTLIER -104.03 99.92 9.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.195 177.699 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.981 ' CE1' HD22 ' A' ' 30' ' ' LEU . 8.9 m-85 -72.66 129.18 37.66 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 117.782 -1.567 . . . . 0.0 107.605 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.893 HD13 ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -77.66 -30.39 52.07 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.162 -1.586 . . . . 0.0 107.295 179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -112.37 -177.19 3.1 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.824 0.821 . . . . 0.0 111.039 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' CB ' ' HA ' ' A' ' 14' ' ' LYS . 15.1 p-10 -109.41 139.58 44.2 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.479 0.657 . . . . 0.0 110.804 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 13' ' ' GLY . 2.1 t -99.24 170.47 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.564 -0.71 . . . . 0.0 109.158 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -74.35 83.34 1.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 110.216 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.89 35.58 54.03 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.483 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -137.74 -41.69 0.54 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -1.152 . . . . 0.0 110.435 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -154.53 161.8 30.36 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.582 ' HG2' ' CB ' ' A' ' 17' ' ' GLU . 12.6 pttt -132.33 175.41 9.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -1.141 . . . . 0.0 110.595 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.583 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -41.5 136.11 1.89 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.313 -0.867 . . . . 0.0 111.92 -179.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 29.91 35.11 0.01 OUTLIER Glycine 0 N--CA 1.507 3.409 0 O-C-N 121.963 -0.46 . . . . 0.0 112.131 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.582 ' CB ' ' HG2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -72.97 123.66 23.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.331 -1.688 . . . . 0.0 108.635 178.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.845 HG23 HG12 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -107.29 123.43 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.142 0.973 . . . . 0.0 111.029 -178.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 7.9 ttpt -161.17 -127.53 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 9.0 p30 -152.11 120.24 6.27 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.347 1.07 . . . . 0.0 108.314 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.927 HG21 HD11 ' A' ' 30' ' ' LEU 0.303 1.4 p -87.48 -146.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 178.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.187 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -72.09 108.7 5.43 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 1' ' ' MET . 1.9 m-20 -30.65 -32.28 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.121 0.486 . . . . 0.0 111.602 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -94.45 -38.85 4.9 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.187 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.299 0.1 OUTLIER -48.61 -57.08 6.76 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.543 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.867 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.39 -60.23 0.15 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.007 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.6 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -89.58 11.69 18.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.992 -1.068 . . . . 0.0 112.786 -179.018 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.0 10.88 8.87 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.522 -1.361 . . . . 0.0 110.616 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.829 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.65 -52.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.144 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.981 HD22 ' CE1' ' A' ' 5' ' ' PHE . 19.1 mt -75.67 -39.94 56.78 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.735 -1.228 . . . . 0.0 109.94 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.067 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.281 8.5 m-30 -81.74 -44.6 16.82 Favored 'General case' 0 C--N 1.272 -2.786 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.88 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -68.29 -5.22 17.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.461 -0.774 . . . . 0.0 111.147 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.59 ' HB2' ' CD1' ' A' ' 35' ' ' LEU . 23.2 mm100 -129.64 -14.96 4.04 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.778 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.681 ' O ' HD23 ' A' ' 6' ' ' LEU . . . 100.69 18.53 20.44 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.414 -1.374 . . . . 0.0 111.675 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.859 HD13 ' HA ' ' A' ' 30' ' ' LEU . 5.3 mp -79.72 -43.24 23.01 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.678 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -142.08 -176.69 4.9 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.157 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.469 ' O ' ' C ' ' A' ' 38' ' ' GLU . 10.6 mt -141.99 136.67 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.468 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.683 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 9.7 pt-20 -38.65 113.83 0.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.613 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.638 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -48.58 99.24 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 117.804 -1.558 . . . . 0.0 110.057 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -112.71 153.51 45.04 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.537 -0.727 . . . . 0.0 109.692 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.564 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 40.1 Cg_endo -50.79 -60.83 0.68 Allowed 'Trans proline' 0 C--N 1.299 -2.031 0 O-C-N 123.971 1.511 . . . . 0.0 110.149 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.79 -54.13 0.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.486 -0.759 . . . . 0.0 111.814 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.622 ' HB2' HG23 ' A' ' 40' ' ' THR . 1.5 m-20 -79.21 -34.7 42.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.956 -1.09 . . . . 0.0 111.193 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.638 HD21 ' HB1' ' A' ' 39' ' ' ALA . 5.3 mp -66.59 -66.58 0.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 44' ' ' LEU . 1.7 ttpt -41.53 -48.93 4.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 110.094 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.89 -46.86 88.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.86 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.521 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -47.58 -53.02 15.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.337 -0.852 . . . . 0.0 110.004 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.477 ' OE1' ' HB2' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -57.88 -37.93 74.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.416 -0.803 . . . . 0.0 110.565 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.35 -49.57 76.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.149 -0.969 . . . . 0.0 109.977 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -31.71 71.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 110.115 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -82.58 -25.45 33.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.0 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.477 ' HB2' ' OE1' ' A' ' 48' ' ' GLU . 4.3 tp60 -73.01 -78.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.195 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.431 ' HG2' ' OE1' ' A' ' 55' ' ' GLN . 8.3 tptt -58.16 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.377 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 114.64 1.71 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 110.171 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' OE1' ' HG2' ' A' ' 53' ' ' LYS . 0.3 OUTLIER -139.18 16.16 2.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 108.991 179.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? . . . . . 0 C--N 1.304 -1.375 0 CA-C-O 117.825 -1.083 . . . . 0.0 110.054 -179.468 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.552 ' CE ' ' HB3' ' A' ' 27' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.778 0.323 . . . . 0.0 110.43 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.613 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 30.4 mttt -59.45 149.71 28.75 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.078 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.27 2.8 t -129.51 131.77 66.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.295 -1.503 . . . . 0.0 114.74 -175.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.834 HG12 HG23 ' A' ' 18' ' ' ILE 0.254 0.0 OUTLIER -99.58 98.4 7.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.534 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.037 ' HE1' HD22 ' A' ' 30' ' ' LEU . 8.6 m-85 -75.65 124.23 26.89 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.106 -1.621 . . . . 0.0 107.854 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.004 HD21 HG23 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -83.03 -27.31 30.43 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 120.656 -1.277 . . . . 0.0 112.144 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -95.72 -152.52 0.37 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.776 ' C ' ' O ' ' A' ' 13' ' ' GLY . 37.7 p-10 -99.02 133.71 42.89 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.465 -0.772 . . . . 0.0 109.543 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.08 HG23 ' HA2' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -88.1 2.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.72 70.12 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 101.75 9.13 44.09 Favored Glycine 0 CA--C 1.549 2.208 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 10.5 mttm -151.15 -87.06 0.07 Allowed 'General case' 0 N--CA 1.511 2.604 0 O-C-N 120.47 -1.606 . . . . 0.0 113.487 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 1.08 ' HA2' HG23 ' A' ' 9' ' ' VAL . . . -156.22 144.67 11.1 Favored Glycine 0 N--CA 1.505 3.292 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.557 ' N ' ' HB ' ' A' ' 9' ' ' VAL . 2.3 mtmt -88.68 145.75 25.47 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 119.895 1.848 . . . . 0.0 111.011 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.64 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -28.7 121.32 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.867 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 20.51 46.3 0.01 OUTLIER Glycine 0 N--CA 1.512 3.74 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -80.04 121.85 26.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.665 -1.491 . . . . 0.0 109.646 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.025 HG21 HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -104.53 123.07 58.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-O 122.482 1.134 . . . . 0.0 111.661 -178.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -161.54 -127.87 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -152.17 120.67 6.42 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 122.37 1.081 . . . . 0.0 108.863 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.01 HG21 HD11 ' A' ' 30' ' ' LEU 0.29 2.5 p -87.55 -149.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.216 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -70.5 109.84 5.05 Favored 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 174.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 1' ' ' MET . 2.1 m-20 -30.59 -31.53 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.046 0.451 . . . . 0.0 111.677 -176.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -98.65 -35.68 4.82 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.216 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.274 0.1 OUTLIER -48.83 -53.51 19.02 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.613 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.769 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -30.32 -57.99 0.19 Allowed 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.177 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.606 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 12.5 p30 -90.15 5.82 45.27 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.958 -1.089 . . . . 0.0 112.054 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 25' ' ' TYR . 4.9 t-20 -108.95 -0.15 19.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.102 . . . . 0.0 111.23 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.777 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.56 -52.88 0.05 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.885 -1.135 . . . . 0.0 111.132 -178.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.037 HD22 ' HE1' ' A' ' 5' ' ' PHE . 20.9 mt -71.39 -44.91 64.07 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 122.269 1.033 . . . . 0.0 110.71 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.078 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.277 7.2 m-30 -78.62 -42.74 28.06 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.573 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 31.0 tptt -69.95 0.28 6.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.468 -0.77 . . . . 0.0 111.446 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.586 ' HB2' ' CD1' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -132.58 -14.4 2.86 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.795 -1.19 . . . . 0.0 111.349 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 100.82 18.62 19.87 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.149 -1.5 . . . . 0.0 111.005 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.928 HD13 ' HA ' ' A' ' 30' ' ' LEU . 4.6 mp -80.83 -49.77 10.65 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.665 -1.491 . . . . 0.0 107.734 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.929 ' HA ' HD22 ' A' ' 6' ' ' LEU 0.262 . . -139.23 -177.06 4.74 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.015 -178.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.004 HG23 HD21 ' A' ' 6' ' ' LEU . 5.8 pt -139.37 161.72 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 6.4 tt0 -55.11 105.06 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.249 -0.907 . . . . 0.0 109.162 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.613 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -54.17 89.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 118.323 -1.351 . . . . 0.0 110.355 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.59 ' OG1' ' CD ' ' A' ' 41' ' ' PRO . 0.9 OUTLIER -115.16 156.46 45.42 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.153 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' OG1' ' A' ' 40' ' ' THR . 50.2 Cg_endo -49.79 -61.27 0.6 Allowed 'Trans proline' 0 C--N 1.3 -2.003 0 O-C-N 124.155 1.608 . . . . 0.0 110.496 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.1 -35.13 0.07 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.689 -0.632 . . . . 0.0 111.267 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' ND2' HD12 ' A' ' 37' ' ' ILE . 2.9 t-20 -99.31 -51.19 3.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.975 -1.078 . . . . 0.0 110.862 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.025 HD11 HG21 ' A' ' 18' ' ' ILE . 1.8 mm? -40.85 -47.47 2.93 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 110.754 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.86 -35.57 75.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 110.757 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -71.38 -39.2 71.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 0.0 110.272 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.528 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -40.52 -45.08 2.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 110.251 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 44.3 tt0 -70.85 -50.64 33.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.149 -0.969 . . . . 0.0 110.551 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.67 67.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.109 -0.994 . . . . 0.0 110.321 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -51.69 -32.22 29.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.854 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -63.77 -38.47 91.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.483 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -59.63 2.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.789 . . . . 0.0 109.334 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -53.45 -72.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.488 -0.757 . . . . 0.0 109.819 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.11 135.21 42.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 109.916 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -148.45 60.08 1.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.485 -179.069 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.715 ' O ' HG23 ' A' ' 3' ' ' VAL . 7.6 tpt . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.645 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 5.8 mtmm -50.57 152.35 1.98 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.114 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.273 3.7 t -132.37 131.84 60.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 119.836 -1.79 . . . . 0.0 114.972 -175.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.868 HG22 ' O ' ' A' ' 4' ' ' ILE 0.25 0.1 OUTLIER -98.99 89.26 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.838 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.933 ' CE2' HD22 ' A' ' 30' ' ' LEU . 11.2 m-85 -65.56 116.18 6.55 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 119.622 -1.924 . . . . 0.0 106.545 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -79.36 -23.46 43.34 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.529 ' N ' ' HG ' ' A' ' 6' ' ' LEU . 20.5 mttt -111.67 -172.4 2.03 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.795 0.807 . . . . 0.0 110.391 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 15.7 p30 -109.06 153.06 24.19 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.969 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.66 HG21 ' CE2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -130.92 -157.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 109.144 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -77.82 75.51 4.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.963 -1.086 . . . . 0.0 110.012 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.58 17.41 13.37 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.9 -40.36 11.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.314 -1.109 . . . . 0.0 109.73 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.493 ' HA2' ' OE1' ' A' ' 17' ' ' GLU . . . -152.11 157.81 27.46 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.505 ' HG2' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -116.18 175.55 5.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -1.083 . . . . 0.0 110.58 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -37.95 134.43 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.583 -0.698 . . . . 0.0 111.19 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 27.14 39.24 0.01 OUTLIER Glycine 0 N--CA 1.507 3.406 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.646 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -74.61 132.01 41.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.669 -1.489 . . . . 0.0 108.94 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.018 HG21 HD11 ' A' ' 44' ' ' LEU . 1.2 mp -112.22 123.54 68.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.907 -1.121 . . . . 0.0 111.693 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 5.5 ttmt -160.97 -126.37 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -151.93 119.86 6.2 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.944 HG21 HD11 ' A' ' 30' ' ' LEU 0.301 3.6 p -87.23 -143.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 178.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.199 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -73.17 109.98 7.11 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -31.42 -30.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.976 -0.452 . . . . 0.0 111.697 -176.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.84 -37.96 4.28 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.199 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.305 0.1 OUTLIER -48.04 -56.92 6.57 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.539 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.79 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -28.69 -60.6 0.12 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.686 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.634 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 24.1 t30 -89.3 34.03 0.81 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.02 -1.05 . . . . 0.0 112.44 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -147.56 9.1 0.91 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.437 -1.414 . . . . 0.0 110.613 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.836 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.69 -46.42 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.068 -1.02 . . . . 0.0 109.254 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.944 HD11 HG21 ' A' ' 21' ' ' VAL . 10.9 mt -87.03 -36.14 18.37 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 120.926 -1.109 . . . . 0.0 109.473 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.114 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.277 8.6 m-30 -82.71 -49.0 10.24 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.508 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -70.4 1.24 5.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.267 -0.896 . . . . 0.0 110.605 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -127.97 -114.31 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.944 -1.098 . . . . 0.0 110.781 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 7' ' ' LYS . . . -145.61 14.97 1.8 Allowed Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.779 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.728 HD13 HD23 ' A' ' 30' ' ' LEU . 1.7 mp -83.93 -51.45 7.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.776 -1.426 . . . . 0.0 109.836 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.71 ' HB3' ' CB ' ' A' ' 30' ' ' LEU . . . -143.72 -179.61 6.56 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.377 1.084 . . . . 0.0 112.99 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.449 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -144.48 149.18 17.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.77 ' O ' HG22 ' A' ' 40' ' ' THR . 17.2 tt0 -37.05 108.94 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.882 -0.511 . . . . 0.0 110.97 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.645 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -55.97 97.85 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 118.113 -1.435 . . . . 0.0 110.289 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.77 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -119.09 155.27 53.39 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.112 -0.993 . . . . 0.0 110.577 179.428 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.553 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 39.6 Cg_endo -49.31 -45.26 30.92 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.803 1.423 . . . . 0.0 108.967 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.96 -57.26 0.83 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.282 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 44' ' ' LEU . 58.5 m-20 -88.31 -46.31 9.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 0.0 110.318 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.018 HD11 HG21 ' A' ' 18' ' ' ILE . 2.9 mm? -36.86 -66.58 0.22 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.512 -0.743 . . . . 0.0 110.769 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -55.06 -36.65 65.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.067 -1.02 . . . . 0.0 110.41 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 49' ' ' ALA . . . -66.22 -39.24 89.46 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.085 -1.01 . . . . 0.0 110.274 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -43.55 -50.22 7.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.028 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' LEU . 20.5 tt0 -45.26 -31.62 1.61 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.19 -0.944 . . . . 0.0 109.012 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . -85.2 -48.46 9.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.504 -0.748 . . . . 0.0 109.456 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.404 ' C ' ' OE1' ' A' ' 50' ' ' GLN . 1.2 tm0? -51.51 -38.81 55.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 109.238 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HE2' ' HE3' ' A' ' 15' ' ' LYS . 2.4 tppp? -62.53 -52.45 63.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.421 -0.799 . . . . 0.0 109.607 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.52 92.47 9.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.835 . . . . 0.0 110.146 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -80.98 72.24 7.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.403 -0.811 . . . . 0.0 109.912 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -116.42 155.19 28.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.335 -0.853 . . . . 0.0 110.574 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -137.28 -31.36 0.82 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.4 -0.812 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.331 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.757 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.657 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 2.2 mttp -49.4 145.79 4.4 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.085 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.283 2.9 t -136.66 130.24 46.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 118.312 -1.355 . . . . 0.0 114.361 -175.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.819 HG22 ' O ' ' A' ' 4' ' ' ILE 0.262 0.1 OUTLIER -98.81 95.3 4.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.633 178.283 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.982 ' CE2' HD22 ' A' ' 30' ' ' LEU . 11.5 m-85 -66.67 124.41 22.79 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.02 -1.675 . . . . 0.0 106.674 177.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.679 HD12 ' HD3' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -78.52 -24.78 45.58 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.672 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.679 ' HD3' HD12 ' A' ' 6' ' ' LEU . 8.3 mptt -118.65 -163.75 0.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.463 0.649 . . . . 0.0 110.361 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -109.65 153.99 23.45 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.904 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 10' ' ' LYS . 1.7 t -124.89 -162.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -0.98 . . . . 0.0 109.86 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.69 ' H ' HG12 ' A' ' 9' ' ' VAL . 4.4 mmtt -65.74 83.05 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 0.0 109.799 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' LYS . . . 45.49 26.5 1.65 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -108.54 -67.61 0.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.351 -1.088 . . . . 0.0 110.111 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' HA2' ' CD ' ' A' ' 17' ' ' GLU . . . -106.2 162.65 13.86 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.522 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 6.1 mmpt? -128.38 -172.56 2.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.358 -1.084 . . . . 0.0 109.541 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.576 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -53.95 129.62 34.69 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 110.302 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 5' ' ' PHE . . . 32.68 37.22 0.04 OUTLIER Glycine 0 N--CA 1.503 3.105 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -76.49 128.35 34.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.879 -1.365 . . . . 0.0 109.48 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 4' ' ' ILE . 1.7 mp -100.51 118.44 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 122.456 1.122 . . . . 0.0 111.258 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.556 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 1.5 tttt -161.92 152.05 16.92 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -87.39 123.91 32.84 Favored 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 116.871 -1.932 . . . . 0.0 109.005 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.919 HG22 ' CD2' ' A' ' 25' ' ' TYR 0.328 2.7 p -87.14 -144.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 178.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.212 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -74.28 111.26 9.28 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 1' ' ' MET . 1.1 m-20 -31.51 -31.2 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.965 -0.46 . . . . 0.0 111.906 -176.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -98.05 -36.89 4.55 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.212 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.309 0.1 OUTLIER -48.73 -57.09 6.85 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 176.797 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.816 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -30.14 -63.97 0.13 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.448 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.703 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 20.3 t30 -85.84 4.62 36.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.521 -0.737 . . . . 0.0 112.814 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -118.19 11.43 13.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.508 -1.37 . . . . 0.0 111.165 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.83 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -161.17 -46.78 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.953 -1.092 . . . . 0.0 110.531 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.982 HD22 ' CE2' ' A' ' 5' ' ' PHE . 16.8 mt -84.03 -34.17 24.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.67 -1.268 . . . . 0.0 110.014 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.085 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.261 7.2 m-30 -82.64 -58.14 3.03 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.236 -178.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -68.87 -1.11 6.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 111.873 -178.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 2.4 mt-30 -114.57 -92.89 0.49 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.734 -1.229 . . . . 0.0 110.273 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.418 ' H ' HD12 ' A' ' 35' ' ' LEU . . . -171.86 28.84 0.11 Allowed Glycine 0 N--CA 1.488 2.166 0 C-N-CA 119.552 -1.309 . . . . 0.0 110.067 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 30' ' ' LEU . 2.9 mp -101.44 -50.51 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.091 -1.24 . . . . 0.0 110.54 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 30' ' ' LEU 0.263 . . -144.36 179.09 7.47 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.906 0.86 . . . . 0.0 112.831 -177.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.507 ' C ' ' CZ ' ' A' ' 31' ' ' PHE . 4.9 pt -136.56 162.25 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 175.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 40' ' ' THR . 15.3 tt0 -55.5 118.88 4.86 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.971 -1.081 . . . . 0.0 109.66 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -59.21 83.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 117.877 -1.529 . . . . 0.0 110.073 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.618 HG23 ' HD2' ' A' ' 41' ' ' PRO . 0.9 OUTLIER -112.0 162.72 19.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.187 -0.946 . . . . 0.0 109.544 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 40' ' ' THR . 45.4 Cg_endo -48.58 -66.4 0.14 Allowed 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 123.78 1.411 . . . . 0.0 110.615 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.52 -30.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.485 -0.76 . . . . 0.0 110.883 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' PRO . 18.4 m-20 -93.71 -60.65 1.71 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 110.337 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.499 HD11 HG21 ' A' ' 18' ' ' ILE . 2.4 mm? -44.7 -39.02 4.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.05 -1.031 . . . . 0.0 110.029 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 21.8 mttt -72.63 -39.52 67.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 109.25 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.3 -40.41 71.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.027 -1.046 . . . . 0.0 109.214 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.425 HD11 ' HA3' ' A' ' 16' ' ' GLY . 3.1 mm? -56.46 -39.3 72.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.698 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 45' ' ' LYS . 12.7 tt0 -59.7 -22.17 61.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.493 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.04 -47.1 30.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.133 -0.98 . . . . 0.0 110.563 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -60.7 -27.78 68.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.514 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -82.06 -46.49 13.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.15 -0.969 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -59.2 110.85 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.06 -1.025 . . . . 0.0 110.302 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.8 119.85 20.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.297 -0.877 . . . . 0.0 110.363 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -123.02 105.0 9.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 110.228 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.83 -41.04 0.17 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.9 . . . . 0.0 108.956 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.597 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.589 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.617 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.717 0.294 . . . . 0.0 110.593 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.597 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 8.8 mtmt -57.46 149.39 21.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.087 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.283 2.9 t -135.57 130.78 50.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 117.527 -1.669 . . . . 0.0 114.863 -175.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 4' ' ' ILE 0.264 0.0 OUTLIER -100.28 98.24 6.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.421 178.324 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.959 ' CE1' HD22 ' A' ' 30' ' ' LEU . 13.5 m-85 -70.15 127.89 34.4 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.052 -1.655 . . . . 0.0 106.923 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.903 HD22 ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -76.5 -29.2 56.71 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 120.538 -1.352 . . . . 0.0 108.207 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.35 165.88 18.2 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.98 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -78.07 156.57 29.95 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.458 -179.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 11' ' ' GLY . 1.9 t -111.18 166.27 5.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 109.082 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.24 82.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 0.0 110.327 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 61.41 48.47 84.94 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -142.99 -61.44 0.42 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.079 -1.248 . . . . 0.0 111.252 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.478 ' HA2' ' OE1' ' A' ' 17' ' ' GLU . . . -121.15 162.57 14.85 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 4.1 mttt -119.36 176.98 5.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -1.119 . . . . 0.0 111.307 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.63 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -45.24 132.33 7.51 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.687 -0.633 . . . . 0.0 112.031 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.562 ' CA ' ' O ' ' A' ' 5' ' ' PHE . . . 33.26 32.61 0.01 OUTLIER Glycine 0 N--CA 1.509 3.548 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.657 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -70.16 125.06 25.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.167 -1.196 . . . . 0.0 109.62 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.936 HG21 HD11 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -103.38 115.5 45.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 120.505 -1.372 . . . . 0.0 110.233 -179.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -161.31 152.99 19.25 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 19.3 p30 -87.51 124.15 33.17 Favored 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 117.216 -1.794 . . . . 0.0 109.807 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.904 HG21 HD11 ' A' ' 30' ' ' LEU 0.299 1.3 p -87.25 -150.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.21 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -68.16 107.91 2.94 Favored 'General case' 0 C--N 1.272 -2.763 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 1' ' ' MET . 88.6 m-20 -30.86 -32.24 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.982 -0.449 . . . . 0.0 111.667 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -96.94 -36.38 5.01 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.21 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.308 0.0 OUTLIER -47.83 -59.14 3.54 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 177.289 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.873 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.25 -57.41 0.15 Allowed 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.314 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.654 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 21.2 t30 -80.72 -35.56 33.3 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.883 -1.136 . . . . 0.0 113.263 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -80.58 15.27 1.74 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.519 -1.363 . . . . 0.0 110.717 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.775 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -160.31 -99.58 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.32 -0.863 . . . . 0.0 109.983 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.062 ' HA ' HD13 ' A' ' 35' ' ' LEU . 14.2 mt -29.81 -42.48 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.574 0 CA-C-O 122.431 1.11 . . . . 0.0 110.296 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.087 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.264 8.8 m-30 -79.37 -56.44 4.34 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.41 -178.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.29 11.9 6.06 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.953 -1.092 . . . . 0.0 110.693 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.7 ' HB3' HD11 ' A' ' 35' ' ' LEU . 1.9 mt-30 -121.08 -19.37 7.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.873 -1.142 . . . . 0.0 111.061 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.466 ' N ' HD12 ' A' ' 35' ' ' LEU . . . 101.04 41.62 2.59 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.947 -1.121 . . . . 0.0 111.594 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.062 HD13 ' HA ' ' A' ' 30' ' ' LEU . 1.9 mp -122.16 -46.49 2.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.008 -1.289 . . . . 0.0 109.433 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.903 ' HA ' HD22 ' A' ' 6' ' ' LEU 0.264 . . -142.14 177.77 8.0 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.656 0.741 . . . . 0.0 111.222 -178.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.896 HG23 HD21 ' A' ' 6' ' ' LEU . 2.7 pp -135.69 174.51 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.03 111.1 2.38 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.228 -0.92 . . . . 0.0 110.007 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -54.4 99.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 118.122 -1.431 . . . . 0.0 110.188 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.59 ' OG1' ' CD ' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -118.37 160.38 39.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 109.647 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.59 ' CD ' ' OG1' ' A' ' 40' ' ' THR . 50.1 Cg_endo -50.12 -62.43 0.41 Allowed 'Trans proline' 0 C--N 1.299 -2.048 0 O-C-N 123.846 1.446 . . . . 0.0 110.662 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.09 -40.64 0.22 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.493 -0.754 . . . . 0.0 110.865 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 76.1 m-20 -85.86 -57.42 3.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.14 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 18' ' ' ILE . 3.7 mm? -42.33 -55.08 3.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.865 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.42 -43.03 88.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.12 -0.987 . . . . 0.0 109.365 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 43' ' ' ASN . . . -56.23 -49.81 73.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.656 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -48.9 -31.85 7.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.349 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 52' ' ' GLN . 4.1 tp10 -72.26 -24.46 61.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.843 . . . . 0.0 110.111 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.84 -59.21 2.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 0.0 109.877 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -45.19 -37.24 4.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 110.657 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 52' ' ' GLN . 0.6 OUTLIER -76.96 -40.38 47.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.224 -0.922 . . . . 0.0 110.63 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 11.0 mt-30 -53.4 -174.35 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.149 -0.969 . . . . 0.0 109.57 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -127.23 -18.31 4.56 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 111.363 -178.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' A' ' 53' ' ' LYS . 15.6 tm-20 -104.32 122.51 45.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.883 -1.136 . . . . 0.0 110.887 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.407 ' CD ' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -159.96 22.84 0.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.921 . . . . 0.0 109.953 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.332 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.672 ' O ' HG23 ' A' ' 3' ' ' VAL . 3.0 ttt . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 8.1 mttp -54.47 149.3 10.6 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.13 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.294 3.1 t -133.33 134.78 57.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 117.716 -1.593 . . . . 0.0 115.252 -175.097 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.862 HG22 ' O ' ' A' ' 4' ' ' ILE 0.271 0.1 OUTLIER -98.91 92.39 2.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.888 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.718 ' CE2' HD22 ' A' ' 30' ' ' LEU . 9.3 m-85 -68.22 126.47 29.65 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 116.881 -1.928 . . . . 0.0 106.9 178.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.649 HD21 ' C ' ' A' ' 34' ' ' GLY . 1.3 pp -78.22 -27.91 47.85 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.62 ' HG3' HD12 ' A' ' 6' ' ' LEU . 9.0 mttm -117.76 -165.75 1.13 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.36 159.78 23.52 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.362 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.68 HG12 ' H ' ' A' ' 10' ' ' LYS . 2.2 t -99.66 -154.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 0.0 109.091 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.68 ' H ' HG12 ' A' ' 9' ' ' VAL . 4.5 ptmt -83.23 64.77 7.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.684 -1.26 . . . . 0.0 110.665 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.85 25.52 45.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -67.8 0.84 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.076 -1.249 . . . . 0.0 110.063 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.04 165.52 34.62 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 67.0 mttt -138.5 173.65 11.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.246 . . . . 0.0 110.282 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -47.1 139.32 5.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.869 . . . . 0.0 111.32 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.673 ' O ' HD12 ' A' ' 47' ' ' LEU . . . 25.49 39.44 0.01 OUTLIER Glycine 0 N--CA 1.511 3.672 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -76.34 127.87 33.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.93 -1.335 . . . . 0.0 108.452 179.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.985 HG21 ' CD1' ' A' ' 44' ' ' LEU . 2.9 mp -108.67 120.93 60.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 122.201 1.001 . . . . 0.0 110.687 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 3.0 tttt -160.99 -127.09 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -151.55 120.3 6.56 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-O 122.18 0.991 . . . . 0.0 108.351 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.913 HG21 HD11 ' A' ' 30' ' ' LEU 0.29 5.4 p -87.02 -141.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 178.421 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.2 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -74.77 113.39 11.99 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 174.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -31.16 -32.31 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 120.934 0.397 . . . . 0.0 111.583 -176.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -99.49 -36.58 4.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.2 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.307 0.1 OUTLIER -48.25 -55.28 10.93 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 177.396 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.802 ' HB2' HG12 ' A' ' 21' ' ' VAL 0.254 . . -29.44 -64.08 0.11 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.25 177.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.666 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 5.5 t30 -89.75 33.54 0.85 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.055 -1.028 . . . . 0.0 112.27 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 25' ' ' TYR . 1.1 m-20 -144.89 8.05 1.25 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.485 -1.385 . . . . 0.0 110.573 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.867 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -160.73 -49.48 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.874 0.845 . . . . 0.0 108.945 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.913 HD11 HG21 ' A' ' 21' ' ' VAL . 12.2 mt -80.85 -34.93 33.42 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 122.629 1.204 . . . . 0.0 109.09 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.13 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.281 7.1 m-30 -88.0 -52.61 5.17 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.448 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -7.76 6.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.621 -0.674 . . . . 0.0 110.75 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 5.3 mt-30 -123.9 -111.16 0.31 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.929 -1.107 . . . . 0.0 110.328 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.649 ' C ' HD21 ' A' ' 6' ' ' LEU . . . -152.39 36.48 0.81 Allowed Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.285 -1.436 . . . . 0.0 110.914 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.706 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 3.0 mp -104.46 -38.64 6.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.832 -1.393 . . . . 0.0 109.403 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -153.3 -176.74 5.93 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.132 0.968 . . . . 0.0 112.703 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.567 ' C ' ' CE1' ' A' ' 31' ' ' PHE . 7.9 pt -143.51 160.15 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.345 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.623 ' O ' HG22 ' A' ' 40' ' ' THR . 8.2 tt0 -51.11 110.3 0.42 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.382 -0.824 . . . . 0.0 110.191 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.543 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -51.31 97.17 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 118.008 -1.477 . . . . 0.0 110.206 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -109.06 152.34 42.43 Favored Pre-proline 0 N--CA 1.505 2.298 0 O-C-N 121.124 -0.985 . . . . 0.0 110.472 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 41.6 Cg_endo -49.78 -58.8 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.827 1.435 . . . . 0.0 110.056 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.73 -60.22 0.62 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.415 -0.803 . . . . 0.0 110.816 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.489 ' ND2' ' CG2' ' A' ' 40' ' ' THR . 29.5 m-20 -67.47 -49.68 62.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.267 -0.896 . . . . 0.0 110.557 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.985 ' CD1' HG21 ' A' ' 18' ' ' ILE . 2.2 mm? -45.91 -33.88 3.53 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.41 -0.806 . . . . 0.0 110.094 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -64.63 -51.29 63.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.051 -1.031 . . . . 0.0 109.551 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.39 -46.85 66.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.936 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -66.63 -51.71 53.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 0.0 109.116 179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -51.34 -31.7 22.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.588 -0.695 . . . . 0.0 110.256 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.64 -43.87 71.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.046 -1.034 . . . . 0.0 110.041 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -79.79 -18.04 51.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 0.0 109.52 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -90.06 -13.33 36.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.819 . . . . 0.0 110.411 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -57.89 -16.18 11.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.099 -1.001 . . . . 0.0 110.333 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.7 -166.72 1.59 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.075 -1.016 . . . . 0.0 110.069 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.48 -51.01 0.25 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.057 -1.027 . . . . 0.0 110.129 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.15 48.89 0.27 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.947 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.41 ' CD ' ' O ' ' A' ' 56' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.293 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.534 ' O ' HG23 ' A' ' 3' ' ' VAL . 6.5 ttt . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.626 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -54.64 156.71 3.36 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.077 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.295 3.2 t -134.05 131.55 55.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 120.161 -1.587 . . . . 0.0 114.918 -175.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.901 HG22 ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -95.45 89.6 2.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.923 ' CE1' HD22 ' A' ' 30' ' ' LEU . 7.2 m-85 -65.0 122.34 16.78 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 116.342 -2.143 . . . . 0.0 106.248 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.819 HD23 ' HA ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -78.98 -23.11 44.69 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.033 -1.067 . . . . 0.0 108.524 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.598 ' HD2' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -137.95 170.95 15.16 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.397 0.617 . . . . 0.0 109.509 178.078 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -81.12 168.98 17.99 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.336 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 10' ' ' LYS . 2.1 t -125.72 -143.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.33 -0.856 . . . . 0.0 109.132 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' H ' HG12 ' A' ' 9' ' ' VAL . 14.6 mttp -75.2 83.78 2.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.993 -1.067 . . . . 0.0 109.543 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 10' ' ' LYS . . . 44.74 51.77 7.99 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -146.06 -75.71 0.21 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -1.077 . . . . 0.0 111.218 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.465 ' HA2' ' OE2' ' A' ' 17' ' ' GLU . . . -62.87 -175.91 2.95 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.445 -0.884 . . . . 0.0 110.932 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.606 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 10.9 mttt -147.26 166.5 26.85 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.638 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -65.71 136.06 55.78 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.842 -1.161 . . . . 0.0 110.72 -178.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 34.35 30.58 0.01 OUTLIER Glycine 0 N--CA 1.503 3.11 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -177.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.606 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -72.23 126.11 28.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.842 -1.387 . . . . 0.0 109.789 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.732 HG21 ' HG ' ' A' ' 44' ' ' LEU . 2.2 mp -106.38 122.59 60.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.043 0.925 . . . . 0.0 110.577 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -161.0 -128.96 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 36.6 p-10 -152.39 119.57 5.89 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 122.221 1.01 . . . . 0.0 108.921 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.07 HG21 HD11 ' A' ' 30' ' ' LEU 0.3 3.9 p -87.51 -146.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.624 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 177.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.192 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -71.52 109.72 5.66 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 22' ' ' ALA . 3.1 m-20 -32.24 -29.88 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.802 -0.561 . . . . 0.0 111.798 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.25 -38.2 4.36 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.321 -1.911 . . . . 0.0 108.321 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.192 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.298 0.1 OUTLIER -48.44 -54.95 12.24 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 177.219 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.779 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.39 -60.39 0.15 Allowed 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.837 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.6 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 16.7 t30 -90.18 14.77 11.68 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.175 -0.953 . . . . 0.0 112.5 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.94 6.24 10.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.67 -1.269 . . . . 0.0 110.044 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.797 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -161.24 -58.59 0.05 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.99 0.9 . . . . 0.0 110.527 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.07 HD11 HG21 ' A' ' 21' ' ' VAL . 22.3 mt -67.98 -39.71 83.26 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 122.674 1.226 . . . . 0.0 110.357 -176.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.077 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.259 10.1 m-30 -77.62 -44.54 27.92 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 114.869 -1.059 . . . . 0.0 113.46 -177.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.22 9.9 24.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.506 -1.371 . . . . 0.0 111.906 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 4.5 mt-30 -125.94 -11.76 6.52 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 120.59 -1.319 . . . . 0.0 111.474 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 27.63 7.28 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.419 -1.372 . . . . 0.0 111.673 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.94 HD13 ' HA ' ' A' ' 30' ' ' LEU . 4.4 mp -101.53 -47.29 4.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.629 -1.512 . . . . 0.0 108.382 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.819 ' HA ' HD23 ' A' ' 6' ' ' LEU 0.255 . . -145.77 -174.81 4.51 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.839 0.828 . . . . 0.0 111.032 -178.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.588 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 1.8 pt -142.3 169.4 13.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.607 ' O ' HG22 ' A' ' 40' ' ' THR . 20.4 tt0 -59.66 107.17 0.56 Allowed 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.393 -0.817 . . . . 0.0 109.774 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.626 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -63.64 96.88 0.13 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.822 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.644 HG23 ' HB2' ' A' ' 43' ' ' ASN . 0.2 OUTLIER -111.61 145.58 32.92 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.028 -1.045 . . . . 0.0 108.91 178.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.499 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 46.0 Cg_endo -48.87 -54.76 4.93 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 O-C-N 123.781 1.411 . . . . 0.0 109.217 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.35 -52.55 1.11 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 111.16 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.644 ' HB2' HG23 ' A' ' 40' ' ' THR . 4.1 m-20 -80.29 -48.48 12.97 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.035 -1.041 . . . . 0.0 111.075 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.732 ' HG ' HG21 ' A' ' 18' ' ' ILE . 6.3 mp -46.12 -22.58 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.966 . . . . 0.0 109.85 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -77.67 -34.77 52.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 48' ' ' GLU . . . -68.76 -37.62 79.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.495 -0.753 . . . . 0.0 110.194 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.482 ' HG ' HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -38.84 -27.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.655 -0.653 . . . . 0.0 110.298 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 46' ' ' ALA . 7.6 tm-20 -68.86 -41.12 78.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 0.0 110.527 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . -76.67 -46.42 25.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 110.124 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -46.53 -41.88 14.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.973 -1.08 . . . . 0.0 109.153 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 50' ' ' GLN . 8.9 tttt -43.9 -49.04 8.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.432 -0.793 . . . . 0.0 109.546 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.63 109.49 2.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 0.0 109.726 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.6 175.07 6.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.058 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.431 ' C ' ' HG2' ' A' ' 55' ' ' GLN . 1.5 mt-10 -158.8 -80.56 0.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.322 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HG2' ' C ' ' A' ' 54' ' ' GLU . 5.1 mm100 -134.47 8.23 3.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.798 . . . . 0.0 109.389 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.144 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.749 ' HE2' ' HB2' ' A' ' 27' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.83 0.347 . . . . 0.0 110.801 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -55.5 150.82 11.32 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 178.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.077 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.293 3.3 t -137.16 134.63 47.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -174.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 4' ' ' ILE 0.285 0.1 OUTLIER -100.64 92.84 2.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.853 178.044 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.997 ' CE1' HD22 ' A' ' 30' ' ' LEU . 8.5 m-85 -63.13 119.46 9.59 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 119.363 -2.085 . . . . 0.0 105.906 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -79.28 -25.04 42.52 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -115.31 -163.39 0.88 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.555 0.693 . . . . 0.0 109.489 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 9' ' ' VAL . 26.4 t0 -106.45 160.78 15.14 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.909 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 10' ' ' LYS . 1.4 t -121.18 -158.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.554 ' H ' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -76.7 54.38 0.97 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.096 -1.003 . . . . 0.0 109.416 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.46 3.61 86.43 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.06 -37.67 10.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -1.225 . . . . 0.0 110.713 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 14' ' ' LYS . . . -121.03 164.18 14.33 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 5.8 mttp -134.61 173.78 11.29 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.508 -0.995 . . . . 0.0 109.596 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.598 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -43.11 134.04 3.68 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 110.95 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' CA ' ' O ' ' A' ' 5' ' ' PHE . . . 27.44 39.03 0.01 OUTLIER Glycine 0 N--CA 1.503 3.166 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -77.41 125.74 29.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.462 -1.611 . . . . 0.0 109.198 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.778 HG23 HG12 ' A' ' 4' ' ' ILE . 1.1 mp -100.55 116.79 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 122.899 1.333 . . . . 0.0 111.572 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.45 155.16 19.55 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.469 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 10.1 p30 -87.37 126.46 34.88 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 117.242 -1.783 . . . . 0.0 109.83 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 30' ' ' LEU 0.308 2.3 p -87.54 -144.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.208 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -73.86 112.09 9.65 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 174.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.532 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.4 OUTLIER -33.57 -30.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.665 -0.647 . . . . 0.0 111.753 -176.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.63 -36.99 4.63 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.208 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.291 0.1 OUTLIER -48.58 -58.37 4.8 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.223 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.845 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.01 -59.21 0.14 Allowed 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.1 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.749 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 4.1 t30 -86.81 -18.19 31.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.024 -1.047 . . . . 0.0 111.981 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.454 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 39.6 t30 -88.64 7.78 31.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.671 -1.268 . . . . 0.0 111.351 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.811 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.71 -77.51 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.941 -1.1 . . . . 0.0 110.715 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.997 HD22 ' CE1' ' A' ' 5' ' ' PHE . 25.7 mt -45.08 -47.95 11.9 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 122.678 1.228 . . . . 0.0 109.561 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.077 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.28 7.2 m-30 -75.85 -47.44 25.53 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.271 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -70.13 -6.11 31.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.52 -0.738 . . . . 0.0 111.489 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.603 ' HB2' ' CD1' ' A' ' 35' ' ' LEU . 8.3 mm-40 -121.42 -17.38 7.61 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.784 -1.166 . . . . 0.0 112.36 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.04 25.46 7.94 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.007 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.914 HD13 ' HA ' ' A' ' 30' ' ' LEU . 5.3 mp -93.19 -45.38 7.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.239 . . . . 0.0 108.126 177.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 30' ' ' LEU 0.258 . . -143.8 178.25 7.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.175 0.988 . . . . 0.0 111.994 -177.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' C ' ' CZ ' ' A' ' 31' ' ' PHE . 24.4 pt -132.08 166.86 27.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.596 ' O ' HG22 ' A' ' 40' ' ' THR . 2.4 tm-20 -64.98 115.3 5.25 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.334 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -49.53 107.07 0.13 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 117.865 -1.534 . . . . 0.0 110.626 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -118.96 156.12 52.36 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.305 -0.872 . . . . 0.0 109.973 179.077 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.538 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 43.2 Cg_endo -56.6 -57.69 1.29 Allowed 'Trans proline' 0 C--N 1.302 -1.898 0 O-C-N 123.92 1.484 . . . . 0.0 110.149 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.86 -54.05 0.93 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.609 -0.682 . . . . 0.0 110.431 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.615 ' HB2' HG23 ' A' ' 40' ' ' THR . 41.7 m-20 -73.84 -54.52 7.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.856 . . . . 0.0 110.638 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.772 HD11 HG21 ' A' ' 18' ' ' ILE . 1.5 mm? -44.92 -27.07 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.903 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -73.07 -49.46 28.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.58 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 49' ' ' ALA . . . -64.14 -42.01 96.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -0.788 . . . . 0.0 109.701 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -48.61 -51.16 29.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.562 -0.711 . . . . 0.0 110.103 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -52.72 -35.15 55.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.374 -0.829 . . . . 0.0 110.581 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -56.88 -44.61 82.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.838 . . . . 0.0 110.412 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -58.72 -53.86 53.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 110.091 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -60.8 -14.38 21.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.181 -0.95 . . . . 0.0 110.13 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.33 -149.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.914 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -57.93 -171.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.128 -0.983 . . . . 0.0 109.89 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.7 115.41 15.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 109.874 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.97 27.56 0.37 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.422 -0.798 . . . . 0.0 109.528 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.114 -179.699 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.616 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.795 0.331 . . . . 0.0 110.249 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -53.62 149.85 7.72 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.054 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.272 3.3 t -136.06 131.91 49.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 O-C-N 120.169 -1.582 . . . . 0.0 115.259 -176.064 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.855 HG12 HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -99.36 94.35 3.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.931 ' CE2' HD22 ' A' ' 30' ' ' LEU . 11.5 m-85 -67.82 127.02 31.28 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 120.034 -1.666 . . . . 0.0 107.218 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.634 HD11 ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER -77.97 -28.83 49.5 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.544 ' HA ' ' HD2' ' A' ' 15' ' ' LYS . 17.3 mtpt -115.81 -166.16 1.11 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.438 0.637 . . . . 0.0 109.833 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.88 143.55 48.86 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.464 -0.773 . . . . 0.0 110.902 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.657 HG23 ' HA3' ' A' ' 13' ' ' GLY . 5.7 t -97.63 149.17 5.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -74.38 63.46 1.05 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.84 -1.162 . . . . 0.0 110.595 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.42 -45.96 0.08 OUTLIER Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -151.55 -25.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.09 -1.241 . . . . 0.0 112.947 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.657 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . -63.16 160.97 34.47 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 120.579 -1.326 . . . . 0.0 110.224 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.532 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 3.9 mtpp -151.27 173.26 14.67 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.667 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -65.93 133.21 50.41 Favored 'General case' 0 C--N 1.289 -2.04 0 O-C-N 120.953 -1.092 . . . . 0.0 110.304 -178.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 38.38 27.66 0.05 OUTLIER Glycine 0 N--CA 1.5 2.916 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 1.1 pt-20 -60.68 125.69 24.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.66 -1.494 . . . . 0.0 109.218 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.855 HG23 HG12 ' A' ' 4' ' ' ILE . 1.1 mp -115.52 119.37 61.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.422 1.106 . . . . 0.0 111.142 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 16.8 tttt -161.79 -121.87 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.415 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 31.9 p-10 -152.02 120.8 6.54 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.957 HG22 ' CD2' ' A' ' 25' ' ' TYR 0.299 4.3 p -86.78 -144.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 178.393 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.209 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -74.34 111.01 9.1 Favored 'General case' 0 C--N 1.274 -2.711 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 174.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 1' ' ' MET . 1.7 m-20 -30.38 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.152 0.501 . . . . 0.0 111.415 -176.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -96.6 -36.86 4.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.209 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.3 0.1 OUTLIER -48.67 -55.25 11.84 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 177.115 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.781 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -30.88 -67.26 0.09 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.302 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -84.87 7.8 19.67 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.208 -0.933 . . . . 0.0 111.829 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 25' ' ' TYR . 3.6 t30 -115.7 4.3 14.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.573 -1.329 . . . . 0.0 111.246 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.871 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -161.01 -43.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.89 -1.131 . . . . 0.0 111.245 -178.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.934 HD11 HG21 ' A' ' 21' ' ' VAL . 12.4 mt -84.94 -32.78 22.89 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.369 -1.457 . . . . 0.0 110.088 -177.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.054 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.266 7.1 m-30 -84.59 -57.54 3.09 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.739 -178.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -7.24 8.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.096 -1.003 . . . . 0.0 110.883 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 2.6 mt-30 -113.89 -105.7 0.39 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.981 -1.074 . . . . 0.0 110.419 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.634 ' O ' HD11 ' A' ' 6' ' ' LEU . . . -159.07 27.57 0.39 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 2.6 mp -97.32 -49.48 4.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.032 -1.275 . . . . 0.0 110.023 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.722 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -144.23 -176.42 5.01 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 122.062 0.934 . . . . 0.0 112.827 -178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -143.81 137.17 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.742 ' O ' HG22 ' A' ' 40' ' ' THR . 6.5 pt-20 -38.85 116.96 0.62 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.178 0.513 . . . . 0.0 110.425 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.631 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . . . -54.8 125.02 18.4 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.601 -1.24 . . . . 0.0 110.786 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.751 ' C ' HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -144.12 149.43 45.33 Favored Pre-proline 0 N--CA 1.501 2.105 0 O-C-N 121.406 -0.809 . . . . 0.0 109.242 179.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.611 ' N ' HD12 ' A' ' 44' ' ' LEU . 43.4 Cg_endo -48.81 -56.69 2.93 Favored 'Trans proline' 0 C--N 1.298 -2.117 0 O-C-N 123.562 1.296 . . . . 0.0 109.994 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.1 -55.87 0.93 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.494 -0.754 . . . . 0.0 110.58 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.671 ' HB2' HG23 ' A' ' 40' ' ' THR . 1.5 m-20 -77.24 -51.38 11.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.196 -0.94 . . . . 0.0 110.873 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.834 ' CD2' HG21 ' A' ' 18' ' ' ILE . 12.0 mt -46.69 -29.12 1.73 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.967 -1.083 . . . . 0.0 108.428 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -79.34 -31.69 43.14 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' ASN . . . -65.87 -43.8 87.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.459 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 1.5 mm? -48.84 -47.0 42.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.378 -0.826 . . . . 0.0 109.067 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.97 -21.72 60.81 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.908 . . . . 0.0 109.375 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 46' ' ' ALA . . . -84.24 -41.89 16.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.787 . . . . 0.0 109.361 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.64 -34.13 64.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.47 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -36.84 81.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.89 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -48.88 -35.92 15.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 110.393 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.03 71.67 0.68 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.192 -0.943 . . . . 0.0 110.306 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.581 ' CG ' ' O ' ' A' ' 54' ' ' GLU . 4.3 pt-20 -75.62 107.2 7.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 109.542 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -140.64 19.37 2.35 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.104 -0.998 . . . . 0.0 109.579 -179.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 56' ' ' ARG . 4.5 tmm_? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.042 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.663 ' O ' HG23 ' A' ' 3' ' ' VAL . 2.0 ttt . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.863 0.363 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.628 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 12.5 mtpt -50.12 154.14 1.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.776 -1.203 . . . . 0.0 107.841 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.076 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.299 3.4 t -137.24 133.22 46.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -175.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.894 HG22 ' O ' ' A' ' 4' ' ' ILE 0.261 0.1 OUTLIER -98.04 91.67 2.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.83 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.999 ' CE2' HD22 ' A' ' 30' ' ' LEU . 15.5 m-85 -70.21 124.05 23.16 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 119.589 -1.944 . . . . 0.0 107.553 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.763 HD22 ' H ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -77.52 -28.24 51.95 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.652 -1.28 . . . . 0.0 108.32 179.258 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -116.86 -170.66 1.87 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.42 0.628 . . . . 0.0 109.349 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -107.5 155.09 20.46 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.054 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 10' ' ' LYS . 1.7 t -106.96 -157.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.812 -1.18 . . . . 0.0 109.833 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.672 ' H ' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -61.73 76.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.821 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 53.08 41.11 59.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -131.65 -83.73 0.51 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -1.126 . . . . 0.0 110.205 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.478 ' HA2' ' OE2' ' A' ' 17' ' ' GLU . . . -71.73 161.24 54.22 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 1.5 mttt -130.71 173.73 10.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.389 -1.065 . . . . 0.0 109.78 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -42.87 141.73 1.04 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 111.079 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 21.85 45.24 0.01 OUTLIER Glycine 0 N--CA 1.512 3.731 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.6 pt-20 -80.6 127.57 32.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.697 -1.472 . . . . 0.0 108.911 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.732 HG21 ' HG ' ' A' ' 44' ' ' LEU . 1.8 mp -106.91 121.13 59.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 111.222 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 22.4 tttt -161.54 -125.72 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 177.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -152.49 121.19 6.47 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.938 HG22 ' CD2' ' A' ' 25' ' ' TYR 0.303 4.2 p -87.33 -142.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 178.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.209 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -75.63 111.27 10.77 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 174.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 1' ' ' MET . 6.2 m-20 -31.66 -31.46 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.836 -0.54 . . . . 0.0 111.37 -176.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -96.31 -37.91 4.69 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.209 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.295 0.1 OUTLIER -48.58 -55.15 11.95 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 177.182 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.786 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -31.52 -66.22 0.12 Allowed 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.462 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.702 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -85.1 11.09 10.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.334 -0.853 . . . . 0.0 112.671 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 3.5 m-80 -123.92 10.43 8.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.07 -1.644 . . . . 0.0 110.946 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.861 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -161.33 -50.85 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.999 HD22 ' CE2' ' A' ' 5' ' ' PHE . 10.9 mt -79.55 -36.48 38.23 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.805 -1.184 . . . . 0.0 109.775 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.076 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.296 7.0 m-30 -85.3 -60.32 2.07 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.436 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -49.93 -21.65 1.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.76 -0.587 . . . . 0.0 111.801 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.566 ' CG ' ' N ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -114.33 -88.6 0.56 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.618 -1.301 . . . . 0.0 110.445 -179.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.566 ' N ' ' CG ' ' A' ' 33' ' ' GLN . . . -174.61 38.45 0.12 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.808 -1.663 . . . . 0.0 111.433 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 3.6 mp -104.58 -45.3 4.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.723 -1.457 . . . . 0.0 108.541 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.744 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -141.2 -176.92 4.88 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.125 0.964 . . . . 0.0 112.27 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.485 ' O ' ' C ' ' A' ' 38' ' ' GLU . 4.1 mt -143.43 135.92 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 31' ' ' PHE . 4.5 tt0 -39.49 115.04 0.47 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.384 -0.823 . . . . 0.0 109.813 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -48.34 102.21 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.356 -1.338 . . . . 0.0 109.865 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.678 HG23 ' HB2' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -113.01 149.08 40.74 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.721 . . . . 0.0 109.757 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.513 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 42.4 Cg_endo -49.19 -59.56 1.19 Allowed 'Trans proline' 0 C--N 1.297 -2.171 0 O-C-N 123.968 1.51 . . . . 0.0 109.858 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.13 -53.18 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.599 -0.688 . . . . 0.0 111.364 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.678 ' HB2' HG23 ' A' ' 40' ' ' THR . 2.2 m-20 -77.64 -44.26 28.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.96 -1.088 . . . . 0.0 111.657 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.732 ' HG ' HG21 ' A' ' 18' ' ' ILE . 4.6 mp -53.25 -39.78 64.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.085 . . . . 0.0 110.665 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 25.6 tptt -78.92 -39.46 34.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.981 -1.075 . . . . 0.0 109.214 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.72 77.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -0.79 . . . . 0.0 109.496 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -58.8 -29.77 67.11 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.446 -0.784 . . . . 0.0 109.368 179.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -81.93 -47.96 12.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 110.113 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.58 -41.7 61.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.134 -0.979 . . . . 0.0 110.141 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.63 -28.58 63.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.396 -0.815 . . . . 0.0 110.27 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.04 -46.18 8.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.273 -0.892 . . . . 0.0 111.013 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.68 90.47 5.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.105 -0.997 . . . . 0.0 111.36 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -99.74 -131.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 108.877 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.9 143.14 36.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.765 -1.209 . . . . 0.0 109.092 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.74 73.16 0.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 109.848 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.188 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.71 ' O ' HG23 ' A' ' 3' ' ' VAL . 7.2 tpt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 3.1 mttm -50.67 152.31 2.06 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.089 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.285 3.4 t -134.26 132.3 55.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 119.972 -1.705 . . . . 0.0 114.739 -176.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.786 HG22 ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -97.25 99.9 9.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.813 ' CE2' HD22 ' A' ' 30' ' ' LEU . 10.5 m-85 -77.11 127.25 32.32 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 119.983 -1.698 . . . . 0.0 107.318 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.94 HD11 HG22 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -77.01 -28.84 55.17 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 120.539 -1.35 . . . . 0.0 107.585 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.5 mppt? -113.47 -174.49 2.47 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.316 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 13' ' ' GLY . 6.3 p-10 -107.4 160.55 15.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 110.146 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 10' ' ' LYS . 0.9 OUTLIER -123.37 -174.73 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 109.867 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' H ' HG12 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -67.13 62.81 0.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 109.652 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 77.33 9.03 87.05 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' CE ' ' HA ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -94.45 -33.77 12.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -1.03 . . . . 0.0 110.558 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' ASP . . . -158.52 157.42 28.35 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 11.5 mmmt -123.28 178.83 4.95 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.438 -1.037 . . . . 0.0 111.115 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -42.35 137.67 1.96 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.259 -0.901 . . . . 0.0 111.722 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 22.29 45.6 0.01 OUTLIER Glycine 0 N--CA 1.509 3.526 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.636 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -82.16 125.66 31.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.948 -1.325 . . . . 0.0 109.547 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.033 HG21 HD11 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -105.5 122.56 59.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 120.436 -1.415 . . . . 0.0 110.086 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -160.79 -127.82 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 178.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.497 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 52.1 p-10 -151.88 122.1 7.22 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 122.713 1.244 . . . . 0.0 109.154 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.965 HG21 HD11 ' A' ' 30' ' ' LEU 0.301 3.9 p -86.89 -142.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 178.229 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.196 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -76.62 110.54 11.28 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 1' ' ' MET . 17.7 p-10 -29.67 -37.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.782 0.801 . . . . 0.0 111.045 -176.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -90.3 -40.02 5.87 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.196 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.299 0.1 OUTLIER -48.7 -56.34 8.84 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.683 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.77 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.97 -63.94 0.12 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.236 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.646 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 62.0 t30 -88.68 35.31 0.77 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 112.484 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 25' ' ' TYR . 0.9 OUTLIER -147.9 8.01 0.84 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.761 -1.212 . . . . 0.0 110.562 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.869 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -160.74 -47.24 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.247 -0.908 . . . . 0.0 109.225 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.965 HD11 HG21 ' A' ' 21' ' ' VAL . 10.8 mt -86.39 -35.33 19.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.918 -1.113 . . . . 0.0 110.135 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.089 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.271 8.9 m-30 -82.65 -57.59 3.26 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.501 -178.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HD2' ' HG2' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -69.63 -1.35 8.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.992 -1.068 . . . . 0.0 111.35 -178.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.558 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 23.8 mt-30 -116.72 -92.13 0.53 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.914 -1.116 . . . . 0.0 110.525 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.46 23.67 0.07 OUTLIER Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.03 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.691 ' O ' HD22 ' A' ' 6' ' ' LEU . 2.6 mp -95.59 -50.18 5.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.773 -1.428 . . . . 0.0 109.294 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.723 ' HB3' ' CB ' ' A' ' 30' ' ' LEU . . . -139.55 -179.54 5.96 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.926 0.869 . . . . 0.0 111.444 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.94 HG22 HD11 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -140.79 160.06 23.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.609 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 18.2 mp0 -48.94 115.65 1.36 Allowed 'General case' 0 C--N 1.293 -1.87 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.642 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -66.99 60.64 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 118.276 -1.369 . . . . 0.0 109.657 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.654 HG23 ' HD2' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -88.85 164.69 30.53 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.222 -0.923 . . . . 0.0 109.343 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.654 ' HD2' HG23 ' A' ' 40' ' ' THR . 49.4 Cg_endo -49.05 -62.38 0.44 Allowed 'Trans proline' 0 C--N 1.299 -2.069 0 O-C-N 123.909 1.478 . . . . 0.0 109.768 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.56 -54.78 0.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.673 -0.642 . . . . 0.0 111.173 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.517 ' ND2' ' CG1' ' A' ' 37' ' ' ILE . 83.6 m-20 -71.23 -43.49 67.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.015 . . . . 0.0 110.512 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.033 HD11 HG21 ' A' ' 18' ' ' ILE . 2.7 mm? -58.02 -61.72 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.924 . . . . 0.0 109.632 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -48.35 -47.12 37.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 0.0 109.643 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -63.98 -37.8 88.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.502 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.633 HD23 ' CD1' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -48.7 -64.67 0.73 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.529 -0.732 . . . . 0.0 109.139 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.82 -25.2 60.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.318 -0.864 . . . . 0.0 109.0 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 46' ' ' ALA . . . -75.55 -45.0 40.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 0.0 109.539 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.92 -15.11 54.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.996 -1.065 . . . . 0.0 108.915 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -89.25 -14.35 36.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.555 -0.716 . . . . 0.0 110.056 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 1.7 mp0 -61.98 -170.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.11 -0.994 . . . . 0.0 110.175 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' C ' ' HG2' ' A' ' 54' ' ' GLU . 3.2 tptp -138.15 31.57 2.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.857 . . . . 0.0 110.369 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' HG2' ' C ' ' A' ' 53' ' ' LYS . 6.3 mm-40 -127.64 40.17 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 0.0 110.24 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 15.6 tp60 -150.64 44.06 0.84 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.035 -0.984 . . . . 0.0 110.086 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.638 ' O ' HG23 ' A' ' 3' ' ' VAL . 2.2 ttt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.893 0.378 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.578 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 7.9 mmtt -55.38 148.8 14.32 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.131 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.297 3.0 t -132.92 133.32 58.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.268 -1.52 . . . . 0.0 114.921 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.85 HG22 ' O ' ' A' ' 4' ' ' ILE 0.267 0.1 OUTLIER -98.58 91.64 2.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.56 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.049 ' CE1' HD22 ' A' ' 30' ' ' LEU . 11.8 m-85 -66.42 118.51 10.17 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 119.393 -2.067 . . . . 0.0 105.863 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -78.98 -20.22 49.68 Favored 'General case' 0 C--N 1.287 -2.149 0 O-C-N 121.445 -0.784 . . . . 0.0 109.175 -178.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.52 ' HD2' ' O ' ' A' ' 34' ' ' GLY . 21.2 mttt -121.97 -164.58 1.17 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 13' ' ' GLY . 44.8 t0 -96.92 167.01 11.34 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.333 -0.854 . . . . 0.0 110.299 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.593 HG21 ' CE1' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -139.71 167.75 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.523 -0.736 . . . . 0.0 109.034 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -54.09 85.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.981 -1.074 . . . . 0.0 110.494 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 44.36 48.66 8.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -146.72 -32.83 0.31 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.068 -1.254 . . . . 0.0 110.918 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.457 ' HA2' ' OE1' ' A' ' 17' ' ' GLU . . . -135.7 162.17 24.88 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.538 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 16.6 mtmm -136.74 -174.08 3.61 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.297 -1.119 . . . . 0.0 110.004 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.621 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -51.61 131.36 29.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 110.258 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 29.79 39.88 0.03 OUTLIER Glycine 0 N--CA 1.504 3.168 0 O-C-N 121.762 -0.586 . . . . 0.0 111.889 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -78.05 127.53 32.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.409 -1.642 . . . . 0.0 109.096 178.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.979 HG21 ' HG ' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -104.61 126.59 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 122.051 0.929 . . . . 0.0 111.923 -178.348 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER -161.4 -130.93 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 2.4 p-10 -151.68 118.3 5.72 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.985 HG21 HD11 ' A' ' 30' ' ' LEU 0.307 5.0 p -86.88 -144.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.273 -2.731 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.201 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -73.07 111.27 8.02 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 1' ' ' MET . 1.6 m-20 -32.05 -30.33 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.96 -0.462 . . . . 0.0 111.47 -176.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.81 -37.57 4.41 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.201 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.307 0.1 OUTLIER -48.58 -55.62 10.65 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 177.384 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.775 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.57 -64.48 0.11 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.76 178.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 17.8 t30 -88.5 52.92 2.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 111.03 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.94 -32.35 0.07 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.262 -0.899 . . . . 0.0 110.862 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.83 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -126.92 -37.89 2.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.303 -0.873 . . . . 0.0 109.743 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.049 HD22 ' CE1' ' A' ' 5' ' ' PHE . 11.9 mt -90.64 -35.42 14.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.433 -1.417 . . . . 0.0 110.161 -177.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.131 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.278 8.5 m-30 -84.36 -51.65 6.8 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.774 -178.373 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -68.19 -3.46 10.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.025 -1.047 . . . . 0.0 110.814 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 1.7 mt-30 -118.84 -102.22 0.42 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 110.335 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' HD2' ' A' ' 7' ' ' LYS . . . -160.67 17.33 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.468 -1.348 . . . . 0.0 110.673 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.674 ' HB2' ' HA ' ' A' ' 30' ' ' LEU . 3.0 mp -84.24 -51.33 7.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.659 -1.495 . . . . 0.0 109.547 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.89 ' HA ' HD23 ' A' ' 6' ' ' LEU . . . -142.22 -178.68 5.84 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.179 0.99 . . . . 0.0 112.841 -177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.523 ' C ' ' CE1' ' A' ' 31' ' ' PHE . 2.4 pt -140.04 161.62 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.636 ' O ' HG22 ' A' ' 40' ' ' THR . 2.4 pt-20 -51.06 108.88 0.27 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.313 -0.867 . . . . 0.0 111.15 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.578 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -49.94 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 117.823 -1.551 . . . . 0.0 109.564 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -107.51 148.54 37.41 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.898 -1.126 . . . . 0.0 110.223 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.543 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 43.8 Cg_endo -49.1 -58.58 1.67 Allowed 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.753 1.396 . . . . 0.0 109.872 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.01 -51.18 0.92 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 110.379 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 5.0 t-20 -77.12 -54.69 6.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -0.999 . . . . 0.0 110.853 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.979 ' HG ' HG21 ' A' ' 18' ' ' ILE . 7.3 mp -45.75 -51.82 12.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 0.0 110.296 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -20.53 65.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 109.749 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 43' ' ' ASN . . . -84.06 -43.78 14.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.417 -0.802 . . . . 0.0 110.617 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.501 ' HG ' HD11 ' A' ' 18' ' ' ILE . 2.8 mm? -42.16 -49.34 4.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 109.835 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -54.01 -60.07 3.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 0.0 110.233 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.02 -40.2 6.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.333 -0.854 . . . . 0.0 110.643 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -27.7 69.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 110.622 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -85.96 -26.48 25.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.246 -0.909 . . . . 0.0 110.385 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.86 134.59 35.09 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 110.721 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.4 120.47 18.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.523 -0.736 . . . . 0.0 110.05 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.36 126.77 9.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -0.929 . . . . 0.0 110.706 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.26 -41.39 0.15 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.833 0.825 . . . . 0.0 108.861 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.462 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.018 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.63 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 120.606 0.241 . . . . 0.0 110.444 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.612 ' CA ' ' O ' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -50.79 156.21 1.0 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.208 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.086 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.311 3.6 t -134.43 134.47 54.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 O-C-N 119.961 -1.712 . . . . 0.0 114.924 -174.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.723 HG12 HG23 ' A' ' 18' ' ' ILE 0.255 0.0 OUTLIER -96.98 108.01 20.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.15 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.081 ' CD1' ' HB2' ' A' ' 36' ' ' ALA . 2.0 m-85 -86.58 125.33 33.72 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.631 -1.293 . . . . 0.0 107.766 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.873 HD13 ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -82.1 -28.09 32.49 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 120.808 -1.182 . . . . 0.0 112.844 -178.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.656 ' O ' ' O ' ' A' ' 13' ' ' GLY . 3.0 mttp -108.98 -142.86 0.38 Allowed 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 118.976 -1.089 . . . . 0.0 113.16 -176.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.826 ' C ' ' O ' ' A' ' 13' ' ' GLY . 5.4 t70 -96.73 154.21 17.42 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.03 -1.043 . . . . 0.0 108.347 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.948 ' HA ' ' H ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -85.96 -5.31 9.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.57 -1.331 . . . . 0.0 114.431 -173.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' NZ ' ' HA ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -72.77 57.24 0.42 Allowed 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 100.96 19.47 17.02 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 2.9 mtpp -151.03 -18.97 0.21 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.566 -1.55 . . . . 0.0 112.64 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.948 ' H ' ' HA ' ' A' ' 9' ' ' VAL . . . 101.5 159.64 26.96 Favored Glycine 0 C--O 1.175 -3.574 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.537 ' HB2' ' CD ' ' A' ' 17' ' ' GLU . 17.7 mttp -87.56 146.33 25.82 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 121.121 2.461 . . . . 0.0 109.565 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.608 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -29.81 122.03 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.65 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 16.23 51.69 0.01 OUTLIER Glycine 1 N--CA 1.516 4.032 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -177.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.594 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -86.72 124.67 33.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.966 -1.314 . . . . 0.0 109.627 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.077 HG21 ' CD2' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -105.84 123.5 60.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.729 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.612 ' O ' ' CA ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -160.96 -129.94 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 178.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.45 ' HB3' ' HG3' ' A' ' 2' ' ' LYS . 13.3 p-10 -151.67 119.95 6.36 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 120.676 -1.265 . . . . 0.0 109.702 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.996 HG21 HD11 ' A' ' 30' ' ' LEU 0.299 4.4 p -87.07 -142.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.208 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -75.65 110.87 10.41 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 174.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 1' ' ' MET . 1.4 m-20 -32.72 -30.13 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.942 -0.474 . . . . 0.0 111.82 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -97.61 -37.84 4.38 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.208 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.299 0.1 OUTLIER -48.9 -56.13 9.71 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.232 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.755 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -28.75 -58.49 0.13 Allowed 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.136 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.58 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 11.6 p30 -90.4 15.11 11.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.862 -1.149 . . . . 0.0 112.629 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -125.74 9.35 7.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.339 -1.475 . . . . 0.0 110.625 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.808 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -159.93 -53.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 109.832 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.996 HD11 HG21 ' A' ' 21' ' ' VAL . 18.7 mt -76.43 -39.26 53.96 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 122.358 1.075 . . . . 0.0 110.577 -176.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.086 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.256 2.6 m-30 -81.46 -68.85 0.66 Allowed 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.315 -178.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -50.29 -16.36 0.32 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.728 -0.608 . . . . 0.0 112.139 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 33.1 mm-40 -106.39 -90.06 0.43 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.615 -1.303 . . . . 0.0 111.229 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.794 ' H ' HD12 ' A' ' 35' ' ' LEU . . . -175.41 39.53 0.11 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.429 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.937 HD13 ' HA ' ' A' ' 30' ' ' LEU . 4.2 mp -109.5 -50.15 3.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.144 -1.21 . . . . 0.0 109.517 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.081 ' HB2' ' CD1' ' A' ' 5' ' ' PHE 0.265 . . -144.31 -166.16 2.31 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.402 1.096 . . . . 0.0 112.057 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.579 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 3.5 pt -146.28 173.07 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.136 175.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.665 ' O ' HG22 ' A' ' 40' ' ' THR . 8.0 pt-20 -66.8 112.49 4.28 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.134 -0.978 . . . . 0.0 110.096 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.609 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . . . -51.76 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 117.835 -1.546 . . . . 0.0 109.764 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -108.84 148.73 38.42 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.094 -1.004 . . . . 0.0 109.963 179.318 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.521 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 45.2 Cg_endo -49.73 -50.03 14.28 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 O-C-N 123.971 1.511 . . . . 0.0 108.774 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -36.77 -46.03 0.58 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.286 0.565 . . . . 0.0 110.211 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -91.36 -46.53 7.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.921 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.077 ' CD2' HG21 ' A' ' 18' ' ' ILE . 2.5 mm? -39.2 -37.77 0.44 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.155 -0.965 . . . . 0.0 110.974 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.51 -29.7 33.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.06 -1.025 . . . . 0.0 109.944 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . . . -75.92 -34.4 59.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.465 -0.772 . . . . 0.0 110.152 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.512 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 2.2 mm? -51.76 -23.62 4.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.464 -0.773 . . . . 0.0 110.957 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.61 -33.95 41.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.974 -1.079 . . . . 0.0 110.068 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.78 26.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.063 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -45.35 -26.94 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.63 -63.72 1.24 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -66.91 95.88 0.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.328 -0.857 . . . . 0.0 110.451 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -82.74 126.91 32.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.281 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -115.65 -39.79 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.738 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -152.08 35.37 0.53 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.903 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.098 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.876 ' HE1' ' HB2' ' A' ' 27' ' ' ASN . 2.1 ttt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.677 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 10.1 mtmm -51.3 152.63 2.39 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.098 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.271 3.3 t -133.21 130.77 58.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 119.991 -1.693 . . . . 0.0 114.532 -176.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.784 HG22 ' O ' ' A' ' 4' ' ' ILE 0.257 0.0 OUTLIER -98.65 102.5 13.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.461 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.04 ' CE1' HD22 ' A' ' 30' ' ' LEU . 11.4 m-85 -78.58 125.93 30.04 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 117.204 -1.798 . . . . 0.0 106.915 177.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.922 HD13 ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -78.21 -29.62 48.44 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.278 -1.514 . . . . 0.0 107.725 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -116.36 179.99 3.84 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.843 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 2.8 p30 -89.23 141.68 28.32 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.602 HG22 ' CD1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -97.92 -167.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.263 -0.898 . . . . 0.0 109.929 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.511 ' H ' HG12 ' A' ' 9' ' ' VAL . 3.2 tttm -75.32 62.63 1.31 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.56 17.37 79.04 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 3.7 mttp -108.2 -41.17 4.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.207 -1.172 . . . . 0.0 110.4 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.508 ' HA2' ' CD ' ' A' ' 17' ' ' GLU . . . -135.32 171.86 22.37 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 15' ' ' LYS . 7.9 mtpt -140.41 177.12 8.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.171 -1.194 . . . . 0.0 109.737 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -34.33 135.06 0.17 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.618 -0.676 . . . . 0.0 111.261 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 21.36 45.06 0.01 OUTLIER Glycine 0 N--CA 1.512 3.72 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -81.36 125.16 30.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.51 -1.582 . . . . 0.0 109.246 179.274 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.924 HG21 ' HG ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -106.4 124.98 62.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 122.219 1.009 . . . . 0.0 110.062 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -159.89 -130.28 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 179.254 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 40.6 p30 -151.76 119.39 6.09 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.957 HG21 HD11 ' A' ' 30' ' ' LEU 0.303 3.7 p -86.62 -145.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.192 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -71.68 110.1 6.02 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 174.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 22' ' ' ALA . 1.1 m-20 -30.8 -30.48 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 122.093 -0.379 . . . . 0.0 111.607 -176.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -99.36 -36.95 4.19 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.192 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.289 0.0 OUTLIER -48.25 -54.52 13.33 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 177.139 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.8 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.89 -63.57 0.13 Allowed 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.259 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.876 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 52.4 t30 -86.7 29.83 0.77 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.267 -0.896 . . . . 0.0 112.409 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 25' ' ' TYR . 3.2 t-20 -133.78 -21.64 1.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.727 -1.233 . . . . 0.0 111.103 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.788 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -135.68 -43.09 0.68 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -0.952 . . . . 0.0 110.525 -178.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.04 HD22 ' CE1' ' A' ' 5' ' ' PHE . 15.0 mt -83.05 -37.36 23.99 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.871 -1.143 . . . . 0.0 109.871 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.098 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.277 7.0 m-30 -85.49 -53.05 5.43 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.825 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -64.27 -4.04 3.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.474 -0.766 . . . . 0.0 111.565 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 17.3 mt-30 -124.61 -103.08 0.37 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.741 -1.224 . . . . 0.0 110.642 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.567 ' H ' HD12 ' A' ' 35' ' ' LEU . . . -159.63 46.55 0.42 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.648 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.855 HD13 ' HA ' ' A' ' 30' ' ' LEU . 3.0 mp -117.47 -48.01 2.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.986 -1.302 . . . . 0.0 109.898 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -144.03 -177.51 5.48 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.132 0.967 . . . . 0.0 112.118 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.659 HG23 HD11 ' A' ' 6' ' ' LEU . 4.0 pt -139.21 168.2 19.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.613 ' O ' HG22 ' A' ' 40' ' ' THR . 3.8 pt-20 -58.28 107.97 0.55 Allowed 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.5 -0.75 . . . . 0.0 109.561 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.677 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . . . -59.25 93.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 118.167 -1.413 . . . . 0.0 110.499 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -105.28 153.05 39.9 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.219 -0.925 . . . . 0.0 109.746 178.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 43.3 Cg_endo -53.28 -55.16 3.89 Favored 'Trans proline' 0 C--N 1.296 -2.2 0 O-C-N 124.057 1.556 . . . . 0.0 109.573 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.19 -51.09 1.0 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.709 -0.619 . . . . 0.0 110.837 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.572 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 70.0 m-20 -83.27 -47.96 10.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.237 -0.914 . . . . 0.0 111.066 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.924 ' HG ' HG21 ' A' ' 18' ' ' ILE . 5.1 mp -47.86 -45.48 30.32 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 110.376 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -30.09 61.15 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.007 -1.058 . . . . 0.0 108.949 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 43' ' ' ASN . . . -71.64 -42.37 67.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 109.347 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 1.2 mm? -55.08 -42.71 73.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.515 -0.741 . . . . 0.0 109.353 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 51' ' ' LYS . 21.5 tt0 -45.45 -43.56 11.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.366 -0.834 . . . . 0.0 109.534 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 52' ' ' GLN . . . -43.4 -40.59 3.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.272 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 2.4 tp-100 -67.33 -39.56 85.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 52.3 mmtt -90.91 12.32 19.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.557 -0.714 . . . . 0.0 110.139 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 15.1 tt0 -43.13 -66.33 0.39 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -85.82 95.69 9.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.216 -0.927 . . . . 0.0 110.205 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 32.3 mt-10 -93.11 -107.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.915 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.05 19.46 0.77 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 109.478 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.203 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.667 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.619 0.247 . . . . 0.0 110.425 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -50.08 151.63 1.92 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.046 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.042 HG22 ' CZ ' ' A' ' 31' ' ' PHE 0.288 3.0 t -133.11 133.85 58.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 119.88 -1.762 . . . . 0.0 114.874 -175.587 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.87 HG22 ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -98.13 89.95 2.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.038 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.014 ' CE1' HD22 ' A' ' 30' ' ' LEU . 10.0 m-85 -62.35 122.64 16.18 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 116.672 -2.011 . . . . 0.0 105.838 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.567 HD23 ' CA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -78.72 -22.13 47.03 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.136 -178.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -132.14 176.57 8.28 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.524 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.66 144.9 34.96 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.737 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 5' ' ' PHE . 1.1 t -106.16 -170.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 109.489 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.527 ' H ' HG12 ' A' ' 9' ' ' VAL . 18.7 mttt -70.24 67.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 110.104 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 69.55 39.36 79.09 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.35 -55.16 0.8 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -1.121 . . . . 0.0 110.877 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.438 ' CA ' HG23 ' A' ' 9' ' ' VAL . . . -117.96 167.78 12.93 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.253 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.499 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 4.4 mttt -128.65 167.66 16.88 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.384 -1.068 . . . . 0.0 109.205 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' N ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -41.84 142.73 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.964 . . . . 0.0 111.375 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 5' ' ' PHE . . . 25.64 39.7 0.01 OUTLIER Glycine 0 N--CA 1.502 3.061 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -83.37 121.85 27.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.586 -1.538 . . . . 0.0 108.64 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.985 HG21 HD11 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -100.33 125.24 54.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.308 1.051 . . . . 0.0 110.503 -178.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 2' ' ' LYS . 3.8 ttpp -161.22 -129.98 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -151.95 117.98 5.52 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.275 1.035 . . . . 0.0 108.913 175.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.037 HG21 HD11 ' A' ' 30' ' ' LEU 0.302 4.1 p -87.34 -146.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 177.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.215 ' HB3' ' CB ' ' A' ' 25' ' ' TYR . . . -72.31 110.16 6.55 Favored 'General case' 0 C--N 1.273 -2.759 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 1' ' ' MET . 3.0 p30 -29.34 -36.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.655 0.741 . . . . 0.0 111.122 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -92.26 -38.73 5.58 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 1.215 ' CB ' ' HB3' ' A' ' 22' ' ' ALA 0.287 0.1 OUTLIER -48.25 -55.21 11.11 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.396 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.742 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -29.46 -64.34 0.11 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.547 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.645 ' HA ' ' HB2' ' A' ' 31' ' ' PHE . 24.0 t30 -89.71 53.91 2.71 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.105 -0.997 . . . . 0.0 110.678 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.5 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 t-20 -154.89 -31.32 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.419 -0.8 . . . . 0.0 110.2 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.829 ' CD2' ' CE1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -130.69 -42.81 1.13 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.335 -0.853 . . . . 0.0 109.849 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.037 HD11 HG21 ' A' ' 21' ' ' VAL . 14.4 mt -81.73 -39.08 24.74 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.613 -1.305 . . . . 0.0 109.868 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 1.042 ' CZ ' HG22 ' A' ' 3' ' ' VAL 0.275 7.2 m-30 -83.06 -51.93 7.1 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.353 -178.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HG3' ' HA ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -62.84 -7.46 5.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.358 -0.839 . . . . 0.0 111.363 -178.633 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 11.8 mt-30 -120.02 -93.78 0.51 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.887 -1.133 . . . . 0.0 110.658 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.672 ' H ' HD12 ' A' ' 35' ' ' LEU . . . -172.03 41.86 0.17 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.173 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.888 HD13 ' HA ' ' A' ' 30' ' ' LEU . 3.9 mp -109.78 -47.76 3.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.091 -1.241 . . . . 0.0 109.873 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.672 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -142.29 178.4 7.6 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.788 0.804 . . . . 0.0 112.423 -177.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.666 HD12 HD22 ' A' ' 43' ' ' ASN . 13.1 pt -131.67 163.69 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.721 ' O ' HG22 ' A' ' 40' ' ' THR . 56.1 tt0 -61.47 115.32 3.8 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.401 -0.812 . . . . 0.0 109.659 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . . . -57.2 82.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.58 -1.248 . . . . 0.0 110.784 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.721 HG22 ' O ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -99.96 146.83 32.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.061 -1.024 . . . . 0.0 109.014 178.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.488 ' HD2' ' OG1' ' A' ' 40' ' ' THR . 45.0 Cg_endo -49.14 -51.74 10.05 Favored 'Trans proline' 0 C--N 1.293 -2.384 0 O-C-N 124.061 1.559 . . . . 0.0 108.808 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -37.06 -59.28 0.73 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.694 -0.629 . . . . 0.0 110.464 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.666 HD22 HD12 ' A' ' 37' ' ' ILE . 2.3 m120 -72.71 -49.33 31.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.52 -0.737 . . . . 0.0 111.051 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.985 HD11 HG21 ' A' ' 18' ' ' ILE . 2.5 mm? -40.68 -36.96 0.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -77.38 -31.01 53.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 109.131 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 43' ' ' ASN . . . -61.58 -38.73 88.63 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 108.797 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -44.45 -24.27 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.477 -0.765 . . . . 0.0 109.409 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -71.87 -35.98 69.95 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.156 -0.965 . . . . 0.0 109.069 179.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' HG2' ' A' ' 52' ' ' GLN . . . -48.93 -40.03 28.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.981 . . . . 0.0 108.776 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -52.48 -20.57 2.99 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.119 -0.988 . . . . 0.0 109.589 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 48' ' ' GLU . 1.4 tttm -90.33 -27.72 19.2 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.422 -0.798 . . . . 0.0 111.116 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -71.59 158.71 35.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.698 -1.252 . . . . 0.0 110.634 -179.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -102.59 -159.97 0.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.669 -0.645 . . . . 0.0 110.624 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.58 -70.58 0.15 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.328 -0.858 . . . . 0.0 110.951 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.32 41.52 1.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.205 -0.934 . . . . 0.0 109.994 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.243 -179.555 . . . . . . . . 0 0 . 1 stop_ save_